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ABSTRACT 
Currently, older people predominantly begin treatment on haemodialysis (HD), with the proportion 
of people starting on peritoneal dialysis (PD) steadily declining over recent years despite survival and 
some quality of life (QOL) indicators appearing similar between those on PD and HD.   
 
This thesis explores whether PD is under-utilised by older people in the UK through three cross-
sectional, multicentre studies focusing on QOL and the modality decision making process.   
 
The first study aims to extend knowledge of HD and PD QOL outcomes.  Seventy older patients on 
PD were matched to patients on HD by age, sex, time on dialysis, ethnicity and index of deprivation.  
QOL assessments included the SF-12 and Illness Intrusiveness Ratings Scale.  Regression analyses, 
adjusted for multiple variables including comorbidities, found that patients on PD experienced less 
illness and treatment intrusion than those on HD, with other QOL outcomes found to be similar 
between the two groups.   
 
The second study investigates the involvement that 65 older patients, new to HD, had in their 
modality selection.  Data was collected using a questionnaire designed for the purpose.  Only 52% of 
the sample perceived having had some involvement in their modality decision and 33% expressed a 
preference for greater involvement than that experienced.   
 
In the final study, experiences of modality decision making and life on dialysis were explored 
through qualitative analysis of narratives from 30 older patients on HD and PD.  Findings 
demonstrate that decisions are influenced by patients’ prior experiences, as well as their medical 
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and social context.  Quality of education can impact on modality selection and the integration of 
dialysis into patients’ lives. 
 
In conclusion, a lack of involvement in modality selection can have a detrimental impact on older 
patients’ QOL.  Healthcare professionals should, therefore, strive to implement effective shared 
decision making in the selection of a dialysis modality.    
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PREFACE 
This preface provides the background to the origins of this thesis from a funding perspective as well 
as an overview of the people involved.  I discuss how my experiences prior to being involved in the 
study contributed to my interest in exploring the patient experience.  Finally, I conclude with a 
comment on the applicability of the findings to dialysis populations outside of the UK.  
 
The financial support originated from Baxter Healthcare, a large global organisation that provides 
and invests in technologies and services related to the blood and circulatory system, including renal 
conditions.  Baxter Healthcare is the leading provider within the UK for peritoneal dialysis (PD) 
related products, as well as services that facilitate supporting patients in managing the PD system.  
Baxter also provides haemodialysis (HD) products and currently manages seven HD centres within 
the UK, although they are not the market leaders in this field.   
 
In 2006, Baxter Healthcare donated £180,000 to the charity Kidney Research UK (KRUK) for the 
purpose of funding research in the elderly, with the aim of improving access to PD within this 
population.  Their interest in older people is likely to be due to the steady reduction in the use of PD 
within the UK over recent years.  KRUK invited nationwide applications for research projects and 
awarded the funding based on their rigorous peer review process.  Baxter Healthcare had no input 
into the design and conduct of the study throughout the duration of the funding, thereby promoting 
objectivity within the research.     
 
This funding partnership between KRUK and Baxter Healthcare was supported by the British Renal 
Society (a charity involved in education and training, planning for improvements in renal services 
and promotion of multi-professional research) and the Renal Association (the professional body for 
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renal physicians and scientists within the UK) and both bodies invited presentation updates at their 
yearly conferences.   
 
In 2007, the funding was awarded to Prof. Edwina Brown (my principal supervisor) and a co-
investigator team.  I was subsequently employed as the researcher.  The team was composed of 
health professionals located within three different renal units (Imperial Renal and Transplant Centre, 
St Helier Renal unit and Lister Renal unit) or those with ties to Imperial College London, the sponsors 
for this research.  The team is listed under “Statement of work”.  The team expanded over time and 
included Dr. Mary Hickson, who is also my second supervisor.  Dr. Glenn Smith was added as a co-
investigator for the third and final study as the expert on qualitative research.     
 
The Imperial Renal and Transplant Centre and Lister renal unit in Stevenage had already collaborated 
together on a study ten years previously, investigating the quality of life and survival in older people 
on dialysis.  St Helier renal unit was recruited due to its geographic proximity to the other units, yet 
is located outside of London.   
 
My background and perspectives 
I have worked as a renal dietitian within three different renal units (including Imperial Renal and 
Transplant centre and St Helier Hospital) for seven years prior to undertaking this programme of 
research as part of a PhD.   
 
Two years prior to the study commencing, two renal units merged together to form the much larger 
Imperial Renal and Transplant Centre.  I detected a change to patient care, particularly in relation to 
the shift in the spread of patients on the different dialysis modalities, with a decline in the numbers 
of people on PD.  These numbers are reflected in the renal registry reports which show a drop in the 
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number of patients on PD at the new Imperial Renal unit from 147 in 2005 to 67 in 2007 (Farrington 
et al. 2006; Farrington et al. 2008).  The drop in the numbers of patients on PD raised the issue of 
whether patients were being provided with a true choice of modality.  I also encountered a few 
patients who were not aware of their modality options and who lacked basic knowledge about their 
renal condition and the dialysis treatment itself.  It is possible that these experiences were present 
prior to the merger of the two renal units but the observations gained added meaning in view of the 
prevailing context.    These anecdotal observations made me consider the reasons behind this 
apparent lack of modality choice and also stimulated an interest within me in the patient experience.   
 
The applicability of the findings 
All the studies within this body of work involve older patients treated by a health care system that is, 
by and large, not limited by resource issues in its delivery of dialysis treatments.  Therefore, older 
people are not denied access to dialysis and, in theory, are offered the choice of alternative 
modalities.  The findings presented, therefore, may not apply to populations where dialysis is not as 
extensively provided or available.    
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CHAPTER 1 
1 END STAGE RENAL DISEASE AND AGING 
 
“For several reasons, biology is not a good friend of old age.” 
Paul B. Baltes. 1993. The Gerontologist, 33, (5) 580 
 
This thesis explores the older person’s journey onto different dialysis treatments and the resulting 
quality of life.  This chapter introduces the topic by providing an overview of end stage renal disease 
(ESRD) and the dialysis modalities of peritoneal dialysis (PD) and haemodialysis (HD).  It also 
introduces the biological and psychological aspects of normal aging and applies these to older 
people on dialysis.   
 
The first section (1.1) provides the reader with an outline of ESRD, as well as an introduction to the 
different forms of dialysis.  It also explores the history of the development and the novelty of renal 
dialysis as a treatment for older people.  The prevalence rates of older people on PD and HD in the 
UK (United Kingdom) are compared over recent years and reasons for the emerging patterns of the 
predominance of HD over PD are explored.  The pattern of distribution, however, remains 
unexplained.   
 
The second section (1.2) describes the aging population in relation to its extending longevity and the 
accompanying development of chronic illness, with a focus on chronic kidney disease (CKD).  The 
process of physiological and cognitive aging is described and related to the observed processes in 
older people with renal disease who are treated with dialysis.  The findings described appear to 
suggest that dialysis exacerbates several features of aging.  This also applies to the presence of 
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depression, which is also found to be more prevalent in those on dialysis compared to the general 
population.   
 
1.1  AN OVERVIEW OF END STAGE RENAL DISEASE 
ESRD is characterised by an irreversible decline in kidney function where renal replacement 
therapies (transplantation or dialysis) are required for survival.  The reduction in renal function leads 
to the retention of metabolic end-products (e.g. urea, uric acid and creatinine) and the development 
of uraemia, as well as hormonal and metabolic derangements.   The renal excretory function is 
measured by the glomerular filtration rate (GFR) which refers to the renal clearance of specific 
substances from the plasma into the urine within a specified period of time (Mohanram and Toto 
2005).  An average value is approximately 120-130 mL/min/1.73 m2 for a young healthy adult 
(normalised to an average adult surface area of 1.73m2 to allow for comparison between people of 
different body sizes).  GFR tends to be eight percent higher in men than in women and it declines 
with age by approximately 1 mL/min/1.73 m2 per year after the age of 20-30 years (National Kidney 
Foundation 2002).    
 
There are several methods available to determine GFR.  One can either assess the renal or plasma 
clearance of exogenous marker substances such as inulin and chromium ethylenediamine tetra-
acetic acid, or through endogenous clearance markers such as serum creatinine and blood urea 
nitrogen.  Each of these methods has their advantages and disadvantages which are described in 
greater detail by Mohanram & Toto (Mohanram & Toto 2005).  Practical and cost-effective 
estimations of GFR (eGFR) are possible through mathematical equations.  The two most commonly 
used are the Cockcroft-Gault (Cockcroft and Gault 1976) and the Modification of Diet in Renal 
Disease (MDRD) equations (Levey et al. 1999).  Both require serum creatinine to be in a steady state.  
The Cockcroft-Gault equation inputs the patients’ age, body weight, gender and serum creatinine 
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levels in mg/dL, whilst the MDRD equation does not require body weight but includes ethnic origin.  
The MDRD equation is the most widely used equation in clinical situations as it does not require 
knowledge of body weight and it has been derived and validated in a large sample, including those 
from different ethnic backgrounds (National Kidney Foundation 2002). 
 
Most of the participants who participated in the studies contained within this thesis would have had 
CKD prior to developing ESRD.  CKD is characterised by a decline in renal function over a period of 
time and is defined by two criteria.  The first criteria is the presence of kidney damage as defined by 
“structural or functional abnormalities of the kidney, with or without decreased GFR manifest by 
either pathological abnormalities or markers of kidney damage, including abnormalities in the 
composition of the blood or urine, or abnormalities in imaging tests” (National Kidney Foundation 
2002).  The second criteria is the presence of a GFR of <60 mL/min/1.73 m2 for ≥ three months, with 
or without kidney damage (National Kidney Foundation 2002).  The decline in renal function and the 
associated reduction in GFR has been classified into five stages:  stage one represents a GFR of ≥ 90 
mL/min/1.73 m2 gradually progressing to stage five, referred to as ESRD with a GFR of <15 
mL/min/1.73 m2 (National Kidney Foundation 2002).   
 
1.1.1 Renal disease in old age 
A decline in renal function accompanies normal aging.  The estimated prevalence of CKD (defined as 
a GFR of <60 mL/min/1.73 m2) in those aged 70 years and older in the US was 22.8% compared to 
only 5.4% observed in the 60 to 69 year age range (Coresh et al. 2005).  In normal aging, the total 
and cortical mass of the kidney itself is estimated to decline by 9 to 43% in individuals in their 20’s 
and 80’s respectively, with a decline in functioning glomeruli (Epstein 1996).  This may translate into 
a decline in GFR in those who are older, yet many still retain a GFR within the normal range (Epstein 
1996).  Older people are also more vulnerable to experiencing renal damage due to the higher 
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prevalence of chronic illnesses and the increased use of medical interventions and medications that 
can be nephrotoxic.   
  
The relatively high prevalence of CKD in older people together with increasing longevity has lead to 
many reaching stage five kidney disease.  Availability of dialysis has meant that in the US, from 1996 
to 2003, the rate of octogenarians and nonagenarians starting dialysis has increased by 57%, taking 
into account population growth (Kurella et al. 2007).  From 2005 to 2009 in the UK, the proportion of 
prevalent older patients on dialysis (aged ≥65 years) increased from 46% (n=9528) to 50% 
(n=12949), rising by approximately 1% per year (Farrington et al. 2006; Steenkamp et al. 2010).   
 
1.1.2 Renal replacement therapies 
Technological advancements have enabled the replacement of the deteriorating or non-functioning 
kidney with an alternate obtained through a cadaveric or living donor renal transplant.   The waste 
removal function of the kidney can partially be replaced through the extracorporeal and 
intracorporeal treatments of HD or PD respectively.  Transplantation and both forms of dialysis are 
referred to collectively as renal replacement therapies.  This thesis focuses on older individuals living 
with either HD or PD.  
 
1.1.2.1 Haemodialysis 
HD is typically delivered over three to five hours, three times a week within a hospital or renal unit 
setting where the nursing staff deliver the treatment and monitor the patient’s response to the 
procedure (e.g. blood pressure).  HD can be managed by the patient at home, if they have the 
required support, the ability to perform the treatment and the necessary equipment.  However, this 
is relatively uncommon compared to in-centre HD due to extensive training and adjustments to be 
made within the home.   
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Haemodialysis removes excess water and solutes from the blood through an extracorporeal device 
that contains an “artificial kidney” (see Figure 1-1).  This kidney contains thousands of hollow fibers, 
composed of a semi-permeable membrane, which hold the blood and allow the removal of waste 
products by osmosis across the concentration gradient from the blood into the dialysate solution.  
HD also removes the solvent through convection (also termed ultrafiltration) as it moves from a high 
pressure environment (in the blood stream), across the membrane into the dialysate, the low 
pressure environment (Yeun and Depner 2005).   
 
 
Figure 1-1: A diagrammatic representation of a dialyser  
Reproduced from “Treatment methods for kidney failure: hemodialysis” (National Institutes of 
Diabetes and Digestive and Kidney Diseases 2006a). 
 
The efficiency or adequacy of each treatment session is determined by the formula Kt/V.  “K” is the 
dialyser urea clearance.  The duration of each dialysis is denoted by “t” and the denominator “V” is 
the patient’s volume of urea distribution which allows for adjustment for the patient’s body size.   
This produces a standardised value to allow for comparisons to be drawn between patients and 
patient populations, with a higher value indicating increased efficiency of dialysis.  Adequate dialysis 
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has been shown to be associated with improved morbidity and mortality outcomes (Eknoyan et al. 
2002).  
 
1.1.2.2 Peritoneal dialysis 
PD is an intracorporeal form of dialysis making use of the highly vascular peritoneal membrane to 
serve the same function as the semi-permeable membrane used in HD.  The peritoneal membrane 
surrounds the peritoneal cavity, into which the dialysate fluid is drained through an abdominal 
placed catheter (see Figure 1-2). 
   
 
Figure 1-2: An outline of peritoneal dialysis 
Reproduced from “Treatment methods for kidney failure: peritoneal dialysis” (National Institutes of 
Diabetes and Digestive and Kidney Diseases 2006b). 
 
The dialysate contains glucose or icodextrin which creates a high osmotic gradient facilitating 
ultrafiltration across the peritoneal membrane (Davies 2005).  Through diffusion and convection, 
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solutes are removed from the blood into the dialysate down the concentration gradient (Heimburger 
2005).  After a period of time, the dialysate containing the metabolic waste products is drained from 
the peritoneal cavity and is replaced with a fresh infusion of dialysate (an exchange).  An exchange 
can be performed by the patient at home but needs to be performed on multiple occasions, usually 
on a daily basis.  It does not require attendance at the hospital as with HD.  There are two forms of 
PD:  Continuous Ambulatory PD (CAPD) which involves between three and five PD exchanges per 
day, every four to six hours (except when asleep) and Automated PD (APD) which is performed with 
the assistance of a machine.  The machine coordinates the automated delivery and removal of 
dialysate, performing between three and five exchanges during the night, whilst the patient is 
asleep.  A day time exchange is then performed in the morning, with this dialysate remaining inside 
the patient during the day.  Guidelines indicate PD delivery to be adequate with a Kt/V of at least 1.7 
per week (National Kidney Foundation/ Kidney Disease Outcomes Quality Initiative 2006; Woodrow 
and Davies 2010). 
 
Not all patients are medically or socially suitable for both dialysis treatments.  For example, some 
patients who have had extensive abdominal surgery may find that they are medically unsuitable for 
PD.  PD also requires storage space within the home to accommodate the necessary equipment to 
undertake the treatment, which may prevent some patients from using it.  When no medical or 
social contra-indications are present, the dialysis modality selection can be determined by patient 
choice.  However, this is often not the case, as will be explored later in this thesis.  The following 
sections will describe the history of the emergence of HD and PD.     
 
1.1.3 The historical context of dialysis  
The transformation of these treatments and their use has occurred during the lifetime of the 
participants involved in the studies presented within this thesis.  In the final study, I found that this 
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historical contextual background influenced some of the patients’ perceptions of dialysis, hence its 
inclusion in this chapter.   
 
1.1.3.1 The history of haemodialysis 
The emergence of dialysis as a treatment for ESRD began with the development of the “artificial 
kidney” in animal models in 1914 by John Jacob Abel (Gottschalk and Fellner 1997) leading to the 
first rotating artificial kidney being built by Dr Willem Kolff in 1943, using principles of diffusion to 
remove metabolic waste products from the blood into the “rinsing fluid” (Cameron 2002).  Similar 
versions of the dialyser were used in the late 1940’s to dialyse patients with acute renal failure for 
between one and five sessions (due to the poor availability of sustainable access), but the survival 
was poor at just under a 50% survival rate post one month after the treatment (Merrill et al. 1950).  
This changed with the invention of the Quinton-Scriber shunt to enable permanent vascular access 
to the blood supply in 1960 and the creation of the arteriovenous fistula in 1966.  In 1966, self-care 
HD at home began in the UK in a few select patients, due to the financial benefits and greater 
accessibility compared to the limited resources of in-centre HD. 
 
1.1.3.2 The history of peritoneal dialysis 
The use of PD in humans began shortly after World War II with the objective to treat battle 
casualties who had developed acute renal failure in the United States (US), in Boston (Cameron 
2002).  Three investigators worked together (Jacob Fine, Howard Frank and Arnold Seligman) and 
they managed to successfully reverse acute renal failure in a patient using “peritoneal irrigation” in 
1945, around the same time as Kolff was having success with his “artificial kidney” (Cameron 2002).  
The first long term PD treatment of a single patient with chronic renal disease began in 1959 and 
lasted six months.  Patients were, however, still plagued with problems of repeated infections due to 
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difficulties with access to the peritoneal cavity.  This was dramatically improved with the 
development of a catheter by Henry Tenchkhoff in the early 1960’s (Cameron 2002).  The growth of 
the treatment was slow in comparison to HD.  In 1970, only 102 patients out of 5133 in Europe were 
using intermittent PD which was characterised by once or twice a week dialysis for 48 to 72 hours 
continuously using hourly exchanges (Cameron 2002).  In 1975, PD in the form of five daily 
exchanges with a dwell time of 4 to 5 hours emerged and was successful.  
 
1.1.4 The availability of dialysis:  then and now 
In the 1960’s, HD was a rationed treatment.  As an example of this, in Seattle, the decision as to who 
was to benefit from in-centre dialysis was ascribed to an anonymous committee (Blagg 2007).  A 
patient who was deemed appropriate for the treatment had to fulfil certain criteria: they had to be 
an “emotionally stable, co-operative patient without severe hypertension, between 20 and 45 years 
of age, who lived within a reasonable distance of the dialysis unit and preferably had some residual 
renal function (the kidney’s remaining capacity to remove waste products and excess fluid from the 
body). They should also have a job, be studying or be looking after a family” (Cameron 2002).  Those 
suffering from diabetes were immediately excluded, as were the elderly and children.  In the UK, 
rationing of dialysis and the use of the in-centre dialysis decision criteria from Seattle were also 
enforced and there was almost no increase in the number of HD units between 1970 and 1990 due 
to budgetary constraints.  Therefore, not all patients who needed dialysis received dialysis, as 
demonstrated in the literature.  In 1984, a survey found that 45% of UK nephrologists would deny 
dialysis to a 50 year old man with ischaemic heart disease (Challah et al. 1984), an event that would 
not occur today.  An age bias was also seen in 1990, where close to 100% of patients under the age 
of 60 years with advanced chronic renal failure were referred to a renal unit, compared to only 49% 
of those aged 60-79 years and 14% of those aged over 80 years (Feest et al. 1990).  It was not until 
1994 that the Department of Health concluded that all patients up to the age of 80 should be 
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offered treatment and if over 80 years, they should be considered for treatment (Health care 
strategy unit 1994).  Dialysis was then considered a potential treatment for all, leading to an 
exponential rise in the number of older people starting dialysis, which has only slowed in terms of 
growth in the five to six years up to 2009 (see Figure 1-3).  Now, the increasing availability and use of 
dialysis in octogenarians (Joly et al. 2003; Ronsberg et al. 2005), nonagenarians and even a 
centenarian (Kurella et al. 2007) is being reported.  Dialysis within most developed countries is now 
so widely available that it is perceived as part of routine care offered to older people, with some 
patients not being aware they have the option of declining treatment (Kaufman et al. 2004).  
 
 
Figure 1-3: New patients accepted for renal replacement therapy in the UK (1980-2009)   
Reproduced from the Thirteenth Annual Report of the UK Renal Registry (Gilg et al. 2010).   
 
The use of PD and HD is not evenly split.  In fact, the use of HD and transplantation has grown far in 
excess to that of PD, which has remained fairly stable since the early 1990’s (Figure 1-4).  This 
appears to be because PD has not been used to treat the emerging older dialysis population.  
Therefore, older people are far more likely to be treated with HD than PD suggesting that PD may be 
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underused in this age group (Figure 1-5).  This could be due to most older people (81%) presenting 
with barriers that prevent them from being suitable for self-care PD (Oliver et al. 2007).   
 
 
Figure 1-4: Growth in prevalent patients by treatment modality (1982-2009)  
Reproduced from the Thirteenth Annual Report of the UK Renal Registry (Steenkamp et al. 2010) 
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Figure 1-5: Percentages and numbers of those on renal replacement therapies by age bands (2009)   
* Transplant in age group 85+, n= 25.  Reproduced from the Thirteenth Annual Report of the UK 
Renal Registry (Steenkamp et al. 2010)   
 
In the UK, there appears to be other factors at play (apart from barriers to self-care PD) contributing 
to the declining usage of PD in older people.  In 2009, 423 patients aged ≥ 65 years were on PD (at 
90 days of treatment), down from 447 patients observed the year before (2008) and lower still in 
comparison to the 492 patients observed in 2007 (Ansell et al. 2008; Ansell et al. 2009; Gilg et al. 
2010).  This decline has occurred despite the increase in total numbers of older people starting on 
dialysis year on year, translating into a decline in PD initiation rate from 17.3% in 2007 to 14% in 
2009.  This thesis aims to contribute to the understanding of the possible contributors to the 
narrowing, as opposed to the broadening, of dialysis modality options available to older people.    
 
1.1.5 The cost of dialysis 
Renal replacement therapies are expensive and cost between one to two percent of the total 
National Health Service (NHS) budget for the UK, despite it affecting only 0.05% of the population 
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(Department of Health 2004b).  In the current constrained financial climate, the NHS is required to 
save between £15 to 20 billion over the next three to five years (Brady and O'Donoghue 2011; Sharif 
and Baboolal 2011).  It is therefore worth exploring if there is a cost differential between PD and HD 
that can help explain the decline in the use of PD in recent years or which may impact on the future 
distribution of the treatments.   
 
A comprehensive analysis in 2008 found that the mean annual cost of delivering PD (APD or CAPD) 
to be significantly lower than HD (hospital or satellite based) with upper estimates of £21655 and 
£35023 respectively (Baboolal et al. 2008).  This, together with an economic analysis by a National 
Institute for Clinical Excellence report, supports the increased use of PD as a cost effective policy for 
the NHS (National Institute for Health and Clinical Excellence 2011).  The costs of dialysing with PD or 
HD, however, were found to be similar in older people in the North Thames area (Grun et al. 2003).  
There is also a substantial variation in the costs of dialysis in different parts of England, which has 
contributed to the delay in implementing a national based tariff for dialysis through “Payment by 
Results” (NHS Kidney Care 2009).    
 
Despite the variability of dialysis costs, it is still widely recognised that PD and home HD are likely to 
be cheaper that in-centre HD due to the lower overheads and staffing required (Baboolal et al. 2008; 
National Institute for Clinical Excellence 2002; NHS Kidney Care 2009).  Therefore, home dialysis 
(whether HD or PD based) is now being promoted as it has the potential to accrue substantial cost 
savings (Brady & O'Donoghue 2011; National Institute for Clinical Excellence 2002; National Institute 
for Health and Clinical Excellence 2011).  This shift in the usage of PD to promote cost benefits is not 
reflected in the latest renal registry data accrued from 2009 (Gilg et al. 2010) but warrants 
monitoring in the future.   
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This section on ESRD provides an overview of the technicalities of PD and HD as well as charting its 
path over the last seventy years from inception, to becoming a rationed treatment through to 
becoming widely available for all.  In-centre HD is increasingly used to treat the elderly, for reasons 
that are difficult to explain.  It is unlikely that this is due to financial reasons as PD is likely to be 
cheaper than (or equivalent to) HD.  Differences in survival and quality of life as well as patients’ 
perceived choice of modality may all be contributing to the current pattern of modality distribution 
and will therefore be explored in chapters two and three.  Financially, however, it would appear that 
the NHS would greatly benefit from a more even distribution of patients on home HD, in-centre HD 
and PD.     
 
The following section describes the process of aging in relation to the physical, cognitive and social 
changes that can occur over time.  This provides a literature based description of the population 
under study within this thesis, which will be used to interpret findings.   
 
1.2 AGING 
There are multiple ways of defining when “old age” begins.  The Oxford English Dictionary provides 
this definition for the word old, a: “having lived for a long time; no longer young; of a specified age” 
(Oxford University Press 1989).  Within the health and renal literature, old age is usually defined as 
anywhere between 50 to 70 years, and older.  In the UK, the current state pension age is 65 years for 
both men and women and therefore this is a widely recognised point when “old age” begins.  For 
the purposes of this thesis, old age is defined as beginning at the age of 65.   
 
1.2.1 The aging population 
Within developed countries survival is increasing and populations are aging (Edwards 2010).  
Increasing life expectancy up to the mid 20th century can be attributed primarily to reductions in 
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infant mortality due to advances in sanitation and hygiene thereby reducing the spread of infectious 
diseases (Taylor and Field 2007).  Medical developments and technologies, as well as improved 
nutrition, have also contributed to increasing survival, particularly in developed countries  (Taylor & 
Field 2007).  As a result of these improvements, life expectancy has dramatically increased during 
the last century.  For men, life expectancy has increased in the UK from 45 years in 1901 to 76.2 
years in 2001.  This has lead to a dramatic rise in the number of centenarians from 100 in 1911 to 
8600 in 2001.  It is therefore unsurprising that the fastest growing segment of the UK population are 
those aged 85 years and above (Office for National Statistics 2005).   
 
1.2.2 Chronic illness in older people 
As a consequence of aging and increasing longevity, the disease spectrum within developed 
countries has changed, with a rising prevalence of chronic illness.  The Continuous Household Survey 
from Northern Ireland, based on a randomly drawn sample of 4500 private household addresses 
each year, found that in 2010 to 2011, 52% of those over the age of 75 years report a long-standing 
illness that limits their activities (Central Survey Unit and Northern Ireland Statistics and Research 
Agency 2011).  In addition, 18% of these people may experience additional strain by providing care 
to others (The Information Centre for Health and Social Care 2010).  Chronic conditions do not 
always occur in isolation.  Renal disease often coexists with other chronic conditions such as 
diabetes and heart disease as demonstrated in an American study on the beneficiaries of Medicare 
and Medicaid services, which found that 49.2% of those receiving care for chronic kidney disease 
(CKD) had two or more additional chronic illnesses, in contrast to only 24.5% of those with cancer 
(Schneider et al. 2009).  
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1.2.3 The aging process 
Aging entails physiological as well as cognitive changes.  These will be discussed in further detail as it 
will provide the background to understanding the findings held within this thesis.   
 
1.2.3.1 Physiological aging 
As people age, body composition can change, as observed in longitudinal studies.  Body weight has a 
tendency to increase year on year by an estimated 0.3-0.55 kg, until this trend is reversed between 
the ages of 60 and 80 years (Buffa et al. 2011).  A ten year follow-up study on older men and women 
(60 ± 7.8 years) found that fat stores tend to be redistributed with a decline in subcutaneous stores 
and an increase in visceral stores and an overall increase in total fat mass (Hughes et al. 2004).  The 
reverse is seen with a loss of “fat free mass”, composed of muscle, skeleton and body water (Guo et 
al. 1999).  This development seems to be particularly pronounced in those on dialysis (Biasioli et al. 
1993).   
 
The progressive and irreversible loss of muscle mass and strength associated with aging is termed 
sarcopenia (Muscaritoli et al. 2010).  Sarcopenia is diagnosed based on the presence of a low muscle 
mass (therefore a percentage of muscle mass of ≥2 standard deviations below the mean measured 
in young adults of the same sex and ethnic background) as well as a low gait speed (therefore slower 
than 0.8 meters per second in the four metre walking test) (Muscaritoli et al. 2010).  In a 
predominantly Caucasian sample from the US, the prevalence of sarcopenia increased from about 
15% in those aged 60 to 69 years to approximately 40% in those 80 years or above.  It was also 
strongly associated with an increased risk for physical disabilities and abnormalities of balance and 
gait, as well as an increased risk of falls over the previous year (Baumgartner 2000).  Sarcopenia can 
also predispose an individual to frailty.  
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There are different ways of defining and measuring frailty, several of which appear to correlate 
significantly with adverse outcomes in older people (Armstrong et al. 2010).  A widely used definition 
of frailty (the “Fried phenotype”) encompasses the presence of three of the following five features: 
weight loss (unintentional weight loss of at least 5% in one year), weakness (determined by grip 
strength), slow walking speed, low physical activity and self-reported exhaustion. These measures 
are all susceptible to decline in illness and age.  With the Fried phenotype, 7% of a population of 
community dwelling elderly, aged 65 years and above, in the US and in France, were identified as 
frail (Avila-Funes et al. 2008; Fried et al. 2001).  This is lower than the 15 to 20% of community living 
elderly with CKD who were found to be frail (Shlipak et al. 2004), rising to 78% in older patients on 
HD (Johansen et al. 2007).  Therefore the level of impaired kidney function is associated with the 
presence of frailty.  Frailty was also seen to be independently associated with the development of 
functional limitations in 2135 (non-CKD) individuals aged 70-79 years, over a period of four years 
(Fried et al. 2006).  Greater functional impairments were also seen both at baseline and at three 
years in older HD patients compared to controls who were comparable in age, ethnic background 
and gender (Kutner N.G. et al. 2000).  Ninety five percent of 162 older people on HD were found to 
need some assistance with day to day activities  (Cook and Jassal 2008).  The above suggests that 
older people on dialysis experience more symptoms of frailty and greater functional difficulties than 
those who are not on dialysis.   
 
1.2.3.2 Cognitive aging 
Cognitive function is defined as mental processing involving the use of memory, attention, 
orientation, language, planning and sequencing of activities (Young et al. 2011).  Aging can lead to 
changes in cognitive functioning.  In older people living in the community or in institutions in 
Canada, prevalence of cognitive dysfunction increased from 11% in those aged 65 to 74 years, to 
30.3% in those aged 85 years and over (Graham et al. 1997).  Other estimates suggest a prevalence 
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of cognitive dysfunction (no dementia) in approximately 22% of older people (Dufouil et al. 1996; 
Plassman et al. 2008).   
 
Cognition has been shown to decline with worsening renal function.  In a sample of 3075 community 
dwelling elderly (68 to 80 years of age), those with the lowest renal function (eGFR < 
45mL/min/1.73m2) had the lowest cognitive function scores and were significantly more likely to 
experience a worsening of these scores over four years compared to those with an eGFR ≥ 
45mL/min/1.73m2 (Kurella et al. 2005).  Similar results were found in another longitudinal study 
(n=3679) on individuals aged 55 years and older, where moderate to severe CKD at baseline 
(creatinine clearance of <45mL/min/1.73m2) was significantly and independently associated with 
new cognitive impairment at two years follow up (Etgen et al. 2009).  Estimates for the prevalence of 
cognitive impairment in those on HD varies from 32% as defined by a mini-mental state examination 
(MMSE) score of ≤ 24 (Sehgal et al. 1997) to 87% in a sample of 338 older HD patients using a battery 
of neuropsychological tests (Murray et al. 2006).  Of these 87%, 37% had severe cognitive 
impairment.  An improvement in cognitive function was, however, observed in patients who were 
one month post transplantation compared to their pre-transplantation scores.  These improvements 
did not occur in those who continued to await transplantation or in matched controls (Harciarek et 
al. 2009).   
 
The pathway linking renal function and cognition is unclear and is likely to be multi-factorial.  Renal 
disease is associated with conditions that predispose to cognitive events such as vascular disease 
and hypertension.  Renal disease (when GFR below 30 mL/min/1.73m2) also leads to a reduction in 
erythropoietin and hence red blood cell production, compromising cerebral oxygen delivery.  
Reversal of this anaemia in dialysis patients through the administration of recombinant human 
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erythropoietin lead to an improvement in cognitive performance through the correction of 
haematocrit levels (Marsh et al. 1991).   
A few studies have attempted to determine whether dialysis modality can influence cognition.  
These studies are, however, characterised by poor methodological design.  One early study 
investigated the cognitive performance in seventeen pairs of patients on HD and CAPD who were 
matched for sex, age, diabetic status and time on dialysis (Wolcott et al. 1988).  Although the CAPD 
group showed better cognitive performance, the small sample size limited the accuracy of the 
interpretation of the results.  Another study found that the neurophysiological results obtained 
before the HD session fell below the normal range (returning to normal after a session of HD), unlike 
those from CAPD patients or in an age matched control group of healthy subjects (Buoncristiani et 
al. 1993).  These findings were corroborated by another study which showed improved performance 
in attention and memory at one hour post HD yet declining steadily during the 67 hours post HD, 
compared to a stable performance in CAPD patients.  The CAPD and HD patients were not, however, 
matched for characteristics such as age (Williams et al. 2004).  Therefore, to date, there is some 
evidence that cognition varies with HD sessions but no substantial evidence that HD places patients 
at greater risk of cognitive problems compared to PD.   
 
Declining cognitive function during aging generally refers to the loss of mental agility and ability.  
This perspective, however, neglects the wealth of experience and knowledge that people 
accumulate over their lifetime.  In 1993, Baltes explored these dual concepts of the aging mind and 
described them respectively as cognitive mechanics and cognitive pragmatics (Baltes 1993).  He 
likened cognitive mechanics to the hard drive of a computer which is determined by the 
neurophysiological architecture, and therefore determined by biological, genetic and health factors.  
Cognitive pragmatics can be described as the software loaded onto the computer as it is determined 
by the socio-cultural environment of the individual acquired throughout their life, such as language 
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and life skills used to cope with adverse events.  Cognitive mechanics experiments have found that 
despite training, younger people consistently outperform older people (Baltes 1993).  Finucane et al 
also empirically demonstrated that by increasing the complexity of a task, greater comprehension 
and inconsistency errors in making decisions were seen in the older compared to the younger age 
group (Finucane et al. 2005).  Investigating cognitive pragmatics revealed, however, a very different 
picture by assessing the presence of “wisdom”, with older people performing at least as well as 
younger people (Baltes 1993).  Therefore, when referring to cognitive ability in aging, it may be 
pertinent to consider cognitive pragmatics as well as cognitive mechanics.   
 
1.2.4 Aging and depression 
Depression is a syndrome defined by a collection of symptoms that reflect the psychological health 
of an individual.  The “gold standard” for diagnosing depression involves a trained professional 
conducting a Structured Clinical Interview for Depression according to the Diagnosis and Statistical 
Manual of Mental Disorders (DSM), termed SCID (American Psychiatric Association 2000).  The 
diagnostic criteria for a major depressive disorder (MDD) include the presence of symptoms such as 
a depressed mood; loss of pleasure or interest; changes in sleep patterns and fatigue or loss of 
energy.  These symptoms must be present on most days, for most of the time, over at least two 
weeks and must be perceived to be distressing and affect functioning.  The depressive disorder can 
be classified according to severity into minor or major, differing only in the number of symptoms 
present (up to four compared to five or more respectively) (American Psychiatric Association 2000).   
 
Several questionnaires have been developed to screen for symptoms indicative of the presence of 
mental disorders (such as anxiety and depression), yet these are unable to provide a diagnosis of the 
condition.  The questionnaires are, however, simple to complete and are therefore practical and 
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useful in measuring depressive symptomatology in different population groups.  Most studies use 
questionnaires as a proxy measure for depression.  
 
The prevalence of depression varies depending on how it is diagnosed and the population studied.  
Within the community dwelling elderly and by using the DSM-IV criteria, the prevalence of major 
depression is between 1 and 3%.  In primary care, this increases to between 10 and 12%.  In nursing 
home care, this is seen to increase further to between 12 and 16% (Mulsant and Ganguli 1999).  
Despite the prevalence of depression increasing with the degree of illness or dependency, older 
people in the US (≥ 65 years) were observed to have an odds ratio (OR) of between 0.27 to 0.47 of 
developing any mental disorder (including a MDD) compared to those aged between 18 and 24 years 
(Regier et al. 1993).  It was also found that women were more likely to experience a MDD (OR 1.8) 
than men, although this difference was not found to be significant (Kuehner 2003; Regier et al. 
1993).   
 
Multi-factorial causes or risk factors for depression in the elderly have been identified and grouped 
into three categories (Mulsant & Ganguli 1999).  The first relates to mental illness which can include 
a family history of depression, cognitive impairment and dementia.  The second involves change in 
social circumstances, which often involves the loss of loved one(s), financial security and familiar 
surroundings due to relocation.  The third category involves physical illness which can lead to 
functional disability or debilitating symptoms.  A longitudinal study over three to four years found 
that incidence of depression was associated with a deterioration in health and in activities of daily 
living as well as poor social support in a sample of 1045 older people living within the community 
setting (Henderson et al. 1997).  A recent meta-analysis of studies on older people found an 
increased OR for depressive symptoms in those with chronic disease or in those with poor self-rated 
health.  The meta-analysis was, however, methodologically flawed as it excluded studies available 
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through the databases PsycINFO and CINAHL, arguably the two databases that are most likely to 
contain several pertinent studies in this field (Chang-Quan et al. 2010).   
 
CKD is a chronic illness and has been associated with an increased prevalence of depression.  With 
SCID, 20% of a predominantly black ethnic sample (n=70) on HD were diagnosed with a MDD (Cukor 
et al. 2007).  Other similarly sized studies diagnosed major depression in 17.3% to 19% of patients on 
HD (Hedayati et al. 2006; Watnick et al. 2005), whilst a higher prevalence of 29.7% was found in 
patients with stage two to five renal disease (not on dialysis) in Sri Lanka (Sumanathissa et al. 2011).  
In a similar sample (participants with stage two to five renal disease) in the US, the prevalence of 
depression was only 21%, with comparable rates across the different stages of renal disease.  This 
was, however, a predominantly male sample who may have a lower prevalence of depression 
compared to females (Hedayati et al. 2009). 
 
Despite the prevalence of MDDs affecting approximately one in five individuals on dialysis, the 
problem is often undiagnosed, potentially due to the similarity between the symptoms of uraemia 
and those seen in depression, as interpreted by patients and health care professionals alike (Wilson 
et al. 2006).  Patients on dialysis often experience tiredness due to anaemia or the dialysis procedure 
and poor appetite due to the underlying pathology of the illness (for example uraemia), yet fatigue 
and anorexia are also common symptoms in depression and are part of the diagnostic criteria 
(American Psychiatric Association 2000).  In primary care, as many as 50% of older people fail to 
receive a diagnosis of, and therefore treatment for depression (German et al. 1987).   
 
The outcomes of patients on dialysis with depression are compromised and are associated with a 
decrease in functionality and reduced quality of life (Kutner N.G. et al. 2000), increased mortality 
(Kimmel et al. 2000), increased demands on spouses (Daneker et al. 2001) and increased usage of 
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services (Hedayati et al. 2005).  Similar findings are seen in the depressed elderly population not on 
dialysis (Charney et al. 2003).    
 
Depression rates in people on the two dialysis modalities have provided contradictory findings, 
mostly due to poor study design.  Sacks et al found no difference in the extent of depression present 
in patients on either modality, although the PD patients were younger and had spent less time on 
dialysis (Sacks et al. 1990).  Martin et al found significantly higher levels of anxiety and depression in 
HD than in PD patients but it was uncertain whether the groups were clinically comparable (Martin 
et al. 2004).  The sample sizes were also small (between 57 and 100 participants) and with an 
uneven distribution of patients on either modality.    
 
Depression and cognitive dysfunction appear to coexist.  Persistent symptoms of depression or the 
development of depressive symptoms over three years were both associated with a rapid decline in 
cognitive function in older people (Dufouil et al. 1996).  High depressive symptom scores at baseline 
were associated with a significantly greater decline in cognitive scores at four years compared to 
those without depressive symptoms at baseline in a sample of over one thousand older people 
(Paterniti et al. 2002).  This association was also observed in HD patients where cognitive 
performance was worse in those with the highest depressive scores in a cross sectional study 
(Agganis et al. 2010).   
 
Therefore, despite older people experiencing life events (e.g. illness and loss) that may predispose to 
depression, there is a lower prevalence rate compared to younger people.  The reasons for this are 
unclear.  Prevalence of depression in those on dialysis is approximately 20 to 30%, with no 
discernable modality dependent differences.   
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1.3 CONCLUSION 
This chapter provides an overview of ESRD and dialysis, including a description of the context of the 
emergence, development and changes in accessibility of these treatments which occurred during the 
lifetime of the participants involved in the studies contained within this thesis.  The descriptions of 
PD and HD hints at the many ways that dialysis can affect an individual’s lifestyle.  The section on 
ESRD concludes with an exploration of the distribution and uptake of HD and PD in the UK, which 
highlights that older people are increasingly unlikely to start on PD.  The reasons for this are likely to 
be multi-factorial and are largely unknown but are likely to extend beyond the potential barriers that 
older people may experience in relation to receiving PD and the cost of dialysis.  It is anticipated that 
this thesis will be able to identify some of the reasons for the low uptake of PD in older people.   
 
Aging is also described in detail in this chapter.  Aging incurs physiological and cognitive changes 
within the body.  It is noted that CKD and ESRD in older people appears to accelerate the rate of 
biological decline with a higher prevalence of frailty, cognitive dysfunction and depression in those 
on dialysis compared to the general older population.  Therefore, the older dialysis population are a 
population with increased needs which require consideration when planning their modality 
treatments. 
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CHAPTER TWO 
2 SURVIVAL AND QUALITY OF LIFE IN OLDER PEOPLE ON DIALYSIS 
 
“The physician’s job description will be changed to focus on patients’ lives rather than patients’ 
bodies.” 
Mark Sullivan. 2003. Social Science and Medicine, 56, (7) 1595 
 
Dialysis is available today to the majority of individuals, regardless of age or severity of co-existing 
illnesses.  This is principally due to the conclusion that dialysis, for most individuals, is a treatment 
whose benefits largely outweigh its side effects.  These benefits include an extension of length of life 
as well as improving the quality of life (QOL).  Both of these have been noted to be of primary 
concern for many patients who are on dialysis and their caregivers (Morton et al. 2011).  This 
chapter therefore explores the outcomes of survival and QOL of older people on PD and HD and 
whether this evidence can explain the current distribution of dialysis modalities amongst older 
people in the UK.   
 
This chapter is divided into two sections.  Section 2.1 focuses on survival on dialysis and illustrates 
that older people are likely to experience equivalent survival outcomes whether they are dialysing 
on PD or HD, provided they have the same degree of preparation and planning prior to the start of 
treatment.  Section 2.2 explores the QOL outcomes in those on dialysis and begins by introducing 
and defining the concept of QOL and health related quality of life (HRQOL).  The HRQOL findings 
suggest that older people have a higher than anticipated mental QOL compared to younger people, 
suggesting that older people may be better prepared to manage chronic illness within their lives.  
The findings also suggest that dialysis modality exerts no individual effect on HRQOL, although this 
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has not been explored extensively in older people.  Therefore, the findings do not appear to support 
the comparatively low usage of PD amongst older people.   
 
2.1 SURVIVAL OUTCOMES OF OLDER PEOPLE ON DIALYSIS  
Living with dialysis may shorten anticipated life expectancy when compared to those who are free 
from a chronic illness or compared to those with other chronic conditions.  As an example, the five 
year survival rate from cancer in men and women who are aged 65 years and older is 58.4% in the 
US (Howlader et al. 2010).  However, the five year survival for incident dialysis patients aged 
between 65 and 74 years is only 28.3%, reducing to 14.5% in those who are 75 years and older 
(U.S.Renal Data System et al. 2010).  As expected, life expectancy is dramatically influenced by age.  
As an illustration of this, the five year probability of survival is just 26.9% in incident dialysis patients 
aged 65 years and older compared to 67.9% in those under the age of 65 (Gilg et al. 2010).  
Transplantation is alternative form of renal replacement therapy. However, the correlation between 
age and the presence of co-existing conditions can limit the eligibility of older patients receiving a 
life related or cadaveric kidney transplant.  In 2008, only 15% of all adult renal transplant recipients 
in the US were aged 65 years and above (United States Renal Data System 2010).  Therefore, 
amongst older people, dialysis is often a permanent and lifelong treatment for ESRD.   
 
2.1.1 Comparison of survival outcomes on HD and PD 
Several studies have attempted to explore if one mode of dialysis confers a survival advantage over 
another.  Such an assessment is not, however, straightforward.  Survival outcomes and 
measurements can be influenced by residual renal function, age, comorbidities, the population 
under study and the statistical methodologies employed in the analysis of the data.   
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Survival outcomes derived from large cohort studies have resulted in conflicting findings.  Some 
studies have demonstrated a survival advantage in patients starting on PD (Liem et al. 2007; 
Weinhandl et al. 2010), others have shown no difference in survival in those on HD and PD (Inrig et 
al. 2006; Mehrotra et al. 2011; Murphy et al. 2000), whilst other studies have found HD to be 
associated with better survival outcomes (Jaar et al. 2005; McDonald et al. 2009).  One study 
focused on the older population (n=2503) starting on dialysis, of whom 21.5% commenced on PD.  
The mortality was found to be higher in the first year of dialysis in those with diabetes who started 
with PD (Winkelmayer et al. 2002).  This was not, however, observed in other studies which 
demonstrated no survival advantage or disadvantage in older people on PD (Harris et al. 2002; Liem 
et al. 2007), nor was it observed in a meta-analysis which concluded that the mortality and 
hospitalisation rate for older people on HD and PD was identical (Selgas et al. 2001).  Recently, it has 
been highlighted that the discrepancies in HD survival findings may be partially attributed to failing 
to take into account the access used to start HD (Perl et al. 2011).  Those with a central venous 
catheter tend to start dialysis unexpectedly and are at a higher risk of sepsis, increased morbidity 
and mortality compared to those with an arteriovenous fistula or graft, which is formed weeks in 
advance and therefore implies a planned approach to starting dialysis.  In that study, those who 
started HD with a planned form of access had similar survival outcomes to those who started on PD 
(Perl et al. 2011).  Another recent study also illustrated that patients with ≥4 months of predialysis 
care and who started dialysis as an outpatient had comparable survival outcomes regardless of their 
dialysis modality and regardless of how long they remained on each modality (Quinn et al. 2011).  
Therefore, this seems to suggest that PD and HD are likely to result in similar morbidity and mortality 
outcomes if the planning period prior to starting dialysis is similar.   
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2.2 QUALITY OF LIFE OUTCOMES ON DIALYSIS 
There is “more to living than dying” (Bargman 2007) implying that the quality versus the quantity of 
life is another valuable and meaningful outcome to consider in older people on dialysis.  
 
Measuring quality of life (QOL) is principally an attempt to quantify well-being.  Prior to measuring 
QOL, it is important to understand what it is.  One of the many definitions of QOL arises from the 
World Health Organisation (WHOQOL Group 1997): 
 
“Quality of life is the individuals’ perception of their position in life in the context of the 
cultural and value systems in which they live and in relation to their goals, expectations, 
standards and concerns. It is a broad ranging concept affected in a complex way by a 
person’s physical health, psychological state, level of independence, social relationships, 
personal beliefs and their relationship to salient features of their environment.” 
 
This broad definition has its origins in the quality of health research literature that arose from the 
study of disabilities.  These origins are described below, as well as the emergence of the concept of 
health related quality of life (HRQOL).   
 
The origins of quality of health research appear to have stemmed from the study of people with 
cognitive dysfunction moving from institutionalised care to residential care in the 1960’s (Felce and 
Perry 1995).  It was found that assessing developmental gain failed to capture other pertinent 
outcomes such as those related to changes in life satisfaction and social relationships.  As a result, 
outcomes such as maintenance of family ties and participation in community life were incorporated, 
creating a more holistic approach to measuring how interventions affect individuals and thereby the 
emergence of the concept of QOL.   
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2.2.1 The conceptualisation of quality of life 
In the 1960’s, the concept of QOL had yet to be defined and refined.  Two distinctive concepts within 
QOL were discussed by Landesman in 1986 (Landesman 1986).  She stated that QOL encompasses 
both objective and subjective measures.  The objective measures involve the quantification of life 
conditions that impact on QOL such as hospitalisations, physical health and income.  The subjective 
measures are the responses to objective life conditions such as personal satisfaction with life.  
Landesman believed that QOL should focus only on assessing the objective life conditions that were 
measureable, yet both objective and subjective measures are required to appreciate the relationship 
between life conditions, experience and perceptions.  An example of this relationship can be 
illustrated by an individual who is satisfied with his or her job until someone with less experience is 
promoted above them.  The individuals’ expectations of their objective life conditions can therefore 
directly impact on the subjective response of job satisfaction.  Different levels of importance are 
attached to different life conditions and, therefore, subjective responses can very much depend on 
personal values.   
 
Felce identified six domains, derived from the literature, that were important for the understanding 
of QOL (Felce 1997).  These six main domains are: physical well-being; material well-being; social 
well-being; productive well-being; civic well-being and finally emotional well-being, which are 
broadly incorporated in the WHO definition, suggesting an attempt to ensure consistency in defining 
the components of QOL.  All these factors are also susceptible to external influences.  The final 
concept and assessment of QOL is shown in Figure 2-1.   
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Figure 2-1: Assessment of Quality of Life   
Reproduced with permission from John Wiley & Sons Ltd. (Felce 1997). 
 
2.2.2 Health Related Quality of Life 
QOL is a term that has been widely used to refer to many different concepts such as happiness, life 
satisfaction and well-being.  The term “health related quality of life” (HRQOL) was created to isolate 
the QOL relating to health, illness and its treatments.   
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Just as QOL is a concept composed of various domains as illustrated in Figure 2-1, there are several 
factors that contribute to the determination of HRQOL (Ferrans et al. 2005).  These factors and how 
they can be assessed, are shown in Table 2-1. 
 
Table 2-1: Factors contributing to the determination of HRQOL and their assessment methods 
Factors contributing to HRQOL Assessment methods of HRQOL  
Biological function Laboratory tests 
Symptoms (physical, emotional and cognitive) Symptom questionnaires e.g. Dialysis Symptom 
Index 
Functional status  
(physical, social, psychological, role function) 
Short form-36 (physical and mental functioning) 
General health perceptions  Short form-36 (incorporates a single question to 
assess one’s health); Illness Perceptions 
Questionnaire 
Overall quality of life (subjective well-being) Satisfaction with life (single question or 
questionnaire); Short form-36 scores (SF-36); 
Kidney Disease Quality of Life scores (KDQOL) 
 
The factors highlighted in Table 2-1 contributing to HRQOL can be influenced both by individual and 
environmental characteristics (Eyler et al. 2002).  These characteristics are highlighted, together with 
examples, in Table 2-2.  
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Table 2-2: Influences on factors contributing to health related quality of life (HRQOL) and examples 
Category Influences on factors 
contributing to HRQOL 
Examples 
Individual  Biological Body mass index, family history 
Demographic Sex, age, education  
Developmental status Recently retired; adolescent  
Psychological Attitudes and beliefs, knowledge, expectations  
Environmental  Social Social support from family, friends and healthcare 
providers 
Physical Home, neighbourhood and workplace 
Policy Reduction of salt in food 
 
Ill health can feature changes in biological functioning, symptoms and functional status and can be 
influenced by other factors such as individual features, including family history of illness or 
environmental conditions such as that in the workplace.  Therefore, HRQOL is formed from the 
individuals’ perception of health within the context of their life experiences but is also determined 
by the individuals’ expectations of their health (Carr et al. 2001).  All these processes are vulnerable 
to change indicating that HRQOL is not fixed.   
 
2.2.3 Health related quality of life in end stage renal disease 
There is a wealth of literature on the HRQOL of patients on dialysis in comparison to the HRQOL in 
patients with a renal transplant or CKD, as well as between patients on PD and HD.  Comparisons 
have also been made with patients with other chronic health conditions and to the general 
population.  The influences of variables such as sex, age and ethnic background have also been 
explored, as well as the association between HRQOL, survival and hospitalisation rates.  The 
measures used to explore HRQOL are extensive, further complicating the interpretation of findings 
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across different studies.  The following section provides a summary of the pertinent HRQOL findings 
within the dialysis literature to date, with a focus on older people.  In this overview, I will structure 
the findings according to the different factors influencing HRQOL as listed Table 2-1, in addition to 
the influence of other dialysis related factors on HRQOL.  
 
2.2.3.1 Biological function 
There is limited data on how biological functions directly impact on HRQOL in renal disease.  One 
large cross-sectional study on HD patients (n=33879) did find, however, an association between the 
incremental achievement rate of quality targets of biological parameters such as serum albumin, 
haemoglobin, dialysis adequacy and serum phosphorous, and a higher QOL (Lacson E Jr et al. 2009).  
In those with CKD not on dialysis, worsening GFR levels are associated with a decline in HRQOL, 
potentially mediated through the increase in symptoms (Rocco et al. 1997).  This relationship is less 
clear in those on dialysis where the residual renal function was found to be independently and 
positively associated with HRQOL, but only to a limited extent (Lew and Piraino 2005; Merkus et al. 
1997).  When on dialysis, the efficiency of the treatment can be assessed through a measure of 
dialysis adequacy.  Positive associations between dialysis adequacy and HRQOL in cross-sectional 
studies involving patients on both PD and HD have been found (Chen et al. 2000; DeOreo 1997; 
Manns et al. 2002).  Longitudinal changes in dialysis adequacy did not, however, reflect changes in 
HRQOL (Bakewell et al. 2002; Merkus et al. 1999b).  It is possible that improvements in dialysis 
adequacy may negatively influence HRQOL due to the increase in treatment commitment, such as 
time on HD and added exchanges in PD.  Therefore, the association between HRQOL and residual 
renal function as well as dialysis adequacy may not be robust, at least for those on dialysis. 
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2.2.3.2 Symptoms 
Symptoms are the subjective experience of a disease or treatment.  The study of symptoms and 
HRQOL in renal disease is extensive.  It is not surprising that a worsening symptom experience is 
seen to be related to a decline in HRQOL.  Merkus et al showed that symptom burden explained 
most of the variability in the physical and mental summary scores from the Short-Form 36 (SF-36) in 
both HD and PD patients (Merkus et al. 1999a).  Weisbord et al also found that physical as well as 
emotional symptom severity was related to impaired HRQOL and depression in a sample of 162 HD 
patients (Weisbord et al. 2005).  More recently, Thong et al assessed the symptom burden in 1553 
incident HD and PD patients and found a greater prevalence of symptoms to be strongly associated 
with poorer SF-36 scores (Thong et al. 2009).  This relationship between symptoms and HRQOL is 
supported in other studies (Kimmel et al. 2003).  Symptoms can therefore be said to directly and 
significantly influence a substantial component of HRQOL.   
 
Symptoms have also been studied in 1813 patients on HD of different age groups (18-54 years; 55-69 
years and ≥ 70 years) over three years (Unruh et al. 2008).  Symptoms were seen to significantly 
worsen over time in those aged ≥70 years compared to those aged 18-54 years.   Yet the Index of 
well-being (a global QOL score) and patient satisfaction scores improved significantly in those aged 
≥70 years, compared to the 55-64 year group.  Therefore, there appears to be another mediator that 
moderates the impact of symptoms on HRQOL in older people on dialysis, for example expectations 
of health.   
 
Findings relating to the symptoms experienced in those on PD and HD are, however, conflicting.  
Symptom scores were found to be no different between those who started on PD or HD at baseline 
and between three months to one year later (Merkus et al. 1999a; Wu et al. 2004).  Symptom scores 
were, however, found to be better in older patients on PD compared to older HD patients (at 
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baseline only) in a 12 month longitudinal study, although the HRQOL outcomes were similar (Harris 
et al. 2002).  Therefore, the experience of symptoms appears to be similar in both dialysis 
modalities, although there may be some differences in the older population.   
 
2.2.3.3 Physical function 
Physical functioning is a recognised component of HRQOL as it is embedded within the global QOL 
assessment tools such as the SF-36 and the Kidney Disease Quality of Life (KDQOL).  It can also be 
assessed through tools such as the Karnofsky performance status scale.  Physical functioning is 
worse in older compared to younger people on dialysis (Kimmel et al. 1995; Mingardi et al. 1999; 
Moreno et al. 1996), yet appears to decline at a slower rate in the older group (Garcia et al. 2006; 
Kimmel et al. 1995).  Most of the variability observed in the SF-36 scores in a sample of HD and PD 
patients was attributed to physical functioning (Merkus et al. 1997), suggesting that physical 
functioning is an important influencing factor on global QOL. 
 
2.2.3.4 Mental function 
Mental functioning is often evaluated as part of global QOL assessment tools, such as the KDQOL, or 
it can be evaluated through independent tests on cognition such as the MMSE.  To date, there has 
been surprisingly little exploration of the relationship between mental functioning and HRQOL in 
dialysis patients.  In the HEMO study (the National Institute of Diabetes and Digestive and Kidney 
Diseases Hemodialysis Study: a randomised study of the effects of haemodialysis dose and 
membrane flux on outcomes), a decline in cognitive function was observed over three years in those 
aged 70 years and older when compared to younger patients on dialysis, yet the measures of global 
QOL (the SF-36) did not vary significantly (Unruh et al. 2008).   This one study suggests that cognitive 
function does not play a significant role in HRQOL in older patients on dialysis.  The lack of studies 
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which involve investigating the relationship between cognitive function and HRQOL could also 
reflect the challenges in recruiting participants and collecting QOL data in those who have cognitive 
dysfunction. 
 
2.2.3.5 Social function 
Social function describes relationships such as those with family and the support obtained from 
close others, including the staff within the renal unit.  It also refers to the patient’s social activities.  
Social function has been found to have a significant impact on all cause mortality and was associated 
with poorer physical well-being in a large international study (Dialysis Outcomes and Practice 
Patterns Study) involving 32332 HD patients (Untas et al. 2011).  Social support has also been found 
to be positively correlated to satisfaction with life in dialysis patients (Kimmel et al. 1995; Kimmel et 
al. 2003).  Therefore, social function makes an important contribution to HRQOL in those on dialysis, 
although this has not been explored in older people.   
 
2.2.3.6 Health perceptions 
Health or illness perceptions are often evaluated as a single question within QOL assessment tools 
such as the KDQOL and the SF-36 (e.g. “In general, would you say your health is: excellent; very 
good; good; fair or poor”), or can be evaluated through separate questionnaires such as the Illness 
Perceptions Questionnaire.  The Illness Perceptions Questionnaire measures the cognitive and 
emotional representations of illness within a patient (Broadbent et al. 2006).  Studies have shown 
that disruptions in illness perceptions are associated with worsening HRQOL in those on PD and HD 
(Covic et al. 2004; Griva et al. 2009; Kimmel et al. 1995) and may be more relevant to the assessment 
of depression in those on dialysis than the use of objective measures of illness severity such as the 
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index of comorbidities (Sacks et al. 1990).  Therefore, the individuals’ perceptions of their health and 
illness can be said to impact on HRQOL and depression.  
 
2.2.3.7 Overall HRQOL in end stage renal disease 
The study of HRQOL in ESRD began in the 1970’s and early 1980’s (De and Shanan 1980; Levy and 
Wynbrandt 1975).  Results from these studies are not presented here as there have been significant 
improvements in dialysis treatments since and dialysis is now widely available compared to thirty to 
forty years ago, which may render the HRQOL findings as not applicable to dialysis populations 
today.   
 
The two most common global QOL assessment tools used within HRQOL research in those with renal 
disease are the SF-36 and the KDQOL.  The SF-36 produces a summary measure for physical health 
referred to as the physical component summary (PCS) score and a summary measure for mental 
health, referred to as the mental component summary (MCS) score.  When comparing the PCS and 
MCS derived from dialysis populations to those in the general population, the findings have been 
consistent.  Those on dialysis, surprisingly, appear to have MCS scores that are only slightly worse 
than those found in the general population, but these patients have vastly reduced PCS scores 
(DeOreo 1997; Unruh et al. 2008).  Similar findings were also seen in older persons on dialysis when 
compared to the older general population (Lamping et al. 2000).  The other surprising age related 
finding is that older people on dialysis appear to have better MCS scores than younger people on 
dialysis, despite older people’s lower PCS scores (Unruh et al. 2008; Walters et al. 2002).   
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2.2.3.8 Further influences on HRQOL in dialysis patients 
Other dialysis related factors have been found to have a significant influence on HRQOL.  
Significantly better MCS scores (on regression analysis) were observed in those whose first dialysis 
session was planned in advance compared to those whose dialysis was started urgently, despite 
both groups having been attended by a nephrologist over one month prior to their first dialysis 
(Caskey et al. 2003).  A similar finding was reflected in older dialysis patients.  Those who had a 
planned dialysis had comparable SF-36 scores to age and sex matched patients with non-renal 
chronic conditions, and had better scores than patients who had an unplanned dialysis start (Loos et 
al. 2003). 
 
2.2.4 HRQOL and renal replacement therapies 
Differences in HRQOL in patients on different renal replacement therapies have been investigated.  
A meta-analysis found, as expected, that transplantation offers by far the best HRQOL outcomes 
compared to either dialysis modality (Cameron et al. 2000), yet were comparable to those who were 
on HD at home as opposed to in-centre HD.  However, those with a failed transplant who had 
returned to dialysis had the worst HRQOL (Bremer et al. 1989).  There are, however, conflicting 
findings as to which dialysis modality offers the best HRQOL outcomes.  The same meta-analysis 
found greater well-being in those on CAPD compared to those on HD, although this was thought to 
be due to case mix differences.  A twelve month prospective study on patients of all ages reported 
that the HRQOL outcome domains of the “effects on daily life”, “burden of kidney disease” and 
“dialysis care” were all statistically reported as better by patients on PD compared to those on HD at 
one year (Kutner et al. 2005).  A cross-sectional study again found PD to be associated with greater 
satisfaction with treatment and with less  impact of the treatment on patients’ lives, using a 
questionnaire focusing on QOL domains identified from patient interviews (Juergensen et al. 2006).  
However, these findings have not been consistent.  A large cross-sectional study on 16755 HD and 
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1260 PD patients found remarkably similar PCS and MCS scores across the two modalities, although 
there were differences between those on CAPD and APD, suggesting that any studies comparing 
HRQOL in modalities should consider the difference in the mode of PD delivery (Diaz et al. 2000).  No 
differences in HRQOL were found in a twelve month study on prevalent HD and PD patients, 
although those who required assistance with daily care or had a less than a grade twelve level 
education, had significantly poorer HRQOL scores on regression analyses (Manns et al. 2003).  There 
was also no difference in SF-36 scores observed between older people (>70 years) on HD and PD in a 
prospective twelve month study, although this study was based on data collected between 1995 and 
1996, with most being treated with CAPD as opposed to APD (Harris et al. 2002).  Therefore, there 
does not appear to be a consensus as to which modality promotes the best HRQOL.   
 
Initial similarities of HRQOL in older people on PD and HD, together with the comparable survival 
outcomes, lend support to and promote the concept that patient choice, where medically feasible, 
should be the primary determinant of dialysis modality selection.  
 
2.3 CONCLUSION 
This chapter demonstrates that life expectancy for people on dialysis is shorter than for many other 
chronic health conditions.  Alongside this, older people are more likely to be ineligible for 
transplantation due to their increased risks and comorbidities.  Therefore, dialysis is likely to be for 
life, suggesting the need to maximise survival and HRQOL whilst on the treatment.   
 
Neither of the dialysis modalities appears to provide a survival advantage in older people when the 
preparation and planning for the first dialysis is accounted for.  Equally, existing studies seem to 
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suggest that neither of the dialysis modalities appear to offer better results in terms of HRQOL, 
although these have not been extensively investigated in older people.    
 
Existing studies of older people on dialysis present rather confusing HRQOL findings when compared 
to both the younger people on dialysis and the general population.  As anticipated, the physical well-
being scores of older people are considerably worse than those in the general population of the 
same age and worse than those in younger people on dialysis.  However, the same was not observed 
for the mental well-being scores.  These were comparable to those in the general population yet 
better than those seen in younger people on dialysis.  This may suggest that older people’s 
expectations and perceptions of their health are more closely aligned, thereby exerting a 
comparatively positive impact on HRQOL.   
 
The evidence presented surrounding HRQOL and survival outcomes in older people on dialysis, fails 
to explain the increasingly weighted distribution of older people on HD within the UK.  This suggests 
that older people may be predominantly starting on HD due to service related reasons and/or they 
may not be involved in determining their choice of dialysis modality.  The following chapter explores 
the latter by outlining how people make decisions about their dialysis modality.   
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CHAPTER THREE 
3 PATIENT INVOLVEMENT IN TREATMENT DECISION MAKING 
 
“Most patients want to see the road map, including alternative routes, even if they don't want to 
take over the wheel.” 
Richard L. Kravitz & Joy Melnikow. 2001. BMJ, 323, (7313) 586 
 
Bowling & Ebrahim state that “where quality of life and life expectancy issues are an important 
consideration, people’s informed preferences should be as important a factor in healthcare decision 
making as the body of evidence on a procedure’s clinical effectiveness and costs” (Bowling and 
Ebrahim 2001).  The following chapter provides an overview of both decision making theory and 
patient involvement in health care decisions, with a particular focus on dialysis modality choices.   
 
This chapter brings together conceptual theories and empirical evidence derived from the wider 
healthcare, as well as the renal literature to date, to present an overview of the area of patient 
decision making.  Where possible, the evidence is described pertaining to dialysis modality decision 
making in older people.   
 
The chapter begins by describing theories on how people make decisions in general before focusing 
in on patient decision making.  The level of patient involvement in their healthcare decisions has 
changed dramatically over the past years and will be described in relation to changing NHS policies 
and the changing relationship between the patient and the physician.  These relationships are 
described conceptually using three models, with a focus on the increasingly favoured approach of 
shared decision making.  The empirical evidence surrounding how patients make decisions, with a 
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focus on modality decision making and its outcomes, is then described.  This chapter concludes with 
an outline of the aims of this thesis.   
 
3.1 DECISION MAKING THEORY 
How people make decisions in everyday life has generated a great deal of research, literature and 
several theories of decision making.  One of the early decision making theories was termed “Rational 
Choice Theory”.  Rational choice theory is based on the individual having a clear understanding of 
the choice problem that they face, is sure about their preferences in relation to alternatives and is 
able to calculate or determine their best course of action.  The theory also states the individual will 
make the same choice when the options are logically the same, regardless of how the descriptions 
are presented or “framed” (Rubenstein 1998).  Although “rational”, this theory makes an 
assumption that all alternatives have predetermined and established outcomes (Heath 1976) and 
that human behaviour is always rational (Rubenstein 1998).  Rational choice theory also 
(unrealistically) assumes that individuals will have access to and will be able to interpret all the 
available information and that individuals and the information they receive is inherently free of 
biases.  This can be illustrated when applying rational choice theory to dialysis modality decision 
making.  In practice, this form of decision making is often not observed as patients may not have 
access to information, it is not presented in a format that is comprehensive or complete or the 
patient may not engage in a systematic weighing up of information. 
 
More recently, Herbert Simon argued that individuals do not make rational decisions but make 
decisions through “satisficing” (a term used to mean “sufficing” and “satisfying”).  This is a “fast and 
frugal” way of making decisions and makes use of environmental or life experience clues to decide 
between options.  Indeed, this method was shown to be relatively effective in understanding how  
people make decisions when Gigerenzer and Goldstein reported on the “take the best” decision 
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making algorithm, which describes how individuals make decisions in the face of limitations 
(Gigerenzer and Goldstein 1996).  They state that in the choice between two objects, an individual 
will select the object that is most recognised and therefore familiar.  When both objects are 
unknown, then selection occurs at random.  When both are familiar, “cue values” are retrieved from 
memory to assist in the selection process.  A cue that attributes a positive or negative value to one 
object is described as a discriminating cue.  In everyday life, the use of heuristics as discriminating 
cues is very common.   
 
Framing of information is also argued to influence decision making.  Within research on patient care, 
several authors have explored how framing a treatment option shapes a patient’s decision. For 
example, in Malenka et al’s study, 470 patients awaiting an appointment with their GP, were given a 
hypothetical situation where they had to decide between two equally efficacious medications for 
the treatment of a fictitious serious illness, but whose equivalent risks were presented in either 
relative (compared to another option) or absolute terms.  Most of the patients (57%) selected the 
medicine whose benefits were described in relative terms and only 15% were indifferent to receiving 
either medication as they correctly deduced that the relative and absolute risks were identical 
(Malenka et al. 1993).  This influence on patient decision making, related to the manner in which risk 
information is presented, was confirmed in a review of the presentation of risk information (Edwards 
et al. 2001) and can lead to inappropriate treatment selection (Redelmeier et al. 1993).  Other 
heuristics involve previous life experiences and irrational concerns.  Although these cues can provide 
satisfactory and less cognitively intensive ways of reaching a decision, they may also lead to spurious 
selection of treatment options (Redelmeier et al. 1993).    
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In 2011, a systematic review of patient decision making concepts suggested that no single theory of 
decision making could capture the complexity of how patients make decisions (Strohschein et al. 
2011).  Instead, they argued that:  
 
“Patient decision making refers to an ongoing process comprising complex cognitive, 
perceptual, affective, behavioural, and relational components by which individuals select an 
acceptable solution or a salient alternative concerning a health-related issue, influenced by 
interactions among individual and contextual factors, culminating in decisional 
consequences and postdecisional appraisal.” 
 
This definition of patient decision making not only highlights the experiential and temporal aspects 
of decision making but recognises the importance of social context in which decision making takes 
place.   
 
3.2 MEDICAL DECISION MAKING MODELS 
Medical decision making models focus on the decisional control dynamics between the patient and 
the physician.  They have been used extensively to describe the nature of relationships between the 
patient and the physician and how this can impact on medical decisional control.  The relationship 
between patients and physicians has changed over time partly due to the shift in the spectrum of 
illnesses, particularly within developed countries.  In the eighteenth century, the discovery that 
micro-organisms were linked to disease causation led to the creation of the biomedical model of 
medicine (Engel 1977).  This model has promoted scientific investigation to elucidate the cause(s) for 
disease(s), such as identifying specific identifiable agents (e.g. bacterium), and developing targeted 
treatments that will restore the patient to health.  This biomedical approach incorporates a 
predominantly “paternalistic” view to patient care, as the patient is expected to cooperate with the 
physician’s recommended treatment until they return to full health.  The patient is also perceived to 
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contribute little necessary information that would influence the treatment plan.  The biomedical 
approach has lead to improvements in survival and longevity, contributing to the emergence of 
chronic illness prevalent in the aging population.  Therefore, the biomedical approach to patient care 
was possibly more relevant when infectious diseases, such as the small pox virus, were prominent, 
as opposed to chronic illness where the patient manages their condition within their social context 
day to day.   
 
Szasz and Hollender were one of the first to describe different medical decision making models in 
1956.  They portrayed each model as being suited to particular medical circumstances, and being 
equally ethical (Szasz and Hollender 1956).  This is in sharp contrast with how medical decision 
making is viewed today, with shared decision making regarded as the model of choice, as will be 
discussed in the following section.  In 1992, four models in which the different patient-physician 
relationships were described (Emanuel and Emanuel 1992).  Medical decision making is now, 
however, predominantly characterised as three models:  paternalistic, informative and shared.  
These will be described below. 
 
3.2.1 The paternalistic model 
The paternalistic model is reminiscent of the biomedical approach described earlier.  In this model 
the physician has both the responsibility to diagnose the illness or condition and to ascertain what 
treatment can restore the patient to health.  The patient is provided with limited information, with 
the objective to encourage the uptake of the advice recommended by the physician.  There is no 
attempt to understand the patient’s values, behaviours or acknowledgment of how these can 
influence the selected treatment outcome.  This model has been described in several other 
conceptual articles and reviews (Charles et al. 1997; Charles et al. 1999; Emanuel & Emanuel 1992; 
Laine and Davidoff 1996; Ong et al. 1995; Quill and Brody 1996) and there is little dispute that this 
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model has dominated the way in which patient care has historically been delivered.  There is now a 
concerted effort to move away from the traditional paternalistic relationship, yet Whitney et al 
highlighted how its use may be appropriate in certain contexts, such as where the nature of the 
consultation is brief and does not incur the development of a relationship between the physician 
and the patient (for example when a patient visits a walk-in centre for a one off treatment).  It may 
also be acceptable and justifiable in emergency care medicine where time for exploring values and 
deliberating on treatment options may be of detriment to the immediate health of the patient 
(Whitney 2003).    
 
3.2.2 The informative model 
The opposite counterpart to the paternalistic model is the informative model (also called the 
independent choice model) which has also been described by several authors (Charles et al. 1997; 
Emanuel & Emanuel 1992; Quill & Brody 1996).  The physician disseminates their technical expertise 
to the patient about their condition and outlines all possible therapeutic interventions, as well as 
their risks (where known).  Similar to what is seen in the paternalistic model, there is no exchange of 
personal thoughts or ideas from either side.  The physician also refrains from sharing their medical 
expertise and experience by not expressing a personal opinion about the best treatment option and 
the information about the patient’s values is not solicited by the physician.  The patient is given full 
control of the final decision as now, in theory, they have all the information to do so:  the relevant 
medical knowledge as well as their own personal beliefs, values and experiences.  This model 
abdicates the physician from having any responsibility for the decision making process which may 
leave the patient feeling unsupported as they may struggle to incorporate their personal values into 
the medical scenario in question.  It also assumes that the patient will possess the full complement 
of knowledge and understanding required about their condition.  In effect, there is no sharing in the 
decision making process at all.  This model is commonly used in clinical practice to obtain informed 
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consent (del Carmen and Joffe 2005) as is suggested by Braddock who states that “informed consent 
in clinical practice has been influenced by a narrow interpretation as motivated by a legal obligation 
towards full disclosure, rather than an ethical obligation towards mutual decision making through 
fostering understanding” (Braddock, III 1998).  It has also been inferred that this model is commonly 
used as a mechanism to deflect physicians from being sued in the US by providing the patient with 
full autonomy over the decision making process (Quill & Brody 1996).   
 
3.2.3 Shared decision making model 
The two models named “interpretative” and “deliberative” described by Emanuel & Emanuel 
(Emanuel & Emanuel 1992), as well as the “enhanced autonomy” model described by Quill et al 
(Quill & Brody 1996) have features in common with the shared decision making model, formalised 
by Charles et al in 1997 (Charles et al. 1997).  This model is often advocated as the ideal balance 
between patient and physician in relation to decision making about treatment options.  The 
physician shares his or her medical expertise and opinions with the patient, and the patient shares 
his or her experiences, knowledge and values with the physician.  In the end, both contribute to and 
agree on the medical decision.   
 
The shared decision making model has gained significant favour as being the ideal approach to 
medical decision making, as referred to in the latest White Paper “Equity and excellence: liberating 
the NHS” (Department of Health 2010a).  The concept of shared decision making has also been given 
an international platform of prominence through the Salzburg Global Seminar which focused on the 
question of “The greatest untapped resource in healthcare? Informing and involving patients in 
decisions about their medical care.”  This seminar drew on the participation of 58 global experts in 
the field and published “the Salzburg statement on shared decision making” which called upon 
clinicians, policy makers and patients globally to work together to enable shared decision making 
67 
 
(Salzburg Global Seminar 2011).  This seminar did not, however, involve the participation of any 
patients.   
 
Translating the ideal and much favoured concept of shared decision making into practice is, 
however, challenging.  Firstly, it appears that the basic requirements to fulfil shared decision making 
are not present within consultations.  This was demonstrated in a study which assessed videos 
submitted by doctors as part of their application for membership to the Royal College of General 
Practitioners.  The results were disappointing.  Patients’ understanding was checked in only 0.3% of 
consultations, the explanation provided by the doctor only took into account the patients’ beliefs in 
1.1% of consultations, management options were shared with the patient in only 4.3% of cases and 
in only 4.5% of the consultations was health understanding explored (Campion et al. 2002).  A 
further study highlighted the lack of shared decision making in practice by assessing the presence of 
minimal shared decision making criteria in 1057 audio taped encounters between patients and 
either primary care physicians or surgeons.  Only 38.2% of all complex decisions met the minimum 
set criteria for decisions to be classified as “informed” (Braddock et al. 1999).  Another study with 
primary care physicians and patients found that 65% of visits were classified as having a “narrowly 
biomedical” or “expanded biomedical” pattern, which is comparable to the paternalistic approach.  
A more psychosocial pattern (reflective of the shared approach) was seen in only 27% of visits and a 
consumerist pattern (reflective of the informative model) was identified in 8% of visits (Roter et al. 
1997).  The barriers physicians face in implementing shared decision making have consistently been 
identified as the lack of time to discuss psychosocial aspects, the lack of applicability of the use of 
shared decision making with certain patients as well as in certain clinical situations, such as 
emergency care (Gravel et al. 2006; Jones et al. 2004; Legare et al. 2008).  Therefore, physicians may 
not always be able or want to facilitate the practice of shared decision making.  Equally, some 
patients may be uncomfortable with shared decision making as they prefer the physician to be in 
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control of making the decision (Edwards and Elwyn 2006), with some patients actively refusing to 
engage in treatment selection (Fallowfield et al. 1994).   
 
The difficulties in implementing shared decision making has lead to the formulation of practical 
guidance and advice on how to elicit patients’ knowledge and beliefs, such as understanding their 
expectations of treatment as well as their experiences of the condition (Epstein et al. 2004).  
However, a recent Cochrane Review entitled “Interventions for improving the adoption of shared 
decision making by healthcare professionals” concluded that there was insufficient evidence 
available to identify which interventions may be suitable and efficacious in increasing the use of 
shared decision making (Legare et al. 2010).  
 
An additional complicating factor that needs to be considered is that the three models described 
above are not mutually exclusive.  Therefore, within a single consultation, more than one model may 
be present or the decision process may start with one model and evolve into another (Charles et al. 
1999).  It is, therefore, still unclear if shared decision making is the ideal model for all clinical 
situations and how best to implement it into clinical practice. 
 
3.2.4 The medical, social and political context of patient decision making 
Health policies, guidelines and recommendations, which impact on the National Health Service 
(NHS), are shaped by the social and political context.  Furthermore, the extent to which patients are 
involved in their healthcare decisions is also influenced by this context.   
 
In the early years of the NHS (circa 1948), a loyal, long-term relationship was encouraged between 
patients and their GP.  This is the first example of patients being involved in their healthcare 
decisions by being allowed to choose their own GP (Greener 2009).  Little support was provided by 
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way of information that could assist the public in making these decisions.  It was only significantly 
later, in 1996, that it was officially recognised by the government that information was a pre-
requisite to enabling patient choice, so that “they could make informed choices about their own 
lives, know what action to take to help themselves, know when and how to seek help, and so they 
can take part in decisions and choices about care and treatment” (Department of Health 1996).  This 
was the first policy that encouraged patients to have some autonomy in relation to their healthcare 
decisions.  However, the General Medical Council’s “Duties of a Doctor” guidelines at the time (in 
force from 1995 to 1998) made no reference to patient autonomy in supporting patients to care for 
themselves, nor did it hint at sharing decisions with patients about their treatment and care 
(General Medical Council 1995).  Providing the public with healthcare choices was aimed at attaining 
economic benefits through increased competition for patients between providers, which would 
inherently drive up standards of care (Greener 2007).  This approach, however, was argued to 
potentially contribute to widening health inequalities as disadvantaged groups may not be able to 
access healthcare choices as effectively as the middle and upper classes (Fotaki 2010; Greener 2009).   
 
The importance of promoting self-care by empowering patients to take a more active role in the 
management of their long-term conditions was highlighted in the Department of Health’s Wanless 
report as a long-term strategy that would promote a cost-effective, high quality healthcare service in 
2022 (Wanless 2002).  There is a strong body of evidence to suggest that many long-term conditions, 
such as asthma, arthritis and renal failure, benefit from education programmes in self-management 
to improve health outcomes, as well as being cost-effective (Bodenheimer et al. 2002; McMurray et 
al. 2002).  The expert patient programme was also introduced in 2001 in the UK to help patients with 
chronic conditions self-manage their condition, as instructed by tutors who themselves had a 
chronic condition (Department of Health 2001).  This expertise that patients have as to how to 
manage their condition in their everyday lives has meant that patients should have an increasing 
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involvement in decisions about their care as stated by Holman & Lorig “when acute disease was the 
primary cause of illness, patients were generally inexperienced and passive recipients of medical 
care. Now that chronic illness has become the principal medical problem, the patient must become a 
co-partner in the process, contributing at almost every decision or action level” (Holman and Lorig 
2000). 
 
In 2004, “shared” decisions were first mentioned in health policy, where patients were encouraged 
to “make choices and share decisions about their healthcare” (Department of Health 2004a).  This 
has become a major focus within the NHS Constitution, which states that “Patients, with their 
families and carers, will be consulted on all decisions about their care and treatment” (Department 
of Health 2010b).  The latest White Paper, “Equity and Excellence: Liberating the NHS”, emphasises 
that “shared decision-making will become the norm: no decision about me without me” (Department 
of Health 2010a).  Some guidance on how to implement patient centred care is now available for 
doctors in the updated General Medical Council’s “Duties of a Doctor” guidelines (General Medical 
Council 2006). Below are a few of the pertinent guidelines reflecting this approach: 
 
“Listen to patients and respond to their concerns and preferences.” 
“Give patients the information they want and need in a way they can understand.” 
“Respect patients' right to reach decisions with you about their treatment and care.” 
“Support patients in caring for themselves to improve and maintain their health.” 
 
The relationship between the patient and the physician has also changed due to the increased 
accessibility to information, to a large extent due to the availability of the Internet.  Carlsson 
illustrated that the Internet was the only source of information that has increased in use from 6% in 
a sample of oncology patients in 1998 to 45% in 2008 (Carlsson 2009).  This access to information 
has contributed to the development of a more informed and empowered patient who seeks greater 
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collaboration from their health professional (McMullan 2006).   Therefore, as a result of these 
changes and in the context of chronic illness, the patient may wish to be actively involved in and 
share the responsibility of managing their condition with their physicians.   
 
This change in patient involvement is also reflected in a change in physician attitudes towards 
medical information.  In 1960, almost 90% of physicians generally did not tell their patients that they 
had a diagnosis of cancer (OKEN 1961).  There was, however, a considerable shift by 1979, when 
97% of physicians preferred to tell the patient about their diagnosis of cancer (Novack et al. 1979).  
Despite this dramatic change in how information was shared with the patient, there are still a 
number of physicians that have a preference for delivering healthcare in a paternalistic style (Murray 
et al. 2007).  The judicial system has contributed to changing how physicians shared information 
with patients.  In 1972, a legal case (Canterbury vs Spence) was won by a patient who suffered 
paralysis following a laminectomy for severe back pain.  He sued the physician because he was not 
informed of the potential risks involved (Miller 1980).  This, as well as other legal cases, led to the 
emergence of “informed consent” encompassing what a reasonable patient has a right to know 
regarding the risks of forthcoming interventions.  Informed consent is now a well established 
procedure, offering the opportunity for patients to decline medical interventions, despite physicians’ 
recommendations.  Therefore, over a comparatively short period of time, patient autonomy has 
been introduced as a dominant aspect within the patient-physician relationship, replacing the 
traditional paternalism described in the biomedical model.   
 
However, despite these changes in how many patients view their relationship with their physician 
and the policy initiatives embracing shared decision making, the impact of these policies in relation 
to patient choice, has been found wanting.  In 2010, a report investigating patient choice of provider 
by The Picker Institute Europe (an organisation that champions the patient experience by working 
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with patients, health care professionals and policy makers) and The Office for Health Economics and 
RAND Europe (a research institute whose aim is to improve policy and decision making through 
research and analysis) was published (Dixon et al. 2010).  This report found that increased 
competition between providers, through the provision of patient choices, was variably effective, as 
55% of patients were not aware that they had a choice of provider.  Furthermore, healthcare 
providers did not think that patients believed choice to be important, despite 75% of patients having 
rated choice as “important” or “very important”.  This illustrates that providers of healthcare, 
despite the introduction of “empowering” health policies, may underestimate the importance of 
involving patients in decisions.  It also illustrates that the provision of healthcare choices is 
insufficient to ensure that patients and healthcare providers will jointly engage in this decision 
making process. 
 
3.3 PATIENT DECISION MAKING – THE EMPIRICAL EVIDENCE 
Decision making is a process (Flynn et al. 2006) and can change over time (Butow et al. 1997).  A 
systematic review found that patient decision making is composed of three main stages: the 
preconditions that are required for the process of decision making to occur; the factors that affect 
decision making and finally the outcomes of the decision making process (Strohschein et al. 2011).  
These three areas will be discussed in turn, firstly in the context of the evidence on patient decision 
making in general and finally in relation to the findings derived from the study of older people with 
ESRD (where available).   
 
3.3.1 Preconditions to patient decision making 
Prior to patients embarking on a decision making process, a few conditions are necessary.  The 
patients should be aware that they have a choice of alternative treatments.  In addition, their 
involvement should be facilitated by physicians through the provision of quality and timely 
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information.  Finally, the patients must want to be involved in the decision making process.  These 
preconditions will be discussed below.   
 
3.3.1.1 Perception of availability of choices 
The perception of the availability of choices may differ between patients and physicians.  Often, the 
choice between selecting between opting for treatment and opting for no treatment, is not 
considered to be a true choice by patients, yet may be regarded as such by physicians.  This was 
observed in breast cancer patients and in bone marrow transplant patients (Charles et al. 1998; 
Forsyth et al. 2011).  Older patients approaching needing dialysis were not aware that they had the 
opportunity to decline dialysis as the question was never posed openly but was superseded by 
multiple small steps, such as agreeing to have a fistula formed.  Eventually these patients found 
themselves on dialysis without having perceived to agree to the treatment (Kaufman et al. 2006).   
 
Overwhelmingly, patients do want a choice of dialysis modality, as was seen in the Netherlands 
Cooperative Study on the Adequacy of Dialysis (NECOSAD), where randomisation onto either HD or 
PD was offered to new patients eligible for both treatments.  Most (95%) of the patients opted to 
exercise their choice of modality rather than being randomised (Korevaar et al. 2003).  Other studies 
in non-renal populations also confirm that over 95% of patients want to be offered choices in 
relation to their care (Flynn et al. 2006; Levinson et al. 2005).  Despite wanting to be offered choices, 
not all patients approaching, or those already on dialysis, perceive that they have or had a choice of 
modality.  A qualitative study on 20 HD and 20 PD patients who had been on dialysis for 
approximately six months found that all the PD patients, but only eight of the HD patients (40%), 
perceived having had a choice of modality, despite the twelve remaining HD patients not having any 
contra-indications to PD (Wuerth et al. 2002).  Lack of choice and lack of information on treatment 
options were major themes that arose from a qualitative systematic review focusing on the 
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experiences of treatment decision making in renal patients and carers (Morton et al. 2010c).  The 
major area of concern appears to be related to the provision of information about self-care dialysis 
options, with 13% of patients not being aware of its existence and between 60 to 70% not being 
offered or not knowing what self-care dialysis entailed (Lee et al. 2008; McLaughlin et al. 2003; 
Mehrotra et al. 2005).  A recent cross-sectional survey found that only 48% of in-centre HD patients 
had received education or training about PD (Fadem et al. 2011) and 65% of those with stage five 
CKD (not yet on dialysis) did not have any knowledge of PD (Finkelstein et al. 2008a).  However, it is 
likely that international variations play a role as a comprehensive study in Australia on 721 incident 
pre-emptive transplant, dialysis and conservatively managed patients found that 84% had been 
presented with options before starting their treatment (Morton et al. 2010b).  This high proportion 
could be due to the considerable distances between the patients’ home and their nearest HD facility, 
thereby leading to the necessity to promote home therapies.   
 
3.3.1.2 Appetite of patients for involvement in decision making 
Several studies have investigated the degree of patient involvement in medical decision making, 
both from the patients’ and the physicians’ viewpoints.  Patients, in general, do not agree on their 
preferred level of involvement in decision making.  Several patients would rather leave the decision 
making in the hands of their physician, whilst others prefer to make a joint contribution to the 
decision, yet many patients prefer to be responsible for the final decision (Butow et al. 1997; Degner 
et al. 1997).  This is also reflected in patient preferences for involvement in the dialysis modality 
decisions, where 34.6% were found to prefer to make their own treatment decisions, 41.5% wanted 
equal input with their healthcare professional and 23.9% preferred the healthcare team to make the 
decision for them (Orsino et al. 2003).  These preferences are, however, dynamic and can change 
over time.  As an example, only 31% of oncology patients expressed the same preferences for 
involvement at two consecutive appointments which were between three and six months apart 
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(Butow et al. 1997).  There is increasingly, however, an appetite for greater patient involvement.  A 
large scale survey in the UK, lead by the Department of Health, found that 75% of the respondents 
thought that involving patients (in general) in decisions about their illness and treatments was one 
of the most important aspects of care and 51% felt that involving patients in decisions was the area 
in need of the most improvement (MORI 2003).  Half the respondents were, however, staff working 
for the NHS and only 35% were members of the general public.     
 
There are also demographic associations with preferences for decision making involvement.  Older 
people appear to prefer less involvement, as do males and those who have serious health conditions 
(Benbassat et al. 1998; Levinson et al. 2005).  The Medical Outcomes Study involved a large sample 
of patients (n=2197) with chronic conditions (hypertension, diabetes, clinical depression and heart 
disease) which showed that a staggeringly high proportion (62%) of patients preferred a passive role 
in decision making (Arora and McHorney 2000).  Cultural influences have also been noted to be 
associated with decision making preferences (Levinson et al. 2005).  One study found a higher level 
of participatory decision making in race concordant compared to race disconcordant patient and 
physician consultations, suggesting that cross-cultural communications may need to improve to 
enhance patient involvement in decision making (Cooper-Patrick et al. 1999).   
 
There is, however, a critical gap observed between patients’ preferred and their actual (or 
perceived) level of involvement.  This was observed in a retrospective survey where at least 25% of 
patients would have preferred more involvement than that which was experienced, in the selection 
of their dialysis modality (Orsino et al. 2003).  Another study observed how 46% of a sample of 
oncology patients expressed a preference for greater involvement in decisions prior to their second 
consultation compared to prior to their first consultation (Butow et al. 1997). 
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3.3.1.3 Information on options 
Patients appear to value receiving information about their treatment options, even when they do 
not want to be involved or responsible for treatment selection (Caress et al. 2002; Coulter et al. 
1999).  This was also observed in older primary care patients, who despite preferring a passive role 
in decision making compared to younger people, still express a desire for good information about 
their healthcare (Bastiaens et al. 2007).  A Department of Health survey found that the vast majority 
of respondents (88%) felt that they needed more information to make decisions and choices about 
their treatment (MORI 2003).  Despite the participants of this survey being mainly NHS or voluntary 
organisation staff, findings amongst primary care and cardiac patients in other studies have been 
similar (Ford et al. 2003; Kennelly and Bowling 2001).   
 
Studies of dialysis patients have highlighted that the type of information received is also important 
in making treatment decisions.  A retrospective survey found that dialysis patients were least 
satisfied with the quality of information received on psychosocial aspects, such as adaptation to 
everyday life on dialysis (Coupe 1998).  This was confirmed in a small qualitative study where pre-
dialysis participants expressed concerns about the impact of dialysis on their lives as opposed to the 
medical consequences (Iles-Smith 2005).  This suggests that there may be a lack of psychosocial 
information provided to renal patients to prepare them for life on dialysis.      
 
The quality of the information provided can influence the patients’ decision making process.  
Information can be compromised by the weighting of the information presented, incompleteness 
and limited time which can limit the usefulness of quality information.  A qualitative study 
demonstrated that patients make modality decisions, regardless of the quality of the information 
they receive (Whittaker and Albee 1996), suggesting that patients will make “fast and frugal” choices 
as described earlier.  The timing of information was seen to dramatically influence modality choices.  
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Receiving modality education prior to starting dialysis was shown to significantly influence the odds 
of patients selecting PD (odds ratio 2.0, p=0.019 on logistic regression analysis) compared to those 
who received modality education at the time of, or after having started dialysis (Little et al. 2001).  
Increased selection of PD with predialysis modality education was a common finding in large cross-
sectional studies (Goovaerts et al. 2005; Jager et al. 2004; Marron et al. 2005; Stack 2002) as well as 
in smaller qualitative studies (Wuerth et al. 2002), although the reasons for this are not clear.  
Weighting of education can also influence choice of modality.  This was seen in a randomised 
controlled trial where an educational programme focusing on self-care dialysis was observed to 
significantly increase the proportion of patients selecting self-care options compared to standard 
predialysis education (Manns et al. 2005).  Therefore, timing and content of information delivery can 
influence modality decision making.   
 
3.3.2 Factors influencing patient decision making 
Factors that form part of the context of the patient can influence their decision making. The 
contextual factors discussed include the influence of others (families, peers and physicians) and the 
influence of previous life experiences.   
 
3.3.2.1 The influence of others 
The relationship of patients to close others, such as their family or partners, plays a critical role in 
decision making, especially when the decision has consequences to those around them.  Charles et 
al expanded their initial model of shared decision making to account for the inclusion of the role of 
significant others in the decision making process (Charles et al. 1999).  One survey study found in 
those who had made a complex health decision over the past two years (n=413), over half stated 
that family members had been involved in the decision process (O'Connor et al. 2003).  The 
involvement of others has also been observed empirically in qualitative studies in cardiac as well as 
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oncology patients (Forsyth et al. 2011; Howard et al. 2011; Kennelly & Bowling 2001) and has also 
been reported by dialysis patients where families were involved in the decision about modality type 
(Breckenridge 1997; Kelly-Powell 1997; Whittaker & Albee 1996).  This was particularly evident in 
the selection of PD compared to HD, since PD may require additional family support as it is a home 
based therapy (Stack 2002; Wuerth et al. 2002).  Families themselves also expressed a desire to be 
part of the dialysis modality decision making process (Lee et al. 2008).   
 
There was also an indication in the literature that patients value other patients’ experiences and 
seek out those who have undergone the same medical interventions to assist them in their decision 
making (Howard et al. 2011).  Peer experiences are influential on treatment decision making in those 
with a range of chronic illnesses, including renal failure (Kelly-Powell 1997).  Predialysis patients 
sometimes regard peer experiences as valuable sources of information about modality, as well as 
providing a sense of what the future may hold (Iles-Smith 2005; Tweed and Ceaser 2005).  However, 
some patients may dismiss a particular dialysis modality upon becoming aware of a negative aspect 
of the treatment through others, as highlighted in a systematic review by Morton et al (Morton et al. 
2010c).  Patient stories, however, were not rated as being of great interest compared to other 
topics, such as diet, in those who were already living with their chosen treatment option, whether 
that be dialysis or transplantation (Fadem et al. 2011).  This could indicate that patient stories are 
more valued when the patient is involved in making a complex medical decision.   
 
The decision making process is also greatly influenced by recommendations made by the physician.  
It was not uncommon for patients to consider their physician’s opinion before making a complex 
medical decision, as was found in 39% of patients through a telephone survey on 635 Canadians 
(O'Connor et al. 2003).  A web based questionnaire on 102 members of the public in the US, found 
that a significant proportion would change their hypothetical preferred treatment option based on 
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their physicians recommendation, even when this option was counter intuitive for maximising health 
(Gurmankin et al. 2002).  Some of the cited reasons for this were interesting and included individuals 
thinking that their physician had additional information that they were not privy to or that simply 
the “physicians know best” (Gurmankin et al. 2002).  In relation to dialysis, a qualitative study found 
that those who did not perceive a choice of modality relied on the recommendation of their 
physician and started on HD.  The majority (33/40; 83%) of this sample of PD and HD patients 
reported their modality selection was influenced by their physician (Wuerth et al. 2002).  This was 
also confirmed in a large cross-sectional survey where 66% (242/369) of in-centre HD patients were 
influenced by their doctor’s recommendation, possibly because they were considered to be the most 
valuable source of information (Fadem et al. 2011).   
 
3.3.2.2 Prior experiences 
A less well explored area within the literature is the influence of prior personal experiences on the 
decision making process, including modality selection, with Kelly-Powell stating that “past personal 
experiences provided the respondents with a frame of reference by which to judge specific 
treatments” (Kelly-Powell 1997).  Some predialysis patients referred to their past experiences 
providing them within insight into renal disease and dialysis (Iles-Smith 2005).  This is an under-
explored resource that is highly variable within individuals, yet one that can play an influential role in 
decision making.   
 
3.3.3 Outcomes of the patient decision making process 
Several different outcomes have been explored in relation to the different styles of decision making.  
These have been of mixed benefit to the patient.   
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3.3.3.1 Patient and physician satisfaction 
Being involved in the decision making process appears to incur benefits to the patient in relation to 
their satisfaction with the physician’s commitment to sharing information (Edwards & Elwyn 2006).  
Both patients and physicians were found to be the most dissatisfied with the biomedical pattern of 
communication (comparable to paternalism), with patients preferring the psychosocial approach 
(comparable to shared decision making) and physicians preferring the consumerist approach which 
is similar to the informative model (Roter et al. 1997).  However, when the patient needed simple 
medical assistance, for example a prescription, the paternalistic approach yielded the greatest 
satisfaction from the patient (Savage and Armstrong 1990).  Therefore, decisions that benefit from 
the sharing of information appear to provide the greatest level of satisfaction to both patients and 
physicians, although there is still some discrepancy as to the approach (shared compared to 
informative models of decision making).   
 
3.3.3.2 Psychological outcomes 
A few studies have reported that the level of involvement in decision making can influence 
psychological outcomes.  A prospective study on 269 women with early stage breast cancer 
compared psychological outcomes in those who had a choice of treatment (masectomy or breast 
conservation surgery), to those whose surgeon decided on their treatment option (Fallowfield et al. 
1990).  Patients who were offered a choice experienced less depression (as assessed by a screening 
tool) than those who had their treatment selected for them.  This was, however, of borderline 
significance on multivariate analysis up to 12 months post surgery (p=0.06), but increased in 
significance (p=<0.05) after three years post surgery (Fallowfield et al. 1994).  Interestingly, out of 
those who were given a choice, there was no difference in depression between those who selected 
their own treatment and those who were unable to do so due to medical contraindications. This 
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finding was also sustained at three years post surgery (Fallowfield et al. 1990; Fallowfield et al. 
1994).   
 
Improved psychological outcomes may not solely be attributed to the level of involvement in 
selecting a treatment option.  A review found that patients’ emotional health was seen to improve 
when physicians’ quality of history taking and discussion of management options improved (Stewart 
1995).  Another review suggested that when a physician engages in patient-centred care by listening 
and demonstrating compassion, then patient outcomes are also better in reference to their 
psychological status (Heritage and Maynard 2006).   
 
Therefore, improvement in psychological outcomes may be due to patients perceiving that the 
physicians are more engaged in their care, which may be a consequence of involving patients in their 
healthcare decisions.  No studies have investigated the relationship between psychological 
outcomes and patient involvement in dialysis modality decision making.   
 
3.3.3.3 Additional outcomes 
Other outcomes that have been explored in relation to involvement in decision making relate to 
physiological parameters, health literacy and adherence to medications.  
 
 A review by Coulter & Ellins sought to quantify the effectiveness of strategies that inform, educate 
and involve patients in their care.  Improvements were found in blood pressure and blood sugar 
control either through self-management programmes or through improved communication between 
patient and physician (Coulter and Ellins 2007; Stewart 1995).  Health literacy was also enhanced 
when well designed information leaflets were used as an additional source of information to the 
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consultation (Coulter & Ellins 2007).  This is especially pertinent as it has been shown that recall of 
information is very poor post consultation (Lloyd et al. 1999).   
 
Cost as an outcome is particularly pertinent in the current economic environment.  The Coulter and 
Ellins review found that patient involvement in treatment decision making can, in some cases, lead 
to cost improvements as fewer patients opt for treatment interventions (Coulter & Ellins 2007).  A 
review also concluded that adherence to medication improved after multiple sessions of a patient 
education program (Joosten et al. 2008).  Joosten et al also found that neurtral outcomes of the 
shared decision making process were likely to occur when the intervention was composed of a single 
session of patient education as opposed to a program of care (Joosten et al. 2008). 
 
There is a school of thought that shared decision making may be difficult to implement (and result in 
mixed outcomes) because the concept fails to acknowledge the inescapable asymmetry that lies at 
the heart of the patient-physician relationship.  The doctor will always have authority due to their 
medical expertise and the patient will always seek out the physician for medical attention and 
guidance.  Therefore, interventions may benefit from acknowledging and accepting this principle, 
rather than promoting a shared partnership which the physician may feel is inappropriate and which 
the patient may not be satisfied with (Pilnick and Dingwall 2011). 
 
3.4 CONCLUSION 
This chapter highlights that patient decision making is a complex and evolving process.  Due to 
political, social, cultural, economic and medical reasons, shared decision making is increasingly 
perceived as the optimal way to manage patients’ medical decisions, especially in those with long-
term conditions.  There are, however, several requirements to enable successful shared decision 
making.  One of these requirements is that the patient should be aware of the options available.  
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Evidence suggests that over half of dialysis patients (as well as those who are approaching needing 
dialysis) are unfamiliar with the existence of self-care dialysis modalities such as PD.  In addition, 
those who are aware of the alternatives may not have been provided with information that is 
complete, balanced and delivered in a timely manner, to engender a sound decision.  Therefore, 
patients are vulnerable to selecting a dialysis treatment that may not have been their preferred 
choice, had they been provided with the proper information.  The opinion or recommendations by 
the physician also carry great weight with patients and may even, in some instances, replace patient 
education on treatment options, as has also been observed in HD patients.   
 
Unsurprisingly, due to the complexities surrounding patient involvement in their care, the reported 
outcomes have been mixed, although positive outcomes are more likely to occur after multiple 
interventional sessions, as opposed to just a single session.  The main benefits to patient 
involvement have been reported in the domain of psychological outcomes, although some 
physiological and cost saving benefits have also been observed.  Very little evidence exists, however, 
in relation to outcomes after involvement in dialysis modality decisions or how older people are 
involved in their modality decisions.   
 
3.5 THESIS AIMS 
The introductory chapters have highlighted that the population is aging, with an increasing number 
of older people developing ESRD and being offered treatment with dialysis.  As older people are 
likely to be on dialysis for the rest of their life, maximising longevity and QOL on dialysis are key 
priorities.  To date, neither HD nor PD appears to offer advantageous survival outcomes.  Neither is 
QOL reported to be better on either modality, according to the limited evidence available.  Despite 
this, there is an increasing trend for older people to commence on HD as opposed to PD in the UK, 
suggesting that other factors, aside from patient preference, are at play.  As cost does not appear to 
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be the determining factor since estimates rate PD treatments as costing less than HD treatments, 
the main focus lies on how older people perceive their modality options and the level of involvement 
that they have in their dialysis modality selection.  Exploring this focus will go some way to explain 
the current distribution of dialysis modalities within the UK in older people.   
 
This thesis aims to answer the following questions around the issues highlighted above: 
 
i. Are the quality of life outcomes in older people different in those on HD compared to PD?  
ii. How and to what extent are older people involved in selecting their dialysis modality?  
iii. What influences older people’s involvement in dialysis modality selection and how does this 
impact on their experiences of living with dialysis?   
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CHAPTER FOUR 
4 COMPARISON OF HEALTH RELATED QUALITY OF LIFE IN OLDER 
PEOPLE ON PERITONEAL DIALYSIS AND HAEMODIALYSIS 
 
4.1 INTRODUCTION 
The null hypothesis tested in this study is that there is no difference in the HRQOL in older people on 
PD and HD.  Therefore, the primary aim was to compare HRQOL in older people on HD and PD 
through the use of various measures. 
  
As has been shown in chapter one, the older population tends to differ from those who are younger 
in aspects of physical as well as mental functioning.  Age related differences are also reflected in 
HRQOL outcomes, suggesting that it would be inappropriate to extrapolate these findings from the 
younger population and apply them to older people.   As dialysis tends to be a lifelong treatment in 
older people, investigating the HRQOL achieved on PD and HD is an important outcome to 
determine.   
 
In this Broadening Options for Long-term Dialysis in the Elderly (BOLDE) study, I will update and 
extend the findings from a previous twelve month prospective study which focused on HRQOL in 
older people on dialysis (amongst other issues), based in the North Thames region in the UK (Harris 
et al. 2002).   The Chief Investigator for BOLDE (Professor Edwina Brown) was heavily involved in this 
original study.  The findings from the original study may not be applicable to the dialysis population 
in 2011.  This is because the participants (70 years and older) were recruited between 1995 and 
1996.  During this period, as can be seen in Figure 1-3 and Figure 1-4, it is likely that not all older 
86 
 
people with ESRD were being offered dialysis as is most often the case today.  The North Thames 
study investigated the SF-36 as the only HRQOL outcome and did not explore several other possible 
confounders such as depression and cognitive function, the former which is now known to influence 
HRQOL.  This BOLDE study, therefore, aims to gain a deeper insight into the HRQOL in older people 
on PD and HD by undertaking a range of HRQOL assessments and by ensuring the patients on each 
modality were comparable in a number of demographic characteristics. 
 
4.2 STUDY DESIGN 
This BOLDE study is cross-sectional in design and involves quantifying HRQOL in two “matched” 
groups of patients which will enable the study to test the hypothesis and provide evidence for the 
aim.  A longitudinal study design was not employed as the hypothesis does not relate to change in 
HRQOL over time, nor was the study designed to understand what contributes to, or predicts 
changes in HRQOL.   
 
4.3 LOCATION OF THE SAMPLE 
The participants of this study were recruited from three renal units based in the South East of 
England.  The three renal units belonged to the following hospitals (and NHS trusts):  Imperial Renal 
and Transplant centre at Hammersmith Hospital (Imperial College Healthcare NHS Trust), Lister 
Hospital (East and North Hertfordshire NHS Trust) and St Helier Hospital (Epsom and St Helier 
University Hospitals NHS Trust).  A comparison of the dialysis populations within the three renal 
units is presented in Table 4-1.  The figures are presented from 2008 as that is when the majority of 
the recruitment for the study occurred.  The renal units are very different in size as reflected in the 
number of prevalent patients on the different dialysis modalities.  There is also a noticeable 
difference in the proportion of older people on PD or HD at 90 days (incident patients).  This 
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information suggests that the likelihood of starting on either PD or HD are different between the 
three renal units.  The Imperial Renal and Transplant centre is not only the largest renal unit but it 
also has the highest proportion of non-white patients on dialysis, even when allowing for a high 
proportion of missing data.   
 
Table 4-1: Features of the dialysis populations from the three renal unit recruitment sites (2008) 
Features Imperial  St Helier  Lister  
Prevalent HD population, n (%) 1236 (96.6) 630 (83.1) 364 (90.1) 
Prevalent PD population, n (%) 44 (3.4) 128 (16.9) 40 (9.9) 
% of incident patients aged ≥ 65 years on HD 93.5 85.4 93.0 
% of incident patients aged ≥ 65 years on PD 6.5 14.6 7.0 
White Europeans on RRT, % 38.2 69.3 76.6 
Blacks on RRT, % 13.5 8.3 7.2 
Asians on RRT, % 20.2 10.1 14.7 
Chinese on RRT, % 0.6 1.5 0.7 
Other ethnic backgrounds on RRT, % 8.8 2.7 0.9 
Missing ethnic backgrounds % 18.8 8.0 0.0 
RRT:  Renal Replacement Therapy.  Data obtained from the twelfth annual report from the Renal Registry 
(Byrne et al. 2009). 
 
4.4 PARTICIPANTS 
The participants were all aged 65 years or older, had ESRD and were being treated with either PD or 
HD.  All participants had been on dialysis for at least 90 days.  This latter criterion helped identify 
patients that were established on a particular treatment modality.  Patients were excluded from 
participating in the study if they had comprehension difficulties that would hinder the completion of 
the assessment forms, if they had been an inpatient in the previous thirty days or if they had an 
expected survival of less than six months.  These exclusions ensured that the participants had a 
cognitive ability that enabled them to undertake the multiple assessments and were clinically stable 
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as determined by their hospital admissions and anticipated length of survival.  Clinical stability was 
deemed important for assessing and comparing HRQOL.  Language was not a barrier to participating 
as the provision of interpreters was available.  The target sample size was limited by the availability 
of suitable PD patients and was therefore set at 70 patients for each modality treatment.  In support 
of this sample size, a power calculation based on the global QOL measure of the SF-36 PCS and MCS 
scores in older people on HD and PD, determined that at least 67 HD and 67 PD patients would be 
required to detect a clinically relevant difference of 3.6 points in the PCS score and 3.1 points in the 
MCS score, at a significance level of 5%, to achieve 80% power.  The power calculation could not be 
based on SF-12 scores as this measure has not been previously reported in older patients on dialysis.  
The scores from the two measures (SF-12 and SF-36), however, are interchangeable as will be 
explained later in further detail in section 4.8.1.1.  The SF-12 was selected as the primary outcome 
measure (as it is a shorter questionnaire compared to the SF-36), with the remainder of the HRQOL 
assessments used as secondary outcome measures.   
 
As the study was designed to compare the HRQOL outcomes in those on PD and HD, the participants 
were recruited in pairs.  Each pair was composed of one HD and one PD participant who were 
matched across six demographic characteristics:   
i. Age (± two years) 
ii. Sex 
iii. Time on dialysis, excluding time treated with transplantation (± one year) 
iv. Ethnic background 
v. Index of deprivation (IOD) score (a measure of social economic status, to be discussed later 
in this chapter)  
vi. Renal centre 
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These matching criteria were chosen as they were potential influencers on how individuals perceive 
their HRQOL.  This has been demonstrated in the literature in relation to age, sex and ethnic 
background.  Time on dialysis, IOD score and the renal centre are thought to potentially have an 
influence on HRQOL and were readily accessible as screening characteristics.  The influences of 
additional characteristics on HRQOL, such as comorbidities, were to be accounted for in the final 
statistical analyses.   
 
4.5 RECRUITMENT 
Participants were recruited between November 2007 and January 2009.  In order to obtain pairs of 
patients who were matched to each other, I had to recruit the PD patient first since the pool of 
potential HD participants was far greater than that of PD patients.  Therefore, each HD participant 
had to be matched to the characteristics of a recruited PD participant.  Prior to initiating the 
recruitment of the PD patient, I ensured that there was a suitable match on HD by screening patient 
lists that held the patients’ date of birth, gender and dialysis start date.  The renal team (the lead 
nurse or consultant) further screened the suitability of both HD and PD patients for the study by 
highlighting issues such as the need for an interpreter or ability to complete an hour’s worth of 
questionnaires.  In some cases, there still remained more than one suitable HD patient match for a 
PD patient.  In this case, the HD patient who had the closest Index of Deprivation (IOD) score to that 
of the PD patient was selected.  Once the patients were identified as suitable for the study, they 
were approached by a member of the renal team to discuss their potential interest in participating 
and to provide verbal consent for me to contact them with further details.  If they remained 
interested, the patients were sent an information sheet about the study which they were able to 
read and reflect on over a period of at least one week.  If they were still interested in participating in 
this study, a mutually agreeable time and place was arranged for the study visit.  All participants 
signed an informed consent form prior to participating in the study visit.   
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As the researcher responsible for recruitment, I was conscious that the control I had over sample 
selection could potentially bias the results.  This risk of biasing the results was mitigated as I 
approached all PD patients who fit the inclusion criteria and the screening of the HD patients was in 
the hands of the lead nurse or consultant.  If there was a choice between two or more suitable HD 
patients, the decision was made objectively based on IOD scores.   
 
4.6 SETTING 
All participants were seen in a hospital or HD satellite unit rather than in their homes.  It was 
important to ensure that all participants were seen in the same setting as it was possible that 
participants may answer questions differently depending on their surroundings.  The hospital setting 
was also selected as it was thought to be the most time efficient way of collecting the data, without 
compromising the results.  PD patients were seen on either side of their routine clinic appointments 
or attended the hospital on a separate occasion (with their transport expenses reimbursed).  HD 
patients were seen prior to their dialysis session or on their non-dialysis day.  There is evidence to 
suggest that after dialysis, HD patients experience a considerable amount of fatigue (Lindsay et al. 
2006), which could influence how they respond to questions about their QOL.  There is, however, 
also evidence to suggest that patients on HD perform better cognitively after dialysis compared to 
before, thus there is also an argument for interviewing after dialysis.  As the study visit was time 
consuming and the population was elderly, minimising the fatigue post dialysis was prioritised.   In 
addition, the aim of the study was to investigate HRQOL and not cognitive function.  The option of 
conducting the assessments during the HD session was dismissed due to the lack of privacy, as well 
as the likelihood for multiple interruptions and distractions.   
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4.7 THE ASSESSMENT 
The study visit was composed of the collection of demographic and biochemical data, undertaking a 
depression screen, as well as nutritional status, cognitive and HRQOL assessments.  The data 
collected included several items that could be possible confounders in the statistical analyses of the 
HRQOL outcomes.  The assessments were conducted in a specific order (see Table 4-2) and this 
sequence was used for each patient.  The priority was to complete the cognitive function assessment 
tools at the start of the visit when the participant was relatively “fresh” and to leave the easier 
assessments and demographic data collection towards the end of the visit.   
 
Table 4-2: Order, category and assessments tools used during the study visit 
Order Assessment category Assessment tools 
1 Cognitive function Trail making test-B 
2  Mini-mental state examination 
3 Social networks Social networks  
4 QOL Symptom assessment tool 
5  Illness Intrusiveness Ratings Scale 
6 Depression screen Hospital Anxiety and Depression Scale 
7 QOL Short form – 12 (version 2) 
8 Nutritional status Subjective Global Assessment 
9 Physical function Hand grip strength 
10 Demographics Years of education, smoking, age, sex, cause of renal failure, 
dialysis start date, renal replacement therapy time line 
11 Clinical data Comorbidities, hospital admissions in previous twelve 
months, dialysis adequacy, list of medications, PD regimen 
and blood values 
 
It was impossible to be blind to the participant’s treatment modality, so in theory, there was a 
possibility that my awareness could have influenced the results.  This was minimised by delivering all 
the assessments in a standardised interview procedure and using highly structured questionnaires.  
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Each patient was provided with as much or as little assistance as required in order to maximise data 
completion.  This involved one patient having to complete the assessments over two visits due to 
fatigue.    
 
4.8 QUESTIONNAIRE TOOLS 
As can be seen from Table 4-2, multiple questionnaires were used.  Each tool will be explored in 
relation to its development, validity and sensitivity, its suitability for use with the current sample and 
how the tool is scored, analysed and interpreted.  
 
4.8.1 Health Related Quality of Life assessment tools 
Three HRQOL assessment tools were included in the study visit: the short form–12 version 2 (SF-12); 
the Illness Intrusiveness and Ratings Scale and the symptoms assessment tool.   
 
4.8.1.1 Short form 12-version 2 (SF-12) 
Background 
The Short Form-36 (SF-36) is one of the most widely used tools for capturing a quantitative global 
QOL score in patients (including those with ESRD) and non-patient groups.  It was first described in 
1992 (Ware and Sherbourne 1992).  It has been used extensively and can be applied to different age 
groups and is available in fifty languages, allowing for comparisons to be made between diverse 
populations.  The SF-36 is composed of 36 questions whose responses are grouped into eight scales 
(physical functioning, role limitations because of physical health problems, bodily pain, social 
functioning, general mental health, role limitations because of emotional problems, vitality and 
general health perceptions), which can be assimilated into a Physical Component Summary score 
(PCS) and a Mental Component Summary score (MCS).  The SF-36 was found to be clinically valid as 
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it distinguishes between different patients groups: those with minor chronic medical conditions, 
serious chronic medical conditions, psychiatric conditions only and serious medical and psychiatric 
conditions (McHorney et al. 1993).  The SF-36 PCS and MCS scores were found to predict mortality 
and hospitalisations in a large sample of patients who were on HD (Lowrie et al. 2003).  The SF-36 
was, however, considered to be too long to be used in some studies and this led to the creation of 
the SF-12.  The SF-12 only yields a MCS and PCS score rather than the additional eight scales.  The 
SF-12 was designed to achieve MCS and PCS scores that would reflect at least 90% of the variance 
found in the SF-36 MCS and PCS scores.  It was validated in a sample of patients with the chronic 
conditions of hypertension, congestive heart failure, depression, myocardial infarction and Type II 
diabetes.  The resulting R2 values when using the SF-12 to predict the SF-36 was 0.904 for the PCS 
scores and 0.939 for the MCS scores, indicating that the two are directly comparable (Ware, Jr. et al. 
1996).  The SF-12 is, however, less reliable than the SF-36 at distinguishing between groups who 
suffer either from a mental or physical condition.  This effect is minimised in larger population sizes 
of, for example, 500 people.   
 
Research evidence for use in renal populations 
High correlation coefficients of 0.94 were found between the SF-12 and SF-36 MCS and PCS scores in 
a large population of dialysis patients (n=44395, 6% on PD).  In addition, the SF-12 was as effective as 
the SF-36 at predicting mortality and hospitalisation outcomes (Lacson E Jr et al. 2010).  Therefore, 
the SF-12 is appropriate for use in dialysis patients.  It is especially suitable for assessing the global 
QOL in an older age group where this is one of several assessments, thereby minimising completion 
burden.   
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Structure, administration and scoring 
The SF-12 is significantly shorter in length compared to the SF-36, is composed of 12 questions and 
takes approximately two to three minutes to complete.  The SF-12 form is presented in appendix 
11.1.1.  The MCS and PCS scores range from 0 to 100.  The higher the score, the better the QOL 
outcome.  The SF tools also use “norm based scoring”, which allows for comparisons to standardised 
values for the general population which equate to a mean score of 50 and a standard deviation of 10 
for both the PCS and MCS scores.    
 
4.8.1.2 Illness Intrusiveness and Ratings Scale (IIRS) 
Background 
Illness intrusiveness is defined as “the degree to which chronic, life threatening illness and its 
treatment interfere with continued involvement in valued activities and interests” (Devins et al. 
1990b).  The assessment tool was developed in patients with ESRD and has now been validated for 
use across a number of other chronic conditions (Devins et al. 2001).  The life domains included in 
the IIRS are based on categories which were found to influence QOL, as identified by Flanagan, who 
investigated these determinants in 1000 30 year olds, 1000 50 year olds and 1000 70 year old 
Americans (Flanagan 1982).  Greater illness intrusiveness has been found to be related to several 
other measures including the presence of depression and distress.  It has also been found to be 
stable over time when repeated within a six week period (r=0.79), suggesting that the measure is 
reliable (Devins 1994).  A copy of the tool can be found in appendix 11.1.2. 
 
Research evidence for use in renal populations 
The IIRS was found to produce significantly different results in patients with a functioning transplant 
and those on dialysis, regardless of modality, indicating that this tool can discriminate between 
treatments that have very different impacts on lifestyle (Devins et al. 1990b).  This study involved 99 
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patients of all ages and found that those with a transplant experienced significantly less illness 
intrusiveness, whereas no significant differences were observed between patients on the different 
dialysis modalities (in-centre HD, home HD and CAPD).  This study also found higher IIRS scores to be 
significantly associated with increased depression and distress (Devins et al. 1990b).  There were, 
however, several limitations.  The study included only ten participants on CAPD and the analyses did 
not account for differences in all the comorbid conditions.  Therefore, it would be valuable to 
measure the intrusiveness of the dialysis treatment on the lifestyle of older people on PD and HD 
taking into account the influence of factors such as depression, social networks and comorbidities.  It 
was also observed that increased uraemic symptoms (fatigue, restless sleep, headache and muscle 
cramps) are associated with worsening perceived illness intrusiveness (Devins et al. 1990a; Devins et 
al. 1990b; Devins et al. 1993a).   
 
Structure, administration and scoring 
The IIRS assesses the level of illness intrusion on thirteen life domains in five areas: physical well-
being and diet; work and finances; marital and family relations; recreation and social relations and 
other activities such as self-expression, religious expression and community and civic activities.  The 
scoring for the level of intrusion (“the degree to which your illness and/or its treatment interferes 
with...”) ranges from a score of one, which is equivalent to “not very much”, through to a score of 
seven which equates to “very much”.  The final score is the sum of the level of intrusion for each life 
domain and ranges from 13 to 91 and is therefore a continuous outcome.  The questionnaire is most 
often completed within ten minutes.   
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4.8.1.3 The assessment of symptoms 
Background 
Symptoms are an important component of the assessment of HRQOL, as seen in Table 2-1.  Indeed, 
several studies in patients on dialysis have confirmed a strong association between worsening 
symptoms and worsening HRQOL scores (Merkus et al. 1999a; Thong et al. 2009; Weisbord et al. 
2005).  Symptoms can be regarded as signs that comprise evidence of disease.  They are subjective 
as their presence and attributed importance depends on the individual’s perception.  Patients with 
ESRD are vulnerable to experiencing several symptoms due to the physiological consequences of 
their declining renal function and possibly due to coexisting illnesses.  Treatments such as dialysis or 
medications may in themselves lead to an additional array of symptoms.  All this can occur on the 
background of the physiological changes that accompany aging, which may lead to the emergence of 
a different spectrum of symptoms to those related to ill health.  Therefore, it may be challenging for 
older people on dialysis to determine the underlying cause of their symptoms.      
 
Several symptom assessment tools have been developed and validated for use in patients on 
dialysis, two examples of which are the Dialysis Symptom Index (Weisbord et al. 2004) and the 
Edmonton Symptom Assessment System (Davison et al. 2006a; Davison et al. 2006b).  The Edmonton 
Symptom Assessment System (ESAS) was designed initially for use in the palliative care setting 
(Bruera et al. 1991).  The modified version by Davison et al, is composed of ten symptoms (addition 
of pruritis and activity) and was validated for use in 507 dialysis patients, 10% of which were on PD 
(Davison et al. 2006a).  The total symptom distress score had a high correlation to the MCS (r= -0.62) 
and PCS (r= -0.54) scores from the SF-12.  It also displayed strong test-retest reliability as established 
by an intraclass coefficient of 0.7 (Davison et al. 2006a).  The range of symptoms in this 
questionnaire was not, however, extensive.  The Dialysis Symptom Index (DSI) incorporates 30 
symptoms, which assesses the presence and severity of physical as well as psychological symptoms 
97 
 
(Weisbord et al. 2003).  The DSI was developed by determining the prevalent symptoms in 
haemodialysis patients through quantitative as well as qualitative methods (Weisbord et al. 2004).  
The symptom severity scores from the DSI have also been found to be significantly associated with 
measures of HRQOL such as the Illness Effects Questionnaire (Weisbord et al. 2005).  The DSI and the 
ESAS have not focused on the symptom experience in PD patients, although a small proportion 
(51/507 patients) of those who participated in the validation of the ESAS were on PD.  One study has 
observed that gastrointestinal symptoms were found to be more prevalent in those on PD compared 
to patients on HD (Strid et al. 2009).   
 
None of the existing symptom assessment tools used in dialysis patients have explored the range of 
symptoms in older people or whether these are comparable between older and younger people on 
dialysis.  One study has, however, explored the prevalence of 33 symptoms in 641 older people (60 
years and older) with isolated systolic hypertension (Bulpitt et al. 1999).  These results provide an 
understanding of the range and frequency of symptoms experienced by older people who are free 
from symptoms of ESRD.   
 
Structure, administration and scoring 
Due to the unavailability of a tool focusing on symptoms prevalent in older people who are also on 
dialysis, the co-investigators in this BOLDE study developed a questionnaire to meet this purpose.  
The questionnaire incorporates 16 of the most prevalent symptoms observed in the study on older 
people with hypertension (Bulpitt et al. 1999), in addition to the most prevalent symptoms found in 
a sample of dialysis patients using the DSI (Weisbord et al. 2005).  Fourteen of the 16 selected 
symptoms were common to both older people and those on dialysis, with the remaining two 
symptoms (“cold hands and feet” and “unsteadiness”) prevalent in older people alone.  The included 
symptoms were somatic in nature, as opposed to emotional, as symptoms of depression and anxiety 
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were to be assessed through the Hospital and Anxiety Depression Scale (HADS).  Gastro-intestinal 
disturbances were also not included as these form part of the Subjective Global Assessment (SGA) of 
nutritional status.   
 
The symptom assessment tool was designed to be completed by the participants.  Each symptom 
was rated by frequency (never, once a week or less, more than once a week and daily) and severity 
(none, mild, moderate and severe) with corresponding scores from 0 to 3.  The number of symptoms 
included was limited to 16 in order to minimise completion burden.  The symptom severity score 
was an addition of all the severity scores for each symptom.  As this questionnaire is new, the 
methods used to validate it are discussed in sections 4.11.1 and 4.11.2.  The symptom assessment 
tool is presented in appendix 11.1.3. 
 
4.8.2 The assessment of Depression 
The gold standard for assessing depression is through the Structured Clinical Interview using criteria 
established in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) (American 
Psychiatric Association 2000).  As the interview is time intensive and requires a trained professional, 
several assessment tools have been developed that enable large numbers of individuals to be 
screened quickly for depression for clinical or research purposes by any trained healthcare 
professional.  This study used the Hospital Anxiety and Depression Scale.   
 
4.8.2.1 The Hospital Anxiety and Depression Scale (HADS) 
Background 
The HADS was first developed in 1983 by Zigmond and Snaith (Zigmond and Snaith 1983) and was 
designed to assist non-psychiatric physicians in assessing the presence of the mood disorders of 
anxiety and depression in patients within a hospital setting.  The design of the questionnaire was 
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such that it focused only on the psychological rather than the physical manifestations of mood 
disorders.  This is particularly useful in patients with ESRD as it has been shown that the criteria for 
the diagnosis of a major depressive disorder often overlap with uraemic symptoms e.g. decreased 
appetite, insomnia and fatigue (Smith et al. 1985).   The HADS was developed with patients aged 
between 16 and 65 years, attending medical outpatient clinics (Zigmond & Snaith 1983).  The 
resulting HADS scores correlated well with a diagnosis derived from a psychiatric assessment of the 
patient for the presence of mood disorders (r=0.54 for anxiety and r=0.79 for depression).  To 
determine whether HADS was influenced by physical illness, those patients who were diagnosed as 
not having a mood disorder through the psychiatric assessment, were age and sex matched to a 
sample free from physical illness (hospital staff), who also completed the HADS.  The results 
observed that those with a physical illness and without a mood disorder had similar HADS scores to 
the healthy, matched sample suggesting that the scale is unaffected by physical illness.   
 
As HADS was developed in younger people, its validity for use in older people was established in a 
study on 6165 Dutch people, 3293 of which were aged 66 years and older.  The Cronbach’s alpha for 
the depression subscale was found to be slightly lower than in some of the other younger population 
groups, suggesting that it may not measure the depression construct as effectively but was still 
found to be valid and reliable across the different age groups (Spinhoven et al. 1997).   
 
HADS has been extensively used to screen for anxiety and depression in patient as well as non-
patient groups.  A review found that psychiatric morbidity as assessed using the DSM-III criteria (the 
previous version of the DSM-IV criteria), was aptly identified using a HADS score of 8 and above for 
the depression items only in the majority of studies in a range of patient groups including cancer, 
primary care and general medical (Bjelland et al. 2002).  In addition, good to very good concurrent 
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validity was found in relation to several other screening tools for mood disorders such as the Beck’s 
Depression Inventory (Bjelland et al. 2002).   
 
Research evidence for use in renal populations 
The Beck’s Depression Inventory (BDI) is the most widely used tool to screen for depression in 
patients with ESRD and has been validated in a sample of PD and HD patients (Watnick et al. 2005).  
The BDI, however, includes items relating to somatic symptoms and is slightly longer than the HADS 
taking between five and ten minutes to complete.  For these reasons, the HADS was selected in 
preference to screen for depression in this study.  The validity of HADS was assessed in a sample of 
70 HD patients of all ages, who were predominantly from an African-American ethnic background 
(Cukor et al. 2008).  In multiple regression analyses, the DSM-IV diagnosis of depression (but not 
anxiety) was found to be a significant independent predictor of the HADS depression subscale score, 
as well as the HADS total score.  The study also found the HADS scores to be very highly correlated 
to the KDQOL scores, as well as the SF-36 scores.  Although the sample size was relatively small and 
was composed of contrasting demographic characteristics to the sample recruited for the BOLDE 
study, it still provided some encouraging findings that suggest that HADS is a valid tool to screen for 
depression in HD patients.   
 
Studies in dialysis patients using the HADS have found rates of possible depression (score of 8-10) 
ranging from 35% to 71% in patients on HD (Martin et al. 2004; Untas et al. 2009) and of 25% in 
patients on PD (Martin et al. 2004).  Rates of probable depression (score of ≥11) have ranged from 
10% to 28% in HD (Cano et al. 2007; Tavallaii et al. 2009) and of 5.6% in PD (Martin et al. 2004).   
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As the evidence suggests that only the HADS depression subscale has been validated against the 
DSM-IV diagnosis for depression in patients on HD (and not the anxiety subscale), this is the only 
component of the scale which will be included in the analyses in this BOLDE study.   
 
Structure, administration and scoring 
HADS can be self-administered and takes between two to five minutes to complete.  It is composed 
of fourteen questions, each of which has a choice of four answers.  Seven of the questions assess 
anxiety and seven assess depression.  The questions relate to how the subject has felt over the past 
week.  The score for each question ranges from 0 to 3, with a total score ranging from 0 to 21 for 
each subscale for anxiety and depression.  A total subscale score of 0 to 7 indicates a probable 
absence of the mood disorder; a score of 8 to 10 indicates a possible presence of the mood disorder 
and a score of 11 and above indicates a probable presence of the mood disorder (Zigmond & Snaith 
1983).  A copy of the HADS form is available in appendix 11.1.4.   
 
4.8.3 The assessment of cognitive function 
Cognitive function was assessed due to its possible role in influencing HRQOL.  There are multiple 
assessment tools that measure different aspects of cognition.  For the purposes of this study, two 
were selected:  the Mini-Mental State Examination and the Trail Making Test B.   
 
4.8.3.1 The Mini-Mental State Examination (MMSE) 
Background 
The MMSE was created in 1975 (Folstein et al. 1975) in response to the length of cognitive 
assessment tools in existence at the time.  It is now one of the most widely used tools to measure 
global cognitive functioning.   The MMSE was found to be a valid test, achieving good test-retest 
results (r between 0.887 and 0.988) and obtained significantly different scores in patients who had 
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diagnoses that affected cognition to different degrees (dementia, depression with cognitive 
impairment and depression). The MMSE was also appropriately responsive to detecting treatment 
induced changes in cognitive functioning (Folstein et al. 1975).   
 
Research evidence for use in renal populations 
The MMSE has been used frequently to assess cognitive function in the dialysis population.  For 
example, the prevalence rates of cognitive impairment were determined in a sample of 336 HD adult 
patients (aged between 23 and 93 years), where 22% were found to have mild cognitive impairment 
and 8% were found to have moderate to severe cognitive impairment with scores of 17 or less 
(Sehgal et al. 1997).   
 
Structure, administration and scoring 
The MMSE tests five areas of cognitive function:  orientation to time and place; registration of three 
words; attention and calculation; recall of three words, as well as language and visual construction.  
The assessment is scored out of a maximum of 30 points.  The scoring can be used to classify 
degrees of cognitive functioning: 24 to 30 indicating no cognitive impairment; 18 to 23 indicative of 
mild cognitive impairment; and a score of 17 or less indicating severe cognitive impairment.  The 
scores have been shown to be related to educational attainment as well as age.  Therefore, these 
two variables have been used as categories in which to present the population MMSE normative 
scores (Crum et al. 1993).  It is easy to administer and takes between five and ten minutes to 
complete. The tool relies on literacy, a good understanding of the English language, as well as having 
visual acuity, good hearing and being free of motor deficits precluding the ability to write or draw 
effectively.  The tool is not, however, sensitive to very mild changes in cognition (Tombaugh and 
McIntyre 1992).  A copy of the assessment tool can be found in appendix 11.1.5. 
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4.8.3.2 The Trail Making Test-B (TMT-B) 
Background 
The TMT-B was first used in 1944 as part of the Army Individual Test Battery for the Army and is now 
one of the most widely used tools in clinical neuropsychology in North America providing 
information on executive functioning including visual search, scanning, speed of processing and 
mental flexibility (Rabin et al. 2005).  O’Sullivan et al refer to executive function as “those higher 
cognitive processes by which performance is optimised in situations requiring the simultaneous 
operation of several cognitive processes” (O'Sullivan et al. 2005).  
 
Its score is the time to completion (in seconds) for a subject to draw lines between encircled 
alternating numbers (1 to 13) and letters (A to L) in sequence (1, A, 2, B, 3, C, 4, D etc) until the test 
is completed.  If an error is made, the examiner will correct the subject in order to allow them to 
continue the test correctly until completion (Tombaugh 2004).   
 
Research evidence for use in renal populations 
In one study, the prevalence of impaired executive functioning, as assessed by the TMT-B, was 
observed in 38% of a sample of 80 patients on HD (Kurella et al. 2004).  The TMT-B was included in 
this BOLDE study as it was found to be more sensitive than the MMSE in detecting cognitive 
dysfunction in patients with CKD, as well as those on HD (Bae and Park 2008; Pereira et al. 2007; 
Slinin et al. 2008).   
 
Structure, administration and scoring  
Test scores (time to completion) more than 1.5 standard deviations below the population mean for 
the corresponding age and education groups are reflective of cognitive impairment (Ashendorf et al. 
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2008).  The normative values used were those published by Tombaugh (Tombaugh 2004).  A copy of 
the TMT-B can be found in appendix 11.1.6. 
 
4.8.4 The assessment of social support 
The assessment of social networks and support is important as it can influence how individuals 
adjust to their chronic condition and therefore impacts on their HRQOL, as illustrated in Table 2-2.  
The framework that describes the concept of social networks is composed of three main areas, as 
illustrated in Table 4-3.  These are succinctly described in a review on social networks and social 
support in those living with chronic kidney disease (Rounds and Israel 1985).   
 
Table 4-3: Overview of the domains and characteristics of the social network 
Domains  Characteristics 
Structural Size Size or range of network members 
Density The number of existing ties in a social network in comparison to 
the number of potential ties that could exist 
Interactional Directedness Reciprocity and mutuality in a relationship between network 
members 
Durability The stability of the links between network members  
Intensity The emotional closeness between network members 
Dispersion The ease with which an individual can make contact with 
network members 
Functional Support The provision of emotional, instrumental and cognitive support 
Identity Maintenance of social identity 
Access Access to social contacts 
 
Social support has been found to play an important role in health outcomes by acting as a “buffer” 
to how individuals react and cope with stressful life events (Cohen and Wills 1985). 
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4.8.4.1 The social network questionnaire 
Background 
The social networks questionnaire used in this BOLDE study was designed by one of the co-
investigators (Professor Tom Sensky).  The aim of the tool was to capture several aspects of the 
social network (as shown in Table 4-3), with particular attention to the level of support provided as 
well as that received (reciprocal support). 
 
Research evidence for use in renal populations 
In dialysis patients, social support has also been shown to mediate increased compliance (Leggat et 
al. 1998) and is negatively correlated to depressive symptoms and positively correlated with 
satisfaction with life (Cohen et al. 2007; Kimmel et al. 1998).  The reciprocal nature of support was 
found to be particularly important, where those on dialysis who did not provide as much support 
(regardless of how much support they received) in comparison to other patients on dialysis, were 
found to be at higher risk of mortality (McClellan et al. 1993). 
 
Structure, administration and scoring 
The tool is designed to be self-administered and is composed of eleven items, each of which has 
three to four possible answers, of which only one must be selected.  Depending on the chosen 
answer, the corresponding score will either be 0, 1 or 2.  The final score corresponds to the additive 
sum of each item and is referred to as the “social network score”.  The higher the score, the greater 
the social support provided and received.  As this questionnaire is new, the methods used to validate 
it are discussed in sections 4.11.1 and 4.11.2.  A copy of the social networks questionnaire can be 
found in appendix 11.1.7. 
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4.8.5 The assessment of nutritional status 
Nutritional status was included as a possible confounder as a number of studies on dialysis patients 
have noted a positive relationship between nutritional status and HRQOL.  This has been 
demonstrated in a two year prospective study on patients on PD where declining nutritional status, 
as assessed by the Subjective Global Assessment (SGA), was associated with declining measures of 
HRQOL (Bakewell et al. 2002).  A measure of physical HRQOL (SF-36 PCS) were found to be 
significantly positively associated with markers of nutritional status (appetite, body mass index and 
serum albumin) in 1387 HD patients from the HEMO study (Dwyer et al. 2002), with similar findings 
reported by Laws et al (Laws et al. 2000).  Another study on HD patients did not, however, find SGA 
to be independently associated with SF-36 outcomes, although this study may have been under-
powered with only 65 participants (Kalantar-Zadeh et al. 2001).  No studies have investigated the 
relationship between HRQOL and nutritional status in older people on dialysis.   
 
4.8.5.1 Subjective Global Assessment (SGA) 
Background 
SGA is a method of subjective nutritional assessment based on history and physical examination that 
was first described in detail by Detsky et al in a sample of patients about to undergo major 
gastrointestinal surgery (Detsky et al. 1987).   
 
Research evidence for use in renal populations 
The SGA was originally validated for use in the dialysis population (36 HD and 23 PD patients) against 
other objective measures of nutritional status such as the anthropometric assessments of mid-arm 
muscle circumference and percentage body fat (Enia et al. 1993).  Several studies have since 
adopted the use of the SGA to determine the presence of malnutrition in dialysis patients.  The 
prevalence has ranged from 20% to 68% depending on the case mix of the sample (Cooper et al. 
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2002; Desbrow et al. 2005; Enia et al. 1993; Laws et al. 2000).  Two studies have found that elderly 
patients on dialysis may be at further risk of malnutrition (as determined by the SGA) with rates 
ranging between 51% to 68% in those aged 65 years and older compared to 30% to 46% of those 
aged 65 years and younger (Cianciaruso et al. 1995; Qureshi et al. 1998).   Therefore, it is possible 
that nutritional status may have an even greater impact on HRQOL in the older age group.   
 
Structure, administration and scoring 
The history examination is comprised of five assessments: weight loss during the preceding six 
months; gastrointestinal symptoms (anorexia, nausea, vomiting and diarrhoea); nutritional intake 
and pattern; functional capacity; and the metabolic demands of the underlying disease state.  The 
physical examination assesses subcutaneous fat loss (triceps and mid-axillary line of lateral chest 
wall) and muscle wasting (deltoids and quadriceps) detectable by palpitation.  The final score is a 
subjective weighting of all the assessments, where it is advised that most of the weighting is 
attributed to weight loss, poor nutritional intake and loss of subcutaneous fat and muscle (Detsky et 
al. 1987).  Nutritional status is subsequently classified along a three point scale: level one indicates a 
good nutritional status; level two indicates moderate malnutrition and level three indicates severe 
malnutrition.  An updated seven point scale was developed and was found to be valid and reliable in 
dialysis patients, which then allowed nutritional status to be measured as a continuous variable 
(Churchill et al. 1996; Steiber et al. 2007; Visser et al. 1999).   In the seven point version, a lower 
score indicates worsening nutritional status.  Therefore, scores of 1 to 2 represent severe 
malnutrition; scores of 3 to 5 indicate mild to moderate malnutrition and scores 6 to 7 represent a 
well nourished state (Churchill et al. 1996).  The seven point SGA form was used in this BOLDE study 
and can be found in appendix 11.1.8.  
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4.9 DEMOGRAPHICS 
Several demographic characteristics were collected as part of this BOLDE study.  These were: age in 
years, sex, dialysis modality, length of time on dialysis (excluding time with a functioning transplant), 
ethnic background, smoking status and the number of years in education.  In addition, a proxy 
measurement for socio-economic status was obtained through the Indices of Deprivation (IOD) for 
England (Department for Communities and Local Government 2007).  The IOD are single measures, 
are based on the participants’ postcode and are a combination of seven separate domain indices: 
income deprivation; employment deprivation; health deprivation and disability; education skills and 
training deprivation; barriers to housing and services; living environment deprivation; and crime.  A 
higher index is indicative of the individual living in a more deprived area.  Each participant’s IOD was 
obtained through the website for the Office of National Statistics: 
www.neighbourhood.statistics.gov.uk/dissemination/.  On this website, I obtained the IOD by 
inputting in the patient’s postcode and selecting the option “Lower layer super output area”.    From 
the generated list of multiple statistics and reports, the “Indices of Deprivation and Classification” 
was selected.  The relevant IOD was obtained from the link to “Indices of Deprivation 2007 for Super 
Output Areas”.   
 
4.10 CLINICAL DATA 
Multiple clinical data were collected and included disease related as well as dialysis related 
measures.  The disease related measures included: the number of days in hospital over the previous 
twelve months, the pill count per day and several biochemical parameters.  These biochemical 
parameters included serum albumin in g/dL, c reactive protein (CRP) in mg/L, haemoglobin in g/dL, 
phosphate in mmol/L and corrected calcium levels in mmol/L.  The disease related clinical data also 
included a measure of comorbidity status which is discussed in further detail in section 4.10.1.  The 
dialysis clinical data included late referral status which was defined as patients who had started 
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dialysis less than 30 days after being assessed by a nephrologist.  This definition aimed to identify 
those patients who were the least prepared for dialysis and was the same as that used in an 
international study which observed that dialysis start was independently associated with HRQOL 
(Caskey et al. 2003).  The other variable recorded was dialysis adequacy.  Adequate dialysis was 
defined as either an equilibrated Kt/V of >1.2 (two pool), a single pool Kt/V of ≥1.4 and urea 
reduction ratio of >65% for HD patients (National Kidney Foundation/ Kidney Disease Outcomes 
Quality Initiative 2006; Williams et al. 2009) or a Kt/V of > 1.7 for PD patients (National Kidney 
Foundation/ Kidney Disease Outcomes Quality Initiative 2006).  
 
4.10.1 Comorbidity Index 
Comorbidity is defined as the “existence or occurrence of any distinct additional entity during the 
clinical course of a patient who has the index disease under study” (Feinstein 1970).  The presence of 
comorbidities has been shown to directly impact on the outcomes of patients with ESRD, whether 
these be related to HRQOL (Moreno et al. 1996) or survival (Collins et al. 1990).   Therefore, 
quantifying the comorbidities present allows one to further understand these outcomes and allow 
for valid comparisons between different groups of patients.   
 
4.10.1.1 Stoke Comorbidity Score 
Background 
There are several methods used to measure comordid illness.  The Charlson Index is one of the most 
widely used indices, including in patients with renal disease (Charlson et al. 1987).  This index 
focuses on the inclusion of conditions weighted according to their relative risk of death within one 
year.  A renal specific comorbidity index (the Stoke Comorbidity Score) was developed and validated 
by Davies et al (Davies et al. 1995; Davies et al. 2002) in PD patients.  The main advantage of the 
Stoke Comorbidity Score, compared to other indices, is that it includes weightings for the different 
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presentations of cardiovascular disease (e.g. ischaemic heart disease and peripheral vascular 
disease).  This is particularly pertinent as cardiovascular disease is highly prevalent in patients with 
renal disease.  The score was shown to be as effective in predicting survival (with the addition of 
age) and was better at predicting hospitalisation rates than the Charlson Index in PD patients (Fried 
et al. 2003).  It is also simpler to use than the Charlson Index.  In relation to HD patients, both scores 
were found to be comparable in their ability to predict one year mortality (Miskulin et al. 2004) but 
the Charlson Index had a slight advantage in predicting two year mortality data (van Manen et al. 
2002).  In this BOLDE study, the Stoke Comorbidity score was selected as it is easier to use than the 
Charlson Index and was as effective, if not more so, in its ability to reflect a score with predictive 
outcomes.    
 
Structure, administration and scoring 
The Stoke Comorbidity Score involves seven areas of comorbidity where evidence of, rather than 
severity of disease is noted.  In order to be included in the scoring, the disease must be present, 
active or be in the process of being treated.  The final score is a cumulative count of each of the 
seven areas present.  These scores can then be classified into three categories of risk: low equates to 
a score of zero; medium equates to a score of one or two and high equates to a score of 3 or more 
(Davies et al. 2002).  Details of the index are provided in appendix 11.1.9.       
 
4.11 STATISTICAL METHODOLOGIES 
Several statistical methodologies were used to analyse the data.  All the analyses were undertaken 
using the Statistical Package for Social Sciences (SPSS), version 17.0.  Statistical significance was 
attributed to a p-value of ≤ 0.05.   
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Prior to comparing the HRQOL in older people on PD and HD, it was important to validate the two 
questionnaires that have not been previously validated (assessment of symptoms and the social 
network questionnaire).  This process of validation is described below.  This is then followed by a 
description of the univariate and regression analyses undertaken within this BOLDE study.   
 
4.11.1 Validity 
Downing states that “assessments are not valid or invalid, rather assessment scores have more (or 
less) validity evidence to support proposed interpretations” (Downing 2003).  There are different 
forms of validity, the main one being construct validity.  This has been defined as “the evidence and 
rationales supporting the trustworthiness of score interpretation in terms of explanatory concepts 
that account for both test performance and score relationships with other variables” (Messick 1995).  
Therefore, construct validity determines whether the test scores accurately measure the construct 
that the questionnaire purports to measure.  Construct validity can be determined by assessing the 
correlations of outcomes between the tool under investigation and other tools which are thought to 
measure the same construct (convergent validity) or by determining the lack of correlation with 
outcomes from tools assessing a different construct (divergent validity).  Construct validity was 
undertaken for the social network and the symptoms questionnaires, which is described in the 
results section 4.13.1.   
 
4.11.2 Reliability 
In addition to assessing validity, it is important to assess whether a questionnaire obtains results that 
are reliable.  The reliability of a scale can be determined by administering the same questionnaire to 
the same individual at two different time points.  An alternative way is to determine the split half 
reliability.  In this method, all the items in the questionnaire are randomly divided into two halves, in 
every possible way.  The Cronbach’s alpha is the mean of all the correlation coefficients between 
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multiple permutations of the two halves (Cronbach 1951).  Values of at least 0.7 to 0.8 are 
considered to be acceptable, demonstrating a reliable scale (Field 2005).  The reliability of both the 
social network and the symptoms questionnaire was assessed and are presented in the results 
section 4.13.1.   
 
4.11.3 Univariate analysis 
Depending on the distribution of the data, the relevant statistical analysis technique was employed 
to determine differences between groups.  This involved using non-parametric tests for data that 
had a skewed distribution:  Mann-Whitney U tests or Chi-squared tests.  These were presented as 
medians and interquartile ranges (IQR).  For non-skewed data, the independent samples t-test was 
used, with means and standard deviations (SD) presented.   To assess the relationship between two 
continuous outcome measures, correlation coefficients were used.  Correlation coefficients were 
particularly useful in determining which variables would be suitable for inclusion in the regression 
models.   
 
4.11.4 Linear regression models 
In this BOLDE study, linear regression modelling was undertaken to determine which variables were 
independently and significantly influencing each of the HRQOL outcomes (SF12-MCS and PCS scores, 
HADS scores and IIRS scores).  This is referred to as multiple linear regression.  In linear regression, 
the dependent variable is always continuous and the independent variables can consist of both 
continuous and categorical variables.  This method determines whether any of the independent 
variables are contributing significantly to the variance observed in the dependent variable.   
 
Several assumptions had to be met to ensure validity of the final model: 
i. At least 10 subjects are available for every variable included in the model. 
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ii. The standardised residuals of the initial and final model were normally distributed. 
iii. The relationship between the dependent and independent variables should be linear.   
 
The independent variables were selected based on their degree of correlation with the outcome 
variable on univariate analysis or due to theoretical reasons that warranted their inclusion in the 
model.  The model therefore contained all the independent variables (main effects) that were 
thought to predict the outcome, as well as the interactions between all the continuous and 
categorical (and categorical with categorical) variables.  I then deleted each individual interaction 
that did not significantly contribute to the outcome variance (those with the highest p-value above 
0.05) and re-ran the model.  The non-significant main effects were only deleted after all the non-
significant interactions had been removed and if the non-significant main effects were absent from 
any significant interactions.  The final model, therefore, contained only the significant main effects 
and/or interactions, signifying that these were the only independent predictors of the outcome 
variable.   
 
The model was assessed for normality by determining the distribution of the standardised residuals 
at the initial and final stages of the model.  The standardised residuals are the standardised 
differences between the values predicted by the model and those that are observed in the sample.  
Plotting the distribution of the standardised residuals allowed for identification of outliers.  In a few 
exceptional cases, outliers were excluded from the model.   
 
In the models, the independent variable of cognitive function was included as a categorical variable, 
with the two outcomes of presence or absence of cognitive dysfunction.  Cognitive dysfunction was 
defined as a score indicative of dysfunction on the MMSE or the TMT-B.  Nutritional status was also 
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categorised into two outcomes of presence (SGA scores of 1-5) or absence of malnutrition (SGA 
scores of 6-7).   
 
4.11.5 Logistic regression models 
Logistic regression was undertaken when the outcome variable was in binary format, such as 
screening positive for depression with a HADS depression subscale score of 0-7 or ≥8.  Logistic 
regression predicts the probability of the outcome occurring in the presence of the predictor 
variables such as modality and comorbidity scores.  Interactions were also assessed in this model. 
The same method of eliminating interactions and main effects was conducted as that undertaken 
with the multiple linear regressions, until the resultant final model.  
 
4.12 ETHICAL CONSIDERATIONS 
Ethical approval was obtained for the study (Charing Cross Research Ethics Committee, reference 
number 06/Q0411/137), evidence for which can be found in appendix 11.3.1. 
 
The study had anticipated that patients may express some emotional distress when discussing issues 
pertaining to their quality of life.  These situations did indeed arise, as study visits appeared to 
provide the participants with the opportunity to express their thoughts about their lives, within a 
relaxed environment, to a health professional.  This lead to the revelation of some very distressing 
life stories, such as the loss of partners and children, as well as the contemplation of suicide.  On 
these occasions, the participants were referred (with their consent) to their local renal counselling 
services and on one occasion the situation was highlighted to the renal consultant and the GP, with 
this particular patient unable to complete the study visit.  This BOLDE study also highlighted patients 
who screened positive for possible or probable depression. These results were brought to the 
attention of the appropriate renal consultant.   
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4.13 RESULTS 
The following section presents the findings for this BOLDE study.  It is divided into several sub-
sections.  The initial results present the validity and reliability of the social network and symptom 
questionnaires.  This is followed by the univariate analyses relating to the demographics and clinical 
data within the sample.  Univariate analyses are also presented, which explore the unadjusted 
HRQOL outcomes in the sample comparing the patients on PD and HD in the whole sample as well as 
in those who had been on dialysis for less than one year.  Additional univariate analyses explored the 
unadjusted differences in HRQOL in patients on APD compared to CAPD, as well as in planned 
compared to late referrals.  Finally, the results from the regression analyses (linear and logistic) 
which identify the independent predictors for the various HRQOL outcomes, are presented.   
 
4.13.1 Validity and reliability 
4.13.1.1 Social network questionnaire 
The reliability of the social network questionnaire was assessed by determining the Cronbach’s 
alpha.  This was found to be 0.785 which supports that the tool is indeed reliable.   
 
It was impossible to determine convergent validity as none of the other measures collected reflected 
aspects of the same construct (e.g. social support).  In this respect, only divergent validity could 
therefore be demonstrated.   None of the measures were associated with the social network score 
as demonstrated with correlation coefficients that did not exceed 0.266 (indicative of a weak 
relationship).  This provides evidence that the social network score was measuring a different 
construct to that of the other tools used such as HRQOL, cognitive function, comorbidity index or 
nutritional status.   
 
116 
 
4.13.1.2 Symptoms questionnaire 
The symptoms questionnaire was found to have a Cronbach’s alpha of 0.806 which demonstrates 
that the questionnaire is reliable.  As the symptoms were all aimed at representing the physical 
manifestations of the illness or treatment, convergent validity was determined by assessing the 
correlation coefficients of the symptom count with the outcomes from SF-12 PCS, the SGA and the 
Stoke comorbidity score.  Divergent validity was determined using the SF-MCS and the TMT-B 
findings.  Validity results are presented in Table 4-4. 
 
Table 4-4: Correlation coefficients determining construct validity for the symptom count 
Variables Pearson’s correlation coefficient (r) 
Convergent validity Divergent validity 
SF-12 PCS -0.494  
Subjective Global Assessment -0.517  
Stoke comorbidity score 0.371  
SF-12 MCS  -0.357 
Trail Making Test-B  0.009 
 
The SF-12 PCS and the SGA show the strongest correlations with symptom count, with the Stoke 
comorbidity score showing a modest correlation.  Surprisingly, the SF-12 MCS showed a modest 
correlation with the symptom count, however, this was lower than the correlation observed with 
the SF-12 PCS scores.  This suggests that the symptom count is more representative of physical 
functioning than mental functioning.  Finally, cognitive function was not correlated at all with the 
symptom count, which was anticipated as the two constructs are very different.  Therefore, these 
results suggest that the symptom questionnaire is predominantly measuring aspects pertaining to 
physical health.   
 
117 
 
4.13.2 The study sample 
The target of recruiting 140 patients (70 on PD and 70 on HD) was achieved.  Out of 186 patients 
approached, 46 (24.7%) declined to participate, as can be seen in Table 4-5.  Patients on HD who did 
not participate were similar in age, sex, ethnicity and dialysis vintage to those on HD who took part.  
This was in contrast to the patients on PD, where a higher proportion of males and Caucasians 
participated compared to those that did not.  The reasons for this difference in recruitment 
demographics amongst only the PD patients is difficult to explain, although lower enrolment rates of 
women, ethnic minorities and older people have been observed in cancer trials (Murthy et al. 2004).  
The demographics of the PD participants shaped the demographics of the whole sample, therefore 
leading to an over-representation of males and Caucasians when compared to the UK dialysis 
population, as can be seen in Table 4-6.   
 
Table 4-5: Difference between participants and non-participants, with reference to matching criteria 
 Participants Non-participants P value 
 PD (n=70) HD (n=70) PD (n=18) HD (n=28) PD/HD* 
Age in years      
    Mean (SD) 73.1 (5.5) 73.4 (5.1) 73.8 (5.6) 73.5 (5.5) 0.637/0.927
a
 
Sex      
    Male n (%) 49 (70) 49 (70) 6 (33) 17 (61) 0.004/0.376
b
 
    Female n (%) 21 (30) 21 (30) 12 (66) 11 (39)  
Ethnicity       
    White n (%) 67 (96) 63 (90) 13 (72) 25 (89) 0.002/0.916
b
 
    Non-white n (%) 3 (4) 7 (10) 5 (28) 3 (11)  
Dialysis vintage  months       
    Median (IQR) 18.6 (49.0) 
 
18.6 (38.0) 24.3 (37.0) 21.1 (56.0) 0.627/0.820
 c
 
* P values for differences between PD participants and non-participants / HD participants and non-
participants. a Independent t-test,  b Pearson chi-square test, c Mann-Whitney U test. SD: standard 
deviation; IQR: interquartile range. 
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Table 4-6 compares demographic and clinical values in the recruited sample to those observed in the 
larger UK dialysis population.  The national values were obtained from the UK renal registry twelfth 
annual report, reporting on the dialysis population values obtained from 2008 (Ansell et al. 2009; 
Byrne et al. 2009; Dawnay et al. 2009; Richardson et al. 2009).  Table 4-6 highlights that the BOLDE 
sample had a greater proportion of men, a higher prevalence of patients from a British or European 
White ethnic background, a higher proportion of older HD patients who were diabetic and lower 
phosphate levels compared to the values seen in the UK dialysis population.  Again, it was difficult to 
understand why the HD sample had such a high proportion of diabetics compared to the PD sample 
and the national average.  The lower phosphate levels may be reflective of the older age of the 
BOLDE sample and due to better dialysis adequacy.  The proportion of diabetics in the PD sample, 
late referrals as well as the mean haemoglobin and calcium levels were comparable in this BOLDE 
study to the UK dialysis population values.   
 
Table 4-6: Demographic and clinical parameters: BOLDE sample compared to the UK dialysis 
population values from 2008 
Demographics and clinical 
parameters 
BOLDE Sample UK prevalent dialysis population  
PD  HD PD HD 
Male % 70 70 62% PD and HD 
a
 
White British or European % 96 90 79.7% RRT 
Diabetes % 19 36 22.6% ≥65 years 26.5% ≥65 years 
Late referral %
 
 13 32 17.6%
 b
 29%
 b
 
Haemoglobin Mean (SD) g/dL 11.6 (1.7) 11.7 (1.2) 11.7 (1.5) 11.5 (1.5) 
Phosphate Mean (SD) mmol/L 1.43 (0.35) 1.46 (0.40) 1.54 (0.42)
 c
 1.55 (0.53)
 c
 
Corrected Calcium Mean (SD) mmol/L 2.32 (0.18) 2.32 (0.19) 2.39 (0.17)
 c
 2.35 (0.19)
 c
 
RRT: renal replacement therapy. 
a 
Values per treatment modality at 90 days.  
b 
Late referral defined as 
presenting to a nephrologist less than 90 days before dialysis initiation for the UK values, yet defined as 
presenting to a nephrologist less than 30 days before dialysis initiation in this BOLDE study sample. 
c 
Values 
from England, Northern Ireland and Wales as opposed to UK. SD: standard deviation. 
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Table 4-7 shows the distribution of the recruited patients (in matched pairs) from each of the three 
participating renal units, as well as the proportion of patients who had experiences of other renal 
replacement therapies.  It shows that twelve patients (17%) from the PD sample had previously been 
on HD either due to medical reasons where HD was required in the short term or the patient started 
dialysis unexpectedly and was commenced on HD before selecting PD.  Only four (5.7%) of the HD 
patients had been on PD previously.  These patients had switched to HD due to no longer being able 
to continue on PD for medical reasons.   
 
Table 4-7: Location of participants and details of their previous renal replacement therapies  
Sample N (%) 
Recruited pairs n 70 
    Imperial n (%) 27 (38.6) 
    St Helier n (%) 33 (47.1) 
    Lister n (%) 10 (14.3) 
APD patients n (% of PD sample) 41 (58.6) 
Previous transplantation in HD sample n (% of HD sample) 0 
Previous transplantation in PD sample n (% of PD sample) 2 (2.9) 
Previous HD in PD sample n (% of PD sample) 12 (17.1) 
    Late referrals n 4 
    Opted for home treatment after being on HD (2 months to 3 years) n 4 
    Catheter repositioning or resting from PD n 4 
Previous PD in HD sample n (% of HD sample) 4 (5.7) 
    Poor ultrafiltration after > 5 years on PD n 1 
    Peritonitis after 2-6 months on PD n 3 
 
4.13.2.1 Demographics 
There were no significant differences between the demographic characteristics of the recruited PD 
and HD sample as can be seen in Table 4-8 indicating that the matching process was successful.   
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Table 4-8: Demographic data for PD and HD patients 
Demographic factors PD (n=70) HD (n=70) P value 
Age years    
    Mean (SD) 73.1 (5.5) 73.4 (5.1) 0.812
a
 
65-69 n (%) 21 (30) 21 (30)  
70-79 n (%) 41 (59) 41 (59)  
80-89 n (%) 8 (11) 8 (11)  
Sex    
    Male n (%) 49 (70) 49 (70) 1.000
b
 
Ethnic Background    
    White British European n (%) 67 (96) 63 (90) 0.189
b
 
    Non-White British European n (%) 3 (4) 7 (10)  
Dialysis vintage in months    
    Median (IQR) 18.6 (49.0) 18.6 (38.0) 0.480
c
 
3-12 n (%) 23 (33) 18 (26)  
>12-36 n (%) 26 (37) 31 (44)  
>36 n (%)  21 (30) 21 (30)  
Index of Deprivation    
    Mean (SD) 13.7 (11.3) 13.7 (8.7) 0.476
a
 
Education years     
    Mean (SD) 11.7 (3.5) 11.7 (3.6) 0.983
a
 
Live alone n (%) 16 (23%) 18 (26%) 0.321
b
 
Social network score     
    Mean (SD) 15.2 (4.4) 14.9 (4.0) 0.630
a
 
a
 Independent t-test, 
b
 Pearson chi-square test, 
c
 Mann-Whitney U test. SD: standard deviation; IQR: 
interquartile range.  
 
4.13.2.2 Clinical data 
Table 4-9 shows that the PD and HD samples were clinically comparable in relation to nutritional 
status, cognitive function, dialysis adequacy, pill count and inpatient hospital days over the previous 
twelve months.  The HD group had a higher number of comorbidities including diabetes (36% v 19%; 
p=0.023) and had a higher number of patients who were late referrals (32% v 13%; p=0.007) 
compared to the PD group.  It is expected that a higher proportion of late referrals would be on HD 
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as this is the modality routinely used to treat those acutely starting dialysis.  Most of the sample, 
regardless of modality, is adequately dialysed.   
 
The Trail Making Test-B (TMT-B) had a large number of missing values.  This was due to several 
patients being unable or unwilling to complete this assessment (five on PD and thirteen on HD).  The 
MMSE in contrast only had two missing values from two patients on HD.  These patients were 
unable to complete the assessment due to difficulties visualising or drawing the object.  The level of 
cognitive dysfunction observed was statistically similar between those on PD and HD.  None of the 
patients had severe cognitive impairment as determined by the MMSE.   
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Table 4-9: Comparison of clinical characteristics in the participants on PD and HD 
Clinical characteristics PD, n=70 HD, n=70 P value 
Stoke comorbidity score    
Median (IQR) 1.0 (1.0) 2.0 (2.0) 0.009
 a
 
0 comorbidities n (%) 15 (21) 12 (17) 0.520
 b
 
1-2 comorbitities n (%) 46 (66) 34 (49) 0.040
 b
 
>3 comorbidities n (%) 9 (13) 24 (34) 0.003
 b
 
Diabetes n (%) 13 (19) 25 (36) 0.023
 b
 
Late referral n (%) 9 (13) 22 (32) 0.007
 b
 
Mild to moderate malnutrition n (%) 11 (16) 17 (24) 0.205
 b
 
Adequately dialysed n (%) 64 (91) 59 (86) 0.274
 b
 
Days in hospital over last 12 months     
    Mean (SD) 6.6 (8.8) 11.0 (18.1) 0.069
 c
 
Pill count    
    Mean (SD) 10.6 (5.3) 11.1 (5.7) 0.436
c
 
Cognitive function    
MMSE scores n 70 68*  
    Median (IQR) 29.0 (2.0) 28.0 (2.0) 0.253
 a
 
    ≥24 (no cognitive impairment) n (%) 68 (97.1) 64 (94.1) 0.384
 b
 
    18-23 (mild cognitive impairment) n (%) 2 (2.9) 4 (5.9)  
TMT-B scores n 65* 57*  
    Median (IQR) seconds 129.0 (100.0) 128.0 (84.5) 0.845
 a
 
    Within expected range for age and education n (%)  38 (59.0) 39 (68.4) 0.255
 b
 
a
 Mann-Whitney U test, 
b
 Pearson chi-square test, 
c
 Independent t-test; * missing values due to patients unable 
to complete assessment. SD: standard deviation; IQR: interquartile range.  
 
The blood values for the PD and HD patients are shown in Table 4-10.  The proportion of patients 
with plasma albumin values within the normal range differed between those on PD and HD (50% of 
PD patients compared to 71% of HD patients; p=0.009).  The normal range was determined from 
each renal unit’s reference ranges.  The lower albumin values observed in PD patients are likely to 
reflect the protein losses that occur through the dialysate and are unlikely to reflect increased 
inflammatory processes compared to the patients on HD.  Only two thirds of the PD and HD sample 
had c-reactive protein (CRP) measurements available.  Most of the missing values were in patients 
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dialysing at the St Helier renal unit where CRP is not routinely assessed.  There were no other 
statistical differences in the remainder of the blood values recorded. 
 
Table 4-10: Comparison of blood values for PD and HD patients 
Blood values PD, n=70 HD, n=70 P value 
Albumin n 70 70  
    Within normal range (unit dependent) n (%) 35 (50) 50 (71) 0.009
 a
 
CRP n 45* 46*  
    Within normal range of ≤10mg/L n (%) 29 (64) 29 (63) 0.889
 a
 
Haemoglobin n 70 70  
    Mean (SD) g/dL 11.6 (1.7) 11.7 (1.2) 0.682
b
 
Phosphate n 70 70  
    Mean (SD) mmol/L 1.43 (0.35) 1.46 (0.40) 0.640
 b
 
Corrected Calcium n 70 70  
    Mean (SD) mmol/L 2.32 (0.18) 2.32 (0.19) 0.941
 b
 
a
 Pearson chi-square test, 
b
 Independent t-test. * missing data due to CRP measurements unavailable. SD: 
standard deviation. 
 
4.13.3 HRQOL outcome analyses 
The following sub-sections focus on the multiple HRQOL outcomes using univariate analyses which 
are then followed by the regression analyses.   
 
4.13.3.1 HRQOL outcomes: univariate analyses 
Table 4-11 presents the unadjusted (raw) outcomes from the multiple HRQOL assessments, together 
with the p values derived from the comparison of the two modalities.  These basic analyses show all 
the HRQOL outcomes to be significantly better in the PD patients, with the exception of the SF-12 
PCS where there was no significant difference between the two modalities.  These findings, 
however, must be interpreted with caution as there is no adjustment for possible confounders.    
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Table 4-11: Unadjusted Health Related Quality of Life (HRQOL) outcomes in PD and HD patients 
HRQOL outcomes PD, n=70 HD, n=70 P value 
SF-12 PCS n 70 70  
     Mean (SD) 36.4 (12.1) 34.3 (9.7) 0.263
 a
 
SF-12 MCS n 70 70  
    Mean (SD) 55.0 (8.4) 51.3 (12.9) 0.046
 a
 
 IIRS n 69* 70  
    Median (IQR) 22.0 (15.0) 26.0 (19.0) 0.006 
b
 
HADS (depression) n 70 70  
    Median (IQR) 4.0 (5.0) 6.0 (5.0) 0.003
 b
 
HADS depression score ≥ 8 n (%) 7 (10.0) 18 (25.7) 0.015
 c
 
Symptom count n 70 70  
    Mean (SD) 8.6 (3.1) 9.7 (3.2) 0.039
 a
 
Symptom severity n 70 70  
    Mean (SD) 13.9 (6.8) 16.8 (8.3) 0.024
 a
 
a
 Independent t-test, 
b
 Mann-Whitney U test, 
c
 Pearson chi-square test, * missing values due to patients 
refusing to complete the assessment. SD: standard deviation; IQR: interquartile range. 
 
 
4.13.3.2 HRQOL in those on dialysis for up to one year 
The PD participants may be viewed as a “select” group of patients as many of the sample have 
succeeded to maintain themselves on a self-administered, daily, home based dialysis treatment.  In 
order to determine whether patients who have been on PD for longer have an advantage in relation 
to QOL compared to those on HD, a sub-analysis is presented in Table 4-12 comparing the HRQOL 
outcomes in matched pairs of patients who have been on dialysis for less than one year (14 pairs).  
The HRQOL outcomes were statistically similar, unlike the results for the whole group.  This indicates 
that the differences in HRQOL between those on PD and HD observed in the whole sample may be 
attributed to those who are on dialysis for over one year.  As 28 patients (i.e. 14 pairs) is a small 
sample size, firm conclusions cannot be drawn.  Considering that a high proportion of patients are 
on dialysis for over a year, it is still important to understand the differences in HRQOL over a longer 
period of time.   
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Table 4-12: Unadjusted Health Related Quality of Life (HRQOL) outcomes for matched PD and HD 
patients on dialysis for less than one year 
HRQOL outcomes PD, n=14 HD, n=14 P value 
SF-12 PCS n 14 14  
     Mean (SD) 41.1 (11.0) 35.1 (11.5) 0.174
 a
 
SF-12 MCS n 14 14  
    Mean (SD) 55.1 (7.4) 58.1 (9.1) 0.346
 a
 
 IIRS n 14 14  
    Median (IQR) 23.5 (18.0) 27.0 (20.0) 0.550
b
 
HADS (depression) n 14 14  
    Median (IQR) 2.5 (4.0) 3.5 (4.0) 0.330
 b
 
HADS depression score ≥ 8 n (%) 0 2 (14.3) 0.142
 c
 
Symptom count n 14 14  
    Median (IQR) 8.0 (2.0) 10.0 (5.0) 0.094
 b
 
Symptom severity n 14 14  
    Mean (SD) 12.1 (4.9) 15.6 (7.6) 0.169
 a
 
a
 Independent t-test, 
b
 Mann-Whitney U test, 
c
 Pearson chi-square test. SD: standard deviation; IQR: 
interquartile range. 
 
The HRQOL has been shown to be worst in dialysis patients who previously had a transplant (Bremer 
et al. 1989).  Only two participants within the sample had a failed transplant (now on PD) so, 
therefore, these results were unlikely to skew the results.  There was also no difference on 
univariate analyses in HRQOL outcomes between those who had changed from PD to HD and those 
who were on HD throughout (data not shown).  This indicates that the HRQOL findings in patients on 
HD were unlikely to be negatively influenced by a few patients who were made to change from PD to 
HD.  
 
4.13.3.3 HRQOL outcomes in APD compared to CAPD 
The HRQOL outcomes were compared between the different forms of PD (APD and CAPD) as 
previous studies have reported HRQOL to be either comparable in those on APD and CAPD 
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(Balasubramanian et al. 2011) or significantly different (Diaz et al. 2000).  There were no differences 
in unadjusted HRQOL outcomes observed in the BOLDE sample when comparing those on APD and 
CAPD (Table 4-13).  Therefore, the PD group were homogenous in their outcomes, thereby allowing 
for valid comparisons between those on HD and those on PD, regardless of the PD modality.   
 
Table 4-13: Health Related Quality of Life (HRQOL) outcomes in patients on Automated Peritoneal 
Dialysis (APD) and Continuous Ambulatory Peritoneal Dialysis (CAPD) 
HRQOL outcomes APD, n=41 CAPD, n=29 P value 
SF-12 PCS n 41 29  
     Mean (SD) 34.7 (12.4) 38.9 (11.3) 0.147
 a
 
SF-12 MCS n 41 29  
    Mean (SD) 54.9 (8.9) 55.2 (7.7) 0.877
 a
 
 IIRS n 40 29  
    Median (IQR) 21.5 (18.0) 24.0 (10.0) 0.719 
b
 
HADS (depression) n 41 29  
    Median (IQR) 4.0 (5.0) 3.0 (5.0) 0.845
 b
 
HADS depression score ≥ 8 n (%) 4 (10.0) 3 (10.3) 0.963
 c
 
Symptom count n 41 29  
    Mean (SD) 8.4 (3.3) 8.8 (3.0) 0.601
 a
 
Symptom severity n 41 29  
    Mean (SD) 14.0 (7.1) 13.8 (6.4) 0.908
 a
 
a
 Independent t-test, 
b
 Mann-Whitney U test, 
c
 Pearson chi-square test. SD: standard deviation; IQR: 
interquartile range. 
 
4.13.3.4 HRQOL outcomes in planned and late referrals 
Studies have shown that HRQOL outcomes are influenced by the degree of dialysis preparation the 
patient has been exposed to (Caskey et al. 2003; Loos et al. 2003).  Therefore, the HRQOL outcomes 
are presented in Table 4-14 for those who had nephrology input for longer than one month prior to 
dialysis start (planned referral) compared to those who had first seen a nephrologist within 30 days 
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of starting dialysis (late referral).  There was one patient who I was unable to determine how long 
they had seen a nephrologist prior to commencing dialysis.   
 
No difference was observed in the unadjusted HRQOL outcomes in those who had a planned or late 
referral onto dialysis.  This partially supports the findings by Caskey et al who found better HRQOL 
outcomes at eight weeks post dialysis when comparing patients who had an early referral and a 
planned dialysis start compared to those who had an early referral yet an unplanned start onto 
dialysis (Caskey et al. 2003).  This level of detail of information regarding the dialysis start within the 
early referrals was not collected for this BOLDE study.    
 
Table 4-14: Health Related Quality of Life (HRQOL) outcomes in patients who had a planned dialysis 
start and late referrals 
HRQOL outcomes Planned referral 
n=108 
Late referral 
n=31 
P value 
SF-12 PCS n 108 31  
     Mean (SD) 35.3 (11.1) 36.0 (10.5) 0.775
 a
 
SF-12 MCS n 108 31  
    Mean (SD) 53.2 (11.2) 52.9 (10.6) 0.919
 a
 
 IIRS n 107 31  
    Median (IQR) 24.0 (16.0) 25.0 (20.0) 0.348 
b
 
HADS (depression) n 108 31  
    Median (IQR) 5.0 (5.0) 4.0 (5.0) 0.770
 b
 
HADS depression score ≥ 8 n (%) 19 (17.6) 6 (19.4) 0.822
 c
 
Symptom count n 108 31  
    Mean (SD) 9.0 (3.2) 9.6 (3.3) 0.328
 a
 
Symptom severity n 107 31  
    Mean (SD) 15.3 (7.6) 15.2 (8.2) 0.936
 a
 
a
 Independent t-test, 
b
 Mann-Whitney U test, 
c
 Pearson chi-square test. SD: standard deviation; IQR: 
interquartile range. 
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4.13.3.5 HRQOL outcomes: Regression analyses 
The multiple linear regression analyses on the HRQOL outcomes (SF-12 MCS, SF-12 PCS, IIRS and 
HADS Depression subscale) were adjusted for several variables that either had the highest 
correlations or had a significant association with the outcome under investigation.  In addition, 
variables were included if there was a strong theoretical reason for their inclusion.  It was also 
determined that the same variables would be used in all the four HRQOL models presented (see 
Table 4-15). 
 
Compared to the unadjusted results, the findings from the regression analyses found that only two 
HRQOL outcomes were positively influenced by the use of PD rather than HD: HADS depression and 
IIRS scores.  Symptom count was found to be the one variable in common influencing all the HRQOL 
outcomes.    
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Table 4-15: Multiple linear regression analyses for Health Related Quality of Life (HRQOL) outcomes   
   95% CI  
HRQOL outcomes and their independent 
predictors  
B 
a
 Standard 
Error 
Lower Upper P value 
SF-12 PCS      
    Symptom count -1.692 0.254 -2.194 -1.190 <0.0001 
SF-12 MCS 
b
      
    Symptom count -0.948 0.273 -1.489 -0.407 0.001 
    Males compared to females  
    (only in the presence of malnutrition) 
10.513 3.788 3.020 18.006 0.006 
    Stoke comorbidity score 
    (only in the presence of malnutrition) 
-3.118 1.335 -5.758 -0.477 0.021 
IIRS 
c
      
    Symptom count 1.054 - 1.036 1.074 <0.0001 
    Increasing age -0.986 - -0.975 -0.996 0.010 
    PD compared to HD -0.881 - -0.784 -0.989 0.032 
HADS Depression      
    Symptom count 0.346 0.080 0.188 0.504 <0.0001 
    PD compared to HD -1.241 0.486 -2.202 -0.280 0.012 
    Stoke comorbidity score 0.551 0.219 0.119 0.984 0.013 
    Cognitive dysfunction 1.080 0.500 0.092 2.069 0.032 
a
 B=Change in outcome variable resulting from a one unit change in the predictor variable. 
b
 3 outliers 
excluded.  
c
 IIRS was logged to normalise the distribution.  Analyses adjusted for age, time on dialysis, Stoke 
comorbidity score, symptom count, social network score, sex, modality, nutritional status and cognitive 
function.   
 
In the analysis presented in Table 4-15, the HADS depression score was analysed as a continuous 
outcome.  Of more practical and clinical significance would be to determine which variables 
influence the outcome of screening positive for possible depression (HADS depression score of ≥8).  
To this effect, a binary logistic regression analysis was undertaken on the dichotomised outcome of 
the HADS depression score (0-7 or ≥8).  The results are presented in Table 4-16 and demonstrate 
that the odds of screening positive for possible depression are higher if the patient has a greater 
symptom count, is female and has a higher comorbidity score.  Surprisingly, modality and cognitive 
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function were no longer significant as was found in the linear regression model on the continuous 
outcome score of HADS.  This indicates that modality and cognitive function may influence 
symptoms of depression but are unlikely to be independently associated with those who are 
screening positive for depression.  The same nine independent variables were adjusted for as seen in 
the multiple linear regression models. 
 
Table 4-16: Binary logistic regression for the presence of possible depression (HADS ≥8) 
    95% CI  
Outcome  
and associated variables 
B
a
 Standard 
Error 
Adj OR Lower Upper P value 
HADS score  ≥8       
    Symptom count 0.461 0.125 1.586 1.242 2.026 <0.0001 
    Female v Male 1.747 0.720 5.737 1.399 23.521 0.015 
    Stoke comorbidity score 0.609 0.242 1.839 1.145 2.953 0.012 
a
 Natural log of the odds of “possible depression” occurring when there is a unit change in the predictor 
variable.  Adj OR: adjusted odds ratio.  Adjusted for age, time on dialysis, Stoke comorbidity scores, symptom 
count, social network score, sex, modality, nutritional status and cognitive function.   
 
4.13.4  Symptom analyses 
The following analyses focuses on the symptomatology in older patients on dialysis.  The regression 
analyses aimed to determine the independent predictors that contributed to increased symptom 
severity for individual symptoms in this sample of older people on dialysis.  As the focus of this study 
was to compare HRQOL outcomes in those on PD and HD, this will be the focus of the reporting of 
the findings in the symptom analyses.   
 
Severity of each symptom was categorised as “not occurring”, “mild”, “moderate” or “severe”, with 
corresponding scores of 0 to 3.  The results were analysed in two ways: 
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i. Each symptom severity score was dichotomised into either “not occurring or mild” or “moderate 
or severe”.  Binary logistic regression modelling was used to determine which of seven predictor 
variables (and their interactions) independently predicted the probability of the occurrence of 
worsening symptoms (i.e. moderate or severe).  The seven predictor variables included were 
age, sex (male/female), Stoke comorbidity score, HADS depression score, malnutrition as 
determined by SGA (present/absent), dialysis modality (HD/PD) and time on dialysis.  These 
were selected due to their significant relationship with the outcome on univariate analysis or 
due to theoretical reasoning.  The results are presented in Table 4-17. 
 
ii. Multiple linear regression analysis identified the variables that were independently associated 
with the continuous outcome of the total symptom severity score.  This model accounted for the 
same variables as with the symptom binary logistic regression, but with the addition of dialysis 
adequacy (adequate/not adequate), late referral (yes/no) and cognitive function 
(impaired/intact).  The results are shown in Table 4-18. 
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Table 4-17: Binary logistic regression for the presence of moderate or severe symptoms 
Symptoms Variable B 
a
 SE Adjusted OR P value 
Headaches Male -2.506 0.819 0.082 0.002 
HD 1.784 0.863 5.955 0.039 
Depression score 0.283 0.114 1.327 0.013 
Dialysis vintage  0.03 0.013 1.031 0.024 
Pain in joints Comorbidities 0.400 0.160 1.491 0.012 
b
Effect of Males v Females in 
malnourished patients  
-2.441 0.918 0.087 0.008 
Lack of energy Male -1.275 0.431 0.279 0.003 
Comorbidities 0.370 0.176 1.448 0.036 
Depression score 0.260 0.070 1.297 <0.0001 
Blurred vision Male -1.008 0.469 0.365 0.032 
Age in years -0.139 0.056 0.870 0.012 
Cold hands and 
feet 
Malnutrition 3.341 0.938 28.254 <0.0001 
b
Effect of Comorbidities in 
well nourished v malnourished 
 
0.673 0.202 1.959 0.001 
Dry mouth HD 1.308 0.400 3.701 0.001 
Comorbidities 0.380 0.163 1.462 0.019 
Short of breath Comorbidities 0.622 0.189 1.863 0.001 
Depression score 0.210 0.068 1.234 0.002 
Taste changes 
b
 Depression in HD v PD 0.356 0.103 1.428 0.001 
Leg cramps 
b
 Comorbidities in HD v PD  0.570 0.212 1.769 0.007 
Nausea Malnutrition 2.124 0.583 8.368 <0.0001 
Swelling of legs Male -1.075 0.437 0.341 0.014 
Unsteadiness Comorbidities 0.703 0.173 2.021 <0.0001 
Itching Comorbidities 0.330 0.150 1.390 0.028 
Weakness of limbs Depression score 0.154 0.057 1.166 0.007 
Dizziness Depression score 0.232 0.078 1.261 0.003 
Sleep problems Depression score 0.227 0.062 1.255 <0.0001 
a
 Natural log of the odds of “moderate or severe” symptoms occurring when there is a unit change in the 
predictor variable. 
b
 Significant interactions between two variables. OR: odds ratio.  Adjusted for age (years), 
time on dialysis (months), Stoke comorbidity score, sex (male/female), modality (HD/PD), nutritional status 
(SGA malnourished/well nourished) and depression (HADS depression score). 
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Table 4-17 presents the adjusted odds ratio (OR) for variables which are independently associated 
with the presence of moderate or severe symptoms.  HD as opposed to PD was found to be 
associated with a higher OR for headaches (5.955; p=0.039), dry mouth (3.701; p=0.001), taste 
changes but only in those with higher depression scores (1.428, p=0.001) and cramps in legs but only 
in those with higher comorbidity scores (1.769, p=0.007).  PD use was not associated with an 
increased OR of experiencing any of the symptoms as moderate or severe when compared to HD 
use.   
 
Table 4-18: Linear regression analysis for the symptom severity score  
 95% CI  
Variables B 
a
 Standard error Lower Upper P value 
Female v male 4.405 1.106 2.218 6.592 <0.0001 
Depression score 0.756 0.166 0.428 1.084 <0.0001 
Stoke comorbidity score 1.877 0.446 0.995 2.760 <0.0001 
Inadequate dialysis v adequate dialysis 3.861 1.565 0.765 76.958 0.015 
Malnutrition v well nourished 2.953 1.326 0.329 5.576 0.028 
a
B=Change in symptom severity score resulting from a one unit change in the predictor variable.  Adjusted for: 
age, time on dialysis, depression (HADS depression score), Stoke comorbidity score, modality (HD/PD), 
nutritional status (SGA malnourished/well nourished), sex (male/female), late referral (yes/no), cognitive 
function (impaired/intact) and adequate dialysis (yes/no). 
 
Table 4-18 displays the results from the multiple linear regression analysis.  Dialysis modality did not 
influence the total symptom severity score.  This suggests that dialysis modality does not influence 
overall symptom severity but potentially has an impact on individual symptoms.   
 
4.13.5 Summary of findings 
The findings derived from the regression analyses demonstrate that older people on PD and HD have 
a comparable HRQOL but patients on PD experience less illness and treatment intrusion than those 
on HD.  In addition, those on PD experience fewer symptoms of depression.  This was not, however, 
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supported when a similar analysis was conducted using a cut-off score to represent the presence of 
possible depression.  In addition, HD was associated with an increased odds of moderate to severe 
occurrence of headaches, dry mouth, taste changes (only in those with higher depression scores) 
and cramps in legs (only in those with higher comorbidity scores) compared to PD patients.  
 
4.14 DISCUSSION 
This study reports on the first focused investigation into HRQOL in a purposively sampled population 
of prevalent HD and PD patients aged 65 years and older.  The results of this cross-sectional study 
demonstrate that older people on PD have a better HRQOL as determined by illness and treatment 
intrusiveness and depressive symptoms.  However, the primary outcome of the HRQOL scores 
derived from the SF-12 MCS and PCS assessments were comparable in patients on either dialysis 
modality.  These findings are interesting, especially in view of the declining use of PD within the UK 
seen over recent years.  This, therefore, lends further support to the concept that older people 
should be supported to enable them to select their preferred choice of modality.   
 
The matching process was successful at identifying patients on PD and HD with similar demographic 
characteristics.  This was done with the aim of comparing “like with like” as far as was practical.  
Additional characteristics were subsequently adjusted for in the regression analyses.  In a relatively 
small sample, the matching process provides a methodological strength for this study.  The 
population recruited were a mixture of incident and prevalent dialysis patients.  The univariate 
analyses appeared to suggest that the HRQOL differences between PD and HD were only present in 
those who had been on dialysis for over a year.  This may be because the long-standing older PD 
patient may be more robust in some aspects compared to the older long-standing HD patient, with 
improved HRQOL measures reflecting characteristics of those who select and successfully remain on 
PD.  Regardless of this speculation, it is relevant to understand the HRQOL of prevalent older dialysis 
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patients, as many are surviving longer on dialysis.  Short of randomising patients to the different 
modalities, there is no other way of further exploring this area.    
 
This study provides values for the various HRQOL measures which can subsequently be used as 
comparators to other older patient groups or indeed younger patient populations.  The literature 
reports SF-36 PCS scores in older people on dialysis ranging from 33.2 ± 10.7 to 46.0 ± 8.1 and MCS 
scores ranging from 48.5 ± 11.0 to 51.2 ± 20.9 (Altintepe et al. 2006; Lamping et al. 2000; Rebollo et 
al. 1998).  The SF-12 PCS scores within this BOLDE study ranged from 34.3 ± 9.7 to 36.4 ± 12.1 and 
SF-12 MCS scores ranged from 51.3 ± 12.9 to 55.0 ± 8.4 (HD and PD respectively).  The PCS and MCS 
scores were, therefore, within the range found in the literature with the exception of the MCS scores 
for the PD patients which were higher by nearly 4 points.  The main difference between the PD 
population in this BOLDE study and that in other studies may concern treatment availability and 
level of comorbidities.  When Lamping et al undertook their study on older people on dialysis 
between 1995 and 1996, approximately 30% of prevalent patients were on PD compared to only 
13% at the time of this BOLDE study.  This highlights the potential difficulties older people may 
currently be experiencing in accessing PD.  Therefore, it is possible that only the patients that are the 
“fittest” (i.e. fewest comorbid conditions) may be able to access PD.  The other two studies were 
undertaken in Spain and Turkey and, therefore, their scores may be affected due to a variety of 
other reasons.   
 
To date, no studies have reported on rates of depression in older dialysis patients, as assessed 
through the HADS.  The prevalence of possible depression in this BOLDE study ranged from 10% in 
the PD group to 25.7% in the HD group (p=0.015).  After adjusting for multiple variables, this 
difference was no longer significant.  Regardless of the screening tool used, rates of depression in 
dialysis patients are thought to be between 20 and 30% (Finkelstein et al. 2008b), with a prevalence 
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of 26.7% in a sample of HD patients diagnosed through the SCID “gold standard” assessment 
(Hedayati et al. 2008).  The prevalence of depression reported in this BOLDE study does, however, 
appear to be lower compared to other studies in adults on dialysis, pointing to a possible degree of 
positive selection of participants, which was also seen in the low rates of cognitive impairment, as 
assessed by the MMSE (4.3%).  This study may also reflect that older dialysis patients have lower 
rates of depression compared to younger dialysis patients (Hung et al. 2011), which is also 
compatible with the rates reported in older compared to younger people in the general population 
(Christensen et al. 1999; Regier et al. 1993).   
 
The IIRS remained significant on regression analysis and indicated a better outcome in older patients 
on PD compared to those on HD.  Within the literature, there is only one study that provides scores 
for each of the 13 domains for the IIRS in persons with ESRD.  In this study by Devins et al, however, 
the 101 participants were either on dialysis or had a transplant, yet they were symptomatic with 
serum creatinine levels exceeding 1000 µmol/L.  Perhaps unsurprisingly, the level of illness and 
treatment intrusiveness was far greater in every domain compared to that observed in the current 
study (Devins et al. 1993b). 
 
There are, however, several aspects to the study that warrant further discussion.  The sample used 
in this study was predominantly of a White European ethnic background.  Therefore, the findings 
may not be applicable to those from other ethnic backgrounds.  The evidence concerning the 
influence of ethnic background on HRQOL is conflicting.  One study found that depression and 
symptoms were comparable between Caucasians and African American HD patients (Weisbord et al. 
2007), yet another study in PD patients found that Indo-Asians had a lower HRQOL than Caucasians 
(Bakewell et al. 2002).   In contrast, a large study (the Dialysis Outcomes and Practice Patterns Study) 
on 6151 patients in the US found that African Americans had higher MCS and PCS scores than 
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Caucasians and that Asians had higher PCS scores than Caucasians (Lopes et al. 2003).  In this BOLDE 
study, achieving an overall demographically matched group of PD and HD patients came at the 
expense of recruiting a more ethnically diverse sample and, as can be seen from the literature, it is 
difficult to speculate how the results may have been different.  Another incidental finding relating to 
ethnicity concerns the high density of Caucasian older patients on PD in comparison to the ethnic 
diversity seen in the population on RRT as a whole (see Table 4-1).  This is suggesting that PD is a 
treatment that is only being presented to and/or being selected by one particular segment of the 
dialysis population which is of concern as it implies barriers related to ethnic backgrounds in 
accessing treatment choices.   
 
The findings are likely to be relevant in developed countries as opposed to areas where dialysis is not 
widely available, as the sample focused on the elderly ranging in age from 65 to 89 years.  The 
recruited elderly were also relatively free from mild cognitive impairment as ascertained by the 
MMSE, suggesting that the findings may also only apply to patients who have cognitive function that 
is largely intact.   
 
4.14.1 Critical evaluation 
There were a small number of limitations to this BOLDE study.  The main confounder that was not 
accounted for was whether the participants had a choice of dialysis modality.  A proxy for this 
measurement was the identification of those who had a planned start onto dialysis.  There are, 
however, likely to be a significant proportion of patients who were under the care of the nephrology 
team for a considerable period of time, yet still started dialysis in an unplanned fashion.  These 
patients mostly start on HD as opposed to PD.  Therefore, the journey onto dialysis may influence 
HRQOL as has already been demonstrated (Caskey et al. 2003). In addition, it would have also been 
appropriate to only select patients on HD who had not previously failed on PD, although the four 
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such patients in the study had similar HRQOL outcomes to those that had not previously experienced 
PD.   Counterbalancing the possible negative influence of dialysis start on HD patients, it is possible, 
however, that the HD patients were positively chosen by the lead nurse or consultant.    
 
The other limitations concerned the inability to assess the convergent validity of the social network 
score, as the study contained no other measures of social support.  This could have been determined 
prior to the start of the study in a separate sample of older dialysis patients, using an existing 
validated tool that assesses reciprocity of social support in older people, such as the Lubben Social 
Network Scale (Bowling 2005).  In the absence of this, it is difficult to conclude whether the social 
network score represents a true reflection of the amount of support the participants had from 
others or provided to others.     
 
4.15 CONCLUSION 
PD use is declining within the UK.  In 2009, although the take-up rate for PD in the elderly was 14.2%, 
the incidence rates ranged from 1.6 to 31.6% throughout the different renal units in the UK.  This 
suggests that PD use is not solely determined by patient choice based on appropriate and optimally 
delivered education, as one would expect a far more homogenous distribution of patients on the 
different dialysis treatments.  International variability in the use of the different dialysis modalities 
points to the influence of financial and geographical constraints.  Within the UK this may, in part, 
explain the variation, although there may be additional factors at play such as limited training of 
physicians in the use of PD, as was observed in the US (Mehrotra et al. 2002) or a breakdown in the 
process of care (Oliver and Quinn 2008).  This BOLDE study reinforces that the HRQOL outcomes in 
older people on PD are no different to a similar sample on HD, with the exception of the illness and 
treatment intrusion measure which was found to be better in older people on PD.  In light of the 
additional fact that neither modality displays a survival benefit, there is growing evidence that all 
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suitable older people should be given a choice of both PD and HD, with the support of appropriate 
education.  The remainder of this thesis, therefore, will focus on how older people perceive their 
dialysis modality choices and their journey onto their dialysis treatment.   
 
4.16 PUBLICATIONS 
This study has been published, as indicated in the following reference.  A copy of the publication can 
be found in appendix 11.2.   
 
Brown, E.A., Johansson, L., Farrington, K., Gallagher, H., Sensky, T., Gordon, F., Da Silva-Gane, M., 
Beckett, N., Hickson, M. 2010. Broadening options for long-term dialysis in the elderly (BOLDE): 
differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients. 
Nephrology Dialysis and Transplantation, 25, (11) 3755-3763 
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CHAPTER FIVE 
5 INVOLVEMENT OF OLDER PATIENTS ON HAEMODIALYSIS IN 
DIALYSIS MODALITY SELECTION 
  
5.1 INTRODUCTION 
As was established in the previous study, HRQOL of older patients on PD is comparable or better 
(depending on the measure used) than that of older patients on HD.  In view of both modalities 
being equally efficacious in relation to survival (as summarised in chapter two), one would expect 
the rate of PD uptake to be more uniformly distributed throughout the UK.  However, in the various 
units in the UK, PD uptake ranges from between 1.6% to 31.6% of all incident dialysis patients in 
2009 (Gilg et al. 2010).  Previous studies have highlighted that modality education leads to a greater 
proportion of patients selecting self-care dialysis, mostly in the form of PD (Goovaerts et al. 2005; 
Manns et al. 2005; Marron et al. 2005).  Therefore, patients on PD are more likely to have been 
exposed to modality education and to have been involved in their modality choice.  Patients on HD 
may have been more vulnerable to not being involved in their modality decision (Marron et al. 2005; 
Wuerth et al. 2002).  This, however, is not necessarily applicable to renal units where HD spaces are 
severely limited and are reserved for those who have contraindications (beyond personal choice) to 
PD.   
 
The design of the following study evolved due to reflections on the distribution of patients on PD 
and HD in one of the three units participating in the study programme.  This unit has a significant 
majority of patients commencing and remaining on HD compared to PD, leading to questions 
regarding the level of patient’s (on HD) involvement in their modality selection.  This unit has 
141 
 
potentially unique practices as it has the lowest incident usage of PD within the UK (Byrne et al. 
2009).  Thus, for the purposes of this study, PD patients were excluded and the focus centred on the 
level of involvement in modality selection in patients on HD.  Limiting the study to older people on 
HD due to the contextual setting of the research may compromise the application of the findings to 
other units within the UK.   
 
The null hypothesis being tested in this study is that older patients on HD do not perceive being 
involved in selecting their dialysis modality.  The primary aim was, therefore, to explore the 
perceived level of involvement (as well as the level of preferred involvement) of older patients 
already receiving HD, in the modality decision making process.  The secondary aims were to establish 
the sources of information patients on HD received about HD and PD, as well as the possible barriers 
to learning. 
 
 
5.2 METHODOLOGY 
 
5.2.1 Study design 
This BOLDE study was cross-sectional in design.  This was appropriate to fulfil the aims of the study 
which were to determine patients’ perceptions of their perceived and preferred level of involvement 
in the modality decision, the sources of their modality information as well as their reported barriers 
to learning about dialysis modalities.  These experiences were explored through a single, structured 
questionnaire.   
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5.2.2 Patient location 
Patients were selected from the same three renal units as that for the previous BOLDE study as 
detailed in section 4.3.   
 
5.2.3 Participants 
All the participants for this BOLDE study were aged 65 years or older, had ESRD which was being 
treated with HD.  The participants had all been on dialysis for between three and six months.  This 
time frame was selected as to maximise the probability that patients would recall their involvement 
and experiences of modality selection, as well as ensuring that HD was likely to remain their ongoing 
treatment.  All patients who were unable to understand the questionnaire and who were unable to 
provide consent were excluded.  Language was not an exclusion criterion as the use of interpreters 
was available.  In addition, patients who had previously been on dialysis prior to the current HD 
episode were also excluded, as it is likely that their modality decisional process would be very 
different.     
 
There were no statistical requirements to achieve a specific target sample size as the analyses were 
descriptives (e.g. means, medians, frequencies).  The sample size, however, had to provide a fair 
representation of the population being studied.  According to the renal registry data for 2007 (the 
year on which the sample size was estimated on), it is estimated that there would have been 
approximately 270 older patients starting on HD across the three renal units in that year.  As 
recruitment was scheduled to take place over a six month period, the feasible number of potential 
participants was reduced to approximately 135.  To allow for a refusal rate of 30% and an estimated 
20% of patients being unable to complete the questionnaire, a target of approximately 67 
participants was set, with a distribution across the three renal units reflecting their HD population 
density.   
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5.2.4 Recruitment 
Recruitment occurred between May 2008 and January 2009, which was longer than anticipated as it 
overlapped with the recruitment for the previous BOLDE study.  The recruitment of suitable patients 
was facilitated through the lead nurses at each HD renal unit who identified appropriate patients for 
the study.  The lead nurse would approach the patient to discuss their potential interest in 
participating in the study and to gain verbal consent for me to contact them with further details.  If 
they remained interested after my initial contact, the patients were sent an information sheet about 
the study which they were able to read and reflect on over a period of at least twenty four hours.  
After this, a suitable date was agreed where I would meet the patient to gain consent and administer 
the questionnaire.  Only 65 participants were recruited as opposed to the target of 70 participants.  
This may have been partially due to not adjusting for a mortality rate for older patients within the 
first six months on HD.   
 
5.2.5   The questionnaire  
This section discusses the design of the questionnaire, its administration, the process of data entry 
and finally the methods used to analyse the data obtained.  The study gained ethical approval from 
the Charing Cross Research Ethics Committee, reference number 08/H0706/41.  A copy of this 
approval letter can be found in appendix 11.3.2. 
 
5.2.5.1 Questionnaire design 
I designed the questionnaire, with input from the co-investigators.  The aims of the questionnaire 
were to determine perceived and preferred levels of patient involvement in the dialysis modality 
decision, the sources of information they had received about dialysis and their barriers (physical or 
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cognitive) to learning.  An overview of all the areas included in the questionnaire is listed in Table 
5-1. 
 
The questionnaire was piloted on ten patients on HD who did not directly fit the study criteria.  This 
was to ensure that the pool of potential participants remained eligible for the study to maximise 
recruitment.  Therefore, the participants of the pilot were either younger than 65 years and had 
been on HD for between three and six months or were aged 65 years or older but had been on HD 
for longer than six months.  The pilot demonstrated that the patients found the questionnaire easy 
to understand, although a few minor amendments were made concerning wording.  The final 
questionnaire can be found in appendix 11.4.   
 
  
145 
 
Table 5-1: Topics explored in the questionnaire. 
Areas for exploration Reason for inclusion Nature of question(s) 
Patient demographics Ascertain how the sample 
compares to that of the older 
dialysis population in general. 
Age; sex; marital status; ethnic 
background.  
Attendance at predialysis 
clinics 
Early referral associated with a 
greater probability of being 
exposed to the available dialysis 
treatments. 
Under the care of a nephrologist for ≥3 
or < 3 months  
Patients’ perceived 
involvement in modality 
decision.  
 Evidence suggests a 
disparity between 
preferred and perceived 
level of involvement.   
 Older people may prefer to 
be less involved in 
treatment decision making.  
Perceived patient involvement, as well 
as perceived involvement of others 
(e.g. physician, family) 
Patient preferred level of 
involvement in modality 
decision making 
Preferred patient involvement, as well 
as preferred level of involvement of 
others (e.g. physician, family) 
Informational resources 
supporting modality decision 
making 
To determine what 
informational resources older 
people are exposed to and find 
useful.     
Exposure to information resources 
including: 
 Resources from healthcare 
professionals. 
 Resources independent from 
healthcare professionals such as 
other patient stories and the 
Internet. 
Physical and cognitive 
barriers to learning about 
dialysis modality 
Older peoples’ perceptions of 
their physical or cognitive 
limitations. 
Difficulties with visual acuity, hearing, 
reading, memory, mobility, attention 
span and understanding.     
 
5.2.5.2 Administration of the questionnaire 
The questionnaire was short and took approximately fifteen to twenty minutes to administer.  The 
questionnaire was designed to be administered by the researcher (myself) as opposed to self-
administered by the participant, in order to enhance completion rates.  This also helped maximise 
the response rate, which may have been lower had the questionnaire been sent out to participants 
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or distributed and collected by the staff at the HD unit.  Being present during completion enabled 
patients to discuss any queries they had.  I administered all the questionnaires, thereby eliminating 
the possibility of inter-rater variability.  I conducted the questionnaire on either side of the 
participant’s HD session or during their dialysis session.  This helped to maximise recruitment as 
there was little or no time cost to the patient to participating in the study.  The questionnaire 
responses were not thought to be influenced by the timing of administration surrounding their HD 
treatment.  This is because the questionnaire did not require a private environment as there was no 
divulging of personal information and could withstand interruptions.  As the questionnaire was quick 
and easy to complete, it was unlikely to be affected by post-dialysis fatigue.  Despite the 
questionnaire being administered by me, there were a few participants who did not answer all of the 
questions.  This limitation will be discussed later in section 5.4.1.  
 
5.2.5.3 Data entry 
All the data was entered into a database using the statistical package, SPSS 17.0.  The data was 
checked by an independent researcher to ensure accuracy of the data transferred from the 
questionnaire to the electronic database for seven randomly selected completed forms (i.e. > 10%).  
This revealed a 100% accuracy rate.   
 
5.2.5.4 Data analysis 
As most of the responses were categorical as opposed to continuous, the questionnaire was 
analysed using univariate statistics, specifically the Pearson chi-square test.  A post-hoc logistic 
regression analysis was also undertaken.  Details of the logistic regression analysis can be found in 
section 4.11.5. 
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5.3 RESULTS 
The demographics of the recruited sample are presented in section 5.3.1.  The subsequent findings 
are grouped into three sections.  The first section explores patients’ perceived and preferred level of 
involvement in the modality decision and explores the influence of being referred late to dialysis, 
medical involvement in the modality decision, family involvement and differences in ethnic 
background.  This section ends with a logistic regression analysis to determine which variables 
significantly and independently contribute to the perception of being involved in the modality 
decision.  The second section describes the information sources and resources about dialysis that 
the participants were exposed to, as well as their perceived usefulness.  The last section quantifies 
older people’s perceived cognitive and physical limitations that can impact on learning about 
dialysis.   
 
5.3.1 Demographics 
The participant demographics are presented in Table 5-2.  They have also been compared, where 
possible, to the demographics of the UK dialysis population in 2008 (Byrne et al. 2009).  The national 
dialysis statistics, however, includes adult patients of all ages as opposed to only those aged 65 years 
and older.  The recruited sample was similar to the UK HD population in relation to the proportion of 
males (65% in the sample compared to 61% nationally) and the proportion of late referrals (25% in 
the sample compared to 29% nationally). 
 
The definition for late referral is identical to that used in the UK renal registry report and is the “time 
between first being seen by a nephrologist and start of RRT being <90 days” (Byrne et al. 2009).  This 
definition varied from that used in the previous BOLDE study (<30 versus <90 days) as the focus was 
no longer on identifying patients who were most likely to have started dialysis unexpectedly.  The 
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renal registry definition of late referral was adequate to identify those patients who may have had 
less exposure to information about their dialysis options in this BOLDE study.   
 
The sample contained a lower proportion of Caucasian patients compared to the national averages 
(71% v 80%).  This is reflective of the high ethnic diversity within the participating renal units, where 
the proportion of patients from British or European white backgrounds ranges from 38% to 77% 
(Table 4-1).  These national and centre-specific figures, however, include all patients on RRT as 
opposed to just those on HD.   
 
Table 5-2: Demographics of participants and comparisons to the UK Renal Registry (UKRR) data  
Demographics Imperial St Helier Lister P value Sample UKRR 2008 
Participants n (%) 25 (38.5) 25 (38.5) 15 (23.1) - 65 (100)  
Age years       
    Mean (SD) 71.7 (5.6) 75.3 (7.4) 74.9 (4.3) 0.104
a
 73.8 (6.2)  
 Sex       
    Male n (%) 16 (64) 15 (60) 11 (73) 0.692
 b
 42 (65) (61) on HD  
    Female n (%) 9 (36) 10 (40) 4 (27)  23 (35) (39) on HD 
Ethnicity        
    White n (%) 13 (52) 22 (88) 11 (73) 0.019
 b
 46 (71) (80) on RRT 
    Non-white n (%) 12 (48) 3 (12) 4 (27)  19 (29) (20) on RRT 
Marital status       
    Partner n (%) 14 (56) 15 (60) 14 (93) 0.038
 b
 43 (66)  
    Single/ Separated/ 
    Widowed n (%) 
11 (44) 10 (40) 1 (7)  22 (34)  
Renal clinic attendance       
    No attendance n (%) 4 (16) 6 (24) 1 (7) 0.172
 b
 11 (17)  
     0-3 months before 
    dialysis n (%) 
4 (16) 1 (4) 0  5 (8)  
    > 3 months before 
    dialysis n (%) 
17 (68) 18 (72) 14 (93)  49 (75)  
Late referral n (%) 8 (32) 7 (28) 1 (7) 0.174
 b
 16 (25) (29) on HD 
 
P value: p values for differences in demographics between the participants from the three renal units. SD: 
standard deviation. 
a 
Independent sample t-test; 
b
 Pearson chi-square test. 
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5.3.2 Patient involvement in the modality decision 
Figure 5-1 illustrates the proportion of the participants who perceived having been involved in their 
dialysis modality decision, whilst Figure 5-2 illustrates the participants’ preferred levels of 
involvement in the modality decision.  The results are shown for the sample as a whole as well as per 
individual renal unit.  Univariate statistics indicate that there are significant unit differences in 
relation to the patients’ perceived choice (p=0.001).  This may suggest that practices within the 
different renal units may be influencing the degree of patient involvement.  There were, however, 
no significant differences in the preferred level of involvement (p=0.475).  This latter observation 
demonstrates that patients, regardless of where they receive their renal care, want similar levels of 
involvement in their dialysis modality decision.   
 
Figure 5-1: Patients’ level of perceived involvement in their modality decision 
 
 
 
  
Difference between renal units, p=0.001 
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Figure 5-2: Patients’ level of preferred involvement in their modality decision 
 
 
 
There were many more participants who perceived having had no involvement (48.4%) compared to 
those who preferred to have no involvement (18.3%) in the modality decision.  In fact, Table 5-3 
shows that a third of the sample would have preferred a greater level of involvement than that 
which was experienced.  Finally, about 10 out of 65 participants were aware that they were 
unsuitable (for medical or social reasons) for PD.  This did not vary across the units.   
 
Table 5-3: Comparison between the patients’ perceived and preferred level of involvement in the 
dialysis modality decision.   
 Imperial St Helier Lister Sample P value
 
 
Preferred involvement compared to 
perceived involvement n (% per unit) 
n=25 n=21 n=14 n=60 0.001 
    Same 9 (36.0) 18 (85.7) 12 (85.7) 39 (65.0)  
    Greater 16 (64.0) 2 (9.5) 2 (14.3)  20 (33.3)  
    Less 0 1 (4.8) 0 1 (1.7)  
P value:  P-values for differences between the renal units using the Pearson chi-square test. 
 
Difference between the units, p=0.475 
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5.3.2.1 Late referral and involvement in dialysis modality decision making 
This sub-section explores whether being referred late for dialysis had any impact on the level of 
involvement in the modality decision.  In Table 5-4 I show that only 31% of the late referral patients 
perceived any degree of involvement in the modality decision compared to 55% of those who had a 
planned start onto dialysis.  No statistics were used due to the small number of observations.   
 
Table 5-4: Proportion of late and planned referral patients who perceived involvement in the 
modality decision   
 Imperial 
n=25 
St Helier 
n=23 
Lister 
n=15 
All 
n=63 
Late referral n (%) 8 (32.0) 7 (28.0) 1 (6.7) 16 (24.6) 
    Perceived involvement in modality decision  
    n (% of all late referrals for each renal unit) 
      1 (12.5) 3 (42.9) 1 (100.0) 5 (31.3) 
Planned referral n (%) 17 (68.0) 18 (72.0) 14 (93.0) 49 (75.0) 
    Perceived involvement in modality decision  
    n (% of all planned referrals for each renal unit) 
4 (23.5) 14 (77.8) 9 (64.3) 27 (55.1) 
 
5.3.2.2 Ethnic background and involvement in dialysis modality decision making 
The previous study on the comparison of HRQOL outcomes in those on PD and HD identified that 
those of non-Caucasian backgrounds may be experiencing barriers to accessing PD.  Univariate 
analysis in the current BOLDE study revealed that there was no difference between perceived 
(p=0.402) and preferred (p=0.520) level of involvement in modality decision making between 
Caucasians and non-Caucasians.  This evidence, however, only examines a small part of this area.  
   
5.3.3 Medical involvement in dialysis modality decision making 
The literature has highlighted that physicians often play a dominant role in modality selection 
(Fadem et al. 2011).  This sub-section, therefore, focuses on the participants’ perceived and 
preferred degree of medical involvement in the modality decision. Medical involvement in this 
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context refers to the involvement of any of the following healthcare professionals: nephrologists, 
renal nurses and general practitioners.  
 
Table 5-5 demonstrates, as anticipated, a high prevalence (87%) of perceived medical involvement.  
This was found to be similar between the renal units (p=0.057).  Perceived medical involvement 
broadly matched the patients’ preferred degree of medical involvement for 88% of the sample, 
however, this did vary significantly between the units, with 7/25 participants from Imperial having a 
preference for either greater or less medical involvement to that which was experienced (p=0.026).  
Overall, these results indicate that most of the sample of older people new to HD value the medical 
team being heavily involved in the modality decision.   
 
However, 10% of all the participants did not think the medical team should be involved in the 
modality decision.  It is possible that this small proportion of older participants prefer a more 
autonomous style of decision making.   
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Table 5-5: Level of perceived and preferred medical involvement in modality decision making 
 Imperial St Helier Lister All P value 
Perceived level of medical involvement  
n (% per unit) 
* n=25 * n=23 *n=14 *n=62  
    None 2 (8.0) 3 (13.0) 3 (21.4) 8 (12.9) 0.057
 a
 
    A little 0 3 (13.0) 2 (14.3) 5 (8.1)  
    Quite a lot 11 (44.0) 13 (56.5) 2 (14.3) 26 (41.9)  
    Very much 12 (48.0) 4 (17.4) 7 (50.0) 23 (37.1)  
Preferred level of medical involvement  
n (% per unit) 
* n=25 * n=21 *n=14 *n=60  
    None 0 3 (14.3) 3 (21.4) 6 (10.0) 0.027
 a
 
    A little 1 (4.0) 3 (14.3) 2 (14.3) 6 (10.0)  
    Quite a lot 15 (60.0) 12 (57.1) 2 (14.3) 29 (48.3)  
    Very much 9 (36.0) 3 (14.3) 7 (50.0) 19 (31.7)  
Preferred compared to perceived medical 
involvement n (% per unit) 
* n=25 * n=21 *n=14 *n=60  
    Same 18 (72.0) 21 (100.0)  14 (100.0)  53 (88.3) 0.026
 a
 
    Greater 3 (12.0) 0 0 3 (5.0)  
    Less 4 (16.0) 0 0 4 (6.7)  
* n=number of respondents, 
a
 Pearson chi-square test between the renal units. 
 
5.3.4 Family involvement in dialysis modality decision making 
Family involvement has been reported as an important influence on modality decision making and 
the results are presented in Table 5-6.  Thirty one percent of the participants perceived that their 
families had been involved in the modality decision.  Surprisingly, only 50% out of the whole sample 
preferred to have their families involved.  Over a fifth of the participants (22%), however, wanted 
their families to be more involved than they were.  This preference was especially pronounced in the 
participants from the Imperial renal unit and was significantly higher than that seen in the other 
renal units (p=0.011).   This may be because the participants from Imperial were less likely to be 
involved in their modality decision (Table 5-3, p=0.001), thereby leaving less opportunity for the 
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families to be involved.  There was no difference between perceived (p=0.081) and preferred levels 
(p=0.583) of family involvement between the different units.     
 
Table 5-6: Level of perceived and preferred family involvement in modality decision making 
 Imperial St Helier Lister All P value 
Perceived level of family involvement  
n (% per unit) 
*n=24 * n=23 *n=14 *n=61  
    None 19 (79.2) 16 (69.6) 7 (50.0) 42 (68.9) 0.081
 a
 
    A little 4 (16.7) 3 (13.0) 4 (28.6) 11 (18.0)  
    Quite a lot 1 (4.2) 4 (17.4) 1 (7.1) 6 (9.8)  
    Very much 0 0 2 (14.3) 2 (3.3)  
Preferred level of family involvement  
n (% per unit) 
*n=25 * n=21 *n=14 *n=60  
    None 11 (44.0) 13 (61.9) 6 (42.9) 30 (50.0) 0.583
 a
 
    A little 5 (20.0) 4 (19.0) 5 (35.7) 14 (23.3)  
    Quite a lot 6 (24.0) 3 (14.3) 1 (7.1) 10 (16.7)  
    Very much 3 (12.0) 1 (4.8) 2 (14.3) 6 (10.0)  
Preferred compared to perceived family 
involvement n (% per unit) 
*n=24 * n=21 *n=14 *n=59  
    Same  14 (58.3) 19 (90.5) 13 (92.9) 46 (78.0) 0.011
 a
 
    Greater 10 (41.7) 2 (9.5) 1 (7.1) 13 (22.0)  
    Less 0 0 0 0  
* n=number of participants, 
a
 Pearson chi-square test between the renal units.  
 
5.3.5 Regression analysis for perceived level of involvement in modality decision 
Section 5.3.2 found that patients’ perceived involvement was significantly different depending on 
the unit delivering the renal care.  This post-hoc regression analysis was undertaken to establish 
whether these findings could have been influenced by other variables.   
 
In order to ascertain the variables which may independently influence the level of perceived 
involvement, logistic regression analysis was undertaken on the dichotomous outcome “involved v 
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not involved”.  “Involved” was defined as any degree of involvement, ranging from “a little” to “very 
much”.  “Not involved” only included the response of no involvement.  The outcome was 
dichotomised as there were too few participants to analyse the data in the original four categories.  
A maximum of six variables could be included in the model due to sample containing only 65 
respondents. These variables were: age (continuous), ethnicity (Caucasian or non-Caucasian), 
partner status (partner or single), renal unit (Imperial, St Helier or Lister), sex (male or female) and 
late referral (yes or no).  Only the main effects (i.e. the variables) were included in the model and all 
the interaction terms between the variables were excluded.  This was due to the high number of 
categorical predictor variables in the model complicating the inclusion and assessment of 
interactions.     
 
The results are presented in Table 5-7.  The final model was found to be of good fit with an 
insignificant Hosmer & Lemeshow chi-square statistic of p=0.486 (Field 2005).   
 
Two variables were found to be independently related to patients’ perceived involvement.  One of 
these variables was the renal unit.  The odds of participants from St Helier perceiving that they were 
involved in the dialysis modality decision increased by a factor of 14.976 compared to participants 
from Imperial (p=0.002).  Odds of participants from the Lister perceiving that they were involved in 
the modality decision increased by a factor of 5.289 compared to participants from Imperial 
(p=0.031).  There was no difference in the odds of patients from St Helier compared to Lister 
perceiving being involved in the modality decision (p=0.221). The second variable found to be 
independently associated with patients’ perceived involvement was partner status.  Patients who 
had a partner had significantly greater odds of perceiving being involved in their dialysis modality 
decision (OR 5.367, p=0.027), regardless of which unit undertook their renal care.   
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Table 5-7: Adjusted odds ratio (adj OR) for variables associated with patients perceived involvement 
in the dialysis modality decision versus not involved 
    95% CI  
Variables B 
a
 SE Adj OR Lower Upper Sig 
St Helier v Imperial 2.707 0.781 14.976 3.241 69.202 0.002 
Lister v Imperial 1.666 0.772 5.289 1.165 24.022 0.031 
St Helier v Lister 1.041 0.850 2.831 0.535 14.986 0.221 
Partner v single 1.680 0.759 5.367 1.213 23.743 0.027 
a 
Natural log of the odds of patient involvement in dialysis modality decision occurring when there is a unit 
change in the predictor variable.  Analysis adjusted for age, sex, renal unit (Imperial, St Helier, Lister), ethnicity 
(Caucasian v non-Caucasian), late referral (yes v no) and partner status (partner v single). 
 
5.3.6 Dialysis modality information: sources and resources 
A pre-requisite to being involved in decisions about dialysis modality is the supply of appropriate 
information.  The questionnaire enquired about the sources and various formats of information 
received about each dialysis modality and their usefulness.   
 
Table 5-8 presents the availability of information from the renal staff and other patients.  The 
findings suggest that most of the participants (77%) had information about HD from their doctors 
and nurses, of whom 92% found this information useful.  This was a similar finding between the 
units (p=0.877).  The results were, however, different for information relating to PD.  Only 38% of 
the participants had been given information about PD from their doctors and nurses, of whom 96% 
found it useful.  There was a significant difference across the units, with only 13% of the participants 
from Imperial being given information about PD compared to 52% to 53% of the participants from 
the other two units (p=0.008).  This corroborates the finding that only 20% of the participants from 
Imperial perceived any involvement in the modality decision, compared to 66% to 74% in the other 
units (Table 5-3). 
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Only 23% attended group education seminars (which provided education on HD).  Of these patients, 
73% found them useful.  There therefore appeared to be an overall low take-up rate of group 
seminar attendance in this sample of older people, the reasons for which were beyond the scope of 
this questionnaire.  There was no difference between the units in the numbers who attended the 
group seminars (p=0.448).   
 
Thirty nine percent of the participants had received information about HD from other patients, of 
whom 84% found this useful.  A significantly higher proportion of patients appeared to speak to 
other patients about HD at the Imperial renal unit (60%) compared to the other units (20% to 33%), 
yet none of the patients at the Imperial unit were discussing PD with each other, compared to 13% 
to 20% of participants at the other units.  One would expect a smaller proportion of patients to be 
discussing PD with other patients compared to HD, as patients on PD are based at home and PD is a 
less visible form of dialysis within the hospital environment.  The fact that a greater proportion of 
participants at the Imperial unit were discussing HD with other patients could be reflective of the 
renal unit set-up, with CKD clinics being run adjacent to the dialysis unit.  
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Table 5-8: Renal staff and patient as sources of information on HD and PD and its’ usefulness  
 Imperial St Helier Lister All P value
 a
 
Doctors and Nurses (HD)  *n=24 *n=25 *n=15 *n=64  
    Available n (% per unit) 17 (70.8)  19 (76.0) 13 (86.7) 49 (76.6) 0.523
 
 
    Useful n (% of available) 16 (94.1) 17 (89.5) 12 (92.3) 45 (91.8) 0.877 
Doctors and Nurses (PD) n  *n=23 *n=25 *n=15 *n=63  
    Available n (% per unit) 3 (13.0) 13 (52.0) 8 (53.3) 24 (38.1) 0.008 
    Useful n (% of available) 3 (100.0) 12 (92.3) 8 (100.0) 23 (95.8) 0.643 
Group education (HD) n  *n=25 *n=25 *n=15 *n=65  
    Attended n (% per unit) 4 (16.0) 6 (24.0) 5 (33.3) 15 (23.1) 0.448 
    Useful n (% of attended) 4 (100.0) 4 (66.7) 3 (60.0) 11 (73.3) 0.360 
Group education (PD) n  *n=24 *n=25 *n=15 *n=64  
    Attended n (% per unit) 2 (8.3) 6 (24.0) 4 (26.7) 12 (18.8) 0.249 
    Useful n (% of attended) 2 (100.0) 5 (83.3) 2 (50.0) 9 (75.0) 0.329 
Other patients (HD) n  *n=25 *n=25 *n=15 *n=65  
    Available n (% per unit) 15 (60.0) 5 (20.0) 5 (33.3) 25 (38.5) 0.013 
    Useful n (% of available) 12 (80.0) 4 (80.0) 5 (100.0) 21 (84.0) 0.551 
Other patients (PD) n  *n=23 *n=25 *n=15 *n=63  
    Available n (% per unit) 0 5 (20.0) 2 (13.3) 7 (11.1) 0.084 
    Useful n (% of available) 0 5 (100.0) 2 (100.0) 7 (100.0) 1.000 
* n=number of participants, 
a
 Pearson chi-square test for differences between the renal units. 
 
Table 5-9 demonstrates the use of educational resources about PD and HD within the sample.  Most 
participants used booklets as an educational resource for information on HD (76%) compared to 
digital videos (18.8%) or the Internet (14.1%).  Only 35% had access to booklets about PD.  
Regardless of content, over 83% of the participants found the booklets useful.  Availability of digital 
videos (DVDs) about HD and PD were significantly more common at the Lister unit compared to the 
Imperial and St Helier units (p=<0.0001 and p=0.005 respectively).  Between 67% to 71% found DVDs 
useful.  Few patients used the Internet, yet of these, 89% to 100% found it a useful source of 
information.  
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Table 5-9: Educational resources used about PD and HD and their usefulness   
 Imperial St Helier Lister All P value
 a
 
Booklets (HD) n  *n=24 *n=24 *n=15 *n=63  
    Available n (% per unit) 17 (70.8) 19 (79.2) 12 (80.0) 48 (76.2) 0.735 
    Useful n (% of available) 13 (76.5) 18 (94.7) 9 (75.0) 40 (83.3) 0.228 
Booklets (PD) n  *n=23 *n=25 *n=15 *n=63  
    Available n (% per unit) 4 (17.4) 10 (40.0) 8 (53.3) 22 (34.9) 0.060 
    Useful n (% of available) 4 (100.0) 9 (90.0) 6 (75.0) 19 (86.4) 0.445 
DVD (HD) n  *n=24 *n=25 *n=15 *n=64  
    Available n (% per unit) 1 (4.2) 2 (8.0) 9 (60.0) 12 (18.8) <0.0001 
    Useful n (% of available) 1 (100.0) 2 (100.0) 5 (55.6) 8 (66.7) 0.368 
DVD (PD) n  *n=23 *n=25 *n=15 *n=63  
    Available n (% per unit) 0 2 (8.0) 5 (33.3) 7 (11.1) 0.005 
    Useful n (% of available) 0 1 (50.0) 4 (80.0) 5 (71.4) 0.427 
Internet (HD) n  *n=24 *n=25 *n=15 *n=64  
    Available n (% per unit) 3 (12.5) 2 (8.0) 4 (26.7) 9 (14.1) 0.249 
    Useful n (% of available) 3 (100.0) 2 (100.0) 3 (75.0) 8 (88.9) 0.495 
Internet (PD) n  *n=23 *n=25 *n=15 *n=63  
    Available n (% per unit) 1 (4.3) 2 (8.0) 1 (6.7) 4 (6.3) 0.873 
    Useful n (% of available) 1 (100.0) 2 (100.0) 1 (100.0) 4 (100.0) 1.000 
* n=number of participants, 
a
 Pearson chi-square test for differences between the renal units. 
 
 
5.3.7 Barriers to learning about dialysis modalities 
Older people have a higher prevalence of physical and cognitive dysfunction which may impinge on 
their ability to access information on, or to learn about the different dialysis treatments.  The final 
section of the questionnaire solicited information on a range of potential barriers to learning.  Most 
of the participants (83%) perceived having at least one barrier. Figure 5-3 illustrates the prevalence 
of the individual barriers to learning about the different dialysis options.   
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Figure 5-3: Prevalence of barriers to learning about dialysis modalities 
 
 
Unit differences were observed as can be seen in Table 5-10.  None of the participants from the 
Imperial unit had problems with their hearing compared to 36% to 53% in the other units 
(p=<0.0001) and 36% of the participants from the St Helier unit had difficulties paying attention 
compared to 0 to 8% in the other units (p=0.004).  These are curious observations as one would 
expect an even distribution of these barriers.  These observations could point to the need for a 
larger sample size to ensure an even distribution of patient characteristics across the three renal 
units.   
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Table 5-10: Prevalence of barriers to learning about dialysis modalities across the three renal units 
 Imperial 
n=25 
St Helier 
n=25 
Lister 
n=15 
All P value
a
 
Problems, n (% per unit)      
    Vision  7 (28.0) 14 (56.0) 5 (33.3) 26 (40.0) 0.108 
    Hearing  0  9 (36.0) 8 (53.0) 17 (26.2) <0.0001 
    Reading 7 (28.0) 10 (40.0) 4 (26.7) 21 (32.3) 0.575 
    Memory 11 (44.0) 16 (64.0) 4 (26.7) 31 (47.7) 0.134 
    Mobility 13 (52.0) 14 (56.0) 4 (26.7) 31 (47.7) 0.171 
    Paying attention 2 (8.0) 9 (36.0) 0 11 (16.9) 0.004 
    Information too complicated 3 (12.5) 4 (16.0) 3 (20.0) 10 (15.4) 0.732 
a
 Pearson chi-square test for differences between the renal units. 
 
5.4 DISCUSSION 
This study tested the null hypothesis that older patients new to HD do not perceive themselves to 
have been involved in their modality decision.  This proved to be the case for 48% of the sample, 
with a third expressing a preference for a greater level of involvement compared to that which was 
experienced.   
 
There could be several reasons for these observations.  Although a substantial proportion of patients 
reported receiving information about HD, either through the medical team (77%) or through 
booklets (76%), only a small proportion (35% and 38% respectively) reported the same regarding 
information about PD.  This could indicate that many older people are not being provided with 
comprehensive information on both modalities, precluding them from being able to make a valid 
contribution to their modality selection.  There was also a high prevalence of cognitive and physical 
dysfunction that may impinge on older patients accessing modality education or in learning about 
the different treatments.   
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No other studies to date have reported the experiences and preferences of older dialysis (or pre-
dialysis) patients in their involvement in making decisions about their dialysis modality.  It has been 
reported, however, that a greater proportion of older compared to younger people prefer their 
healthcare teams to take their medical decisions.  Orsino et al from Canada reported that in a 
sample of 197 PD and HD patients (aged 21 to 86 years), 35% preferred to make the decision about 
their dialysis modality on their own, 42% preferred to make the decision together with the 
healthcare team, whilst 24% preferred the healthcare team to make the final decision (Orsino et al. 
2003).  When comparing the BOLDE findings to Orsino’s findings on preferred level of involvement 
respectively, we can compare that 9% versus 35% preferred to make the decision on their own and 
that 18% versus 24% preferred the healthcare team to make the final decision.   Therefore, a lower 
proportion of older individuals on HD in this BOLDE study were observed to have a preference to 
take the modality decision on their own, with most wanting some involvement from their healthcare 
team.  When comparing the BOLDE findings to Orsino’s findings on the perceived level of 
involvement respectively, we find that 13% versus 27% of participants perceived having taken the 
modality decision on their own and that in 50% versus 48% of participants, the healthcare team was 
perceived to make the modality decision.  This suggests that approximately half of the patients 
studied perceived not being involved in this life affecting decision.  This is further supported in the 
literature where it has been noted that some patients were not aware of their modality options, 
thereby suggesting that these patients would not have perceived themselves to have selected a 
modality treatment (Fadem et al. 2011; Finkelstein et al. 2008a; Marron et al. 2005; Mehrotra et al. 
2005).   
 
One further finding that has not been explicitly reported elsewhere is the apparent influence of the 
renal unit on perceived patient involvement.  This finding suggests that the environment where the 
patient receives their care has the potential to impact the level of patient involvement in their 
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modality decision and possibly on their resulting mode of treatment.  This environmental influence is 
likely to be partially mediated by the quality and timing of education delivered within each renal 
unit.  The effect of education on modality selection has been explored extensively (Breckenridge 
1997; Gomez et al. 1999; Jager et al. 2004; Kelly-Powell 1997; Little et al. 2001; Manns et al. 2005; 
Marron et al. 2005; Whittaker & Albee 1996).  The units where there was a comparatively low 
prevalence of patient involvement could be reflective of a “paternalistic” approach to decision 
making by the healthcare team.  Therefore, the influence of the renal unit on patient involvement 
may extend beyond that of the quality of modality education and may include other variables such 
as the interactions between the patient and the physician. 
 
5.4.1 Critical evaluation 
Designing and administering a questionnaire was an important learning experience.  On reflection, 
there were a number of aspects of the process that could have contributed to improving the quality 
of the outcomes obtained or need to be borne in mind during interpretation of the findings.  These 
are described below.   
5.4.1.1 Recall 
Any findings based on retrospective questionnaires are going to be subject to issues surrounding 
memory recall and/or recall bias.  In this study, 48% of the sample reported problems with their 
memory.  This finding alone is likely to indicate that the high reported rates of non-involvement in 
the dialysis modality decision may be due to impaired memory recall of their modality selection 
decisions three to six months previously.  In addition, recall bias may have also influenced the 
findings.  It is possible that some individuals may not have had any recollection of the degree of 
involvement in the modality decisions if they did not perceive PD to be an option they wished to 
consider or if they preferred the medical team to take the lead in the modality decision.  Prospective 
studies are likely to be able to address the issues of recall more effectively.        
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5.4.1.2 Questionnaire design 
The questionnaire was based on several assumptions, which I believe contributed to some 
participants experiencing difficulties during its completion.  In the demographics section, one 
question refers to marital status with possible responses ranging from whether the respondent was 
married, single or lived with a partner or carer.  Aside from the inappropriate use of the word 
“marital” (whether a patient is married or not is irrelevant), this question was aiming to gather 
information regarding the level of support the patient may have had at home.   In hindsight, this 
question fails to provide the information that it sought to retrieve.  It would have been more 
appropriate to enquire who the participant lived with (if anyone) and if these persons provided them 
with any support.   
 
The format of the questionnaire was, on reflection, designed to meet the needs of those who had 
experienced a choice of modality, as opposed to those who had not.  The flow of the questions 
assumed that all the respondents would be aware of the existence of PD, which was not, in reality, 
observed.  Awareness of PD should have been included as a separate question, leading onto 
appropriate follow-on questions, depending on the response.  Five participants had difficulties 
answering some questions providing further evidence that some questions may have been poorly 
phrased.  Some of the questions were lengthy and incorporated several constructs that needed to be 
understood prior to answering the question.  Indeed, Boynton and Greenhalgh suggest a maximum 
of twelve words within a single question (Boynton and Greenhalgh 2004).  This issue is exemplified 
with question 13 in  
 
 
 
Table 5-11.   
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Table 5-11: Question 13 and its constructs 
Question 13 Construct 
“From your own personal experience...” Reflection on what has happened to the patient.  In hindsight 
this is unnecessary as the patient is only going to refer to 
their own personal experience.   
“...to what extent....” Request to assess a degree of relativity, but the respondent 
is still unaware of what the question is referring to. 
“...were the following people...” Request to consider the role of several others, but the 
respondent is still unaware of what the question is referring 
to. 
“...involved in making decisions...” Only now does the respondent understand what they are 
being asked to consider. 
“...about the type of dialysis you are on.” This last part is confusing if patients have not been aware of 
the different dialysis options available.   
  
Question 13 may have been better placed as two questions (once it had been established that the 
participant was aware of the existence of PD):  
i. “Were you involved in the decision to start on HD as opposed to PD?”   
ii. “To what extent were other people involved in the decision for you to start on HD as 
opposed to PD?” 
 
Therefore, this study has helped me to value the importance of fully understanding the range of 
possible responses prior to designing a questionnaire to minimise the risk of phrasing questions 
inappropriately that can then impair the quality and scope of the responses.  It has also highlighted 
that the questions need to be absolutely clear and comprehensible.  The optimum way of clarifying 
the level of question comprehension is through piloting the study.  Although a small pilot was 
undertaken, it is likely that my focus was on the ability of the patients to respond to the questions as 
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opposed to their interpretation or thoughts about the questions.  The important aspects to consider 
when piloting a questionnaire are listed in Table 5-12.  These considerations are based on a 
combination of existing literature on questionnaire design (Boynton 2004) as well as the experiences 
I have gained throughout this study. 
 
Table 5-12: Issues to observe during the piloting of a questionnaire 
Topics for piloting a questionnaire Questions to consider whilst piloting a questionnaire 
Practicalities of questionnaire 
delivery 
1. How long do participants take to complete the questionnaire? 
2. Are participants satisfied with the format of the questionnaire? 
E.g. paper and pen, self or interview delivered, or computer 
delivered. 
3. Is the questionnaire being delivered at an appropriate time and 
place to enable completion?   
Respondent comprehension 1. Do any of the questions need to be repeated or explained? 
2. Do respondents understand the question in the way they were 
designed to be interpreted? 
3. What is the process by which participants arrive at an answer? 
4. How do they react to the suggested responses provided and 
why? 
 
5.4.1.3  Data collection 
The data was collected for all the respondents but no data was collected on the non-respondents. 
This was mostly due to the process of recruitment.  Often the lead nurse would inform me of the 
patients that had provisionally agreed to have further information about the study, rather than the 
patients that refused any further involvement.  Therefore, the adequacy of the recruited sample 
could only be compared to the national averages.   
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5.4.1.4 Questionnaire reliability 
The questionnaire was not tested for reliability through testing and retesting.  This measure would 
have provided an indication as to whether the responses were consistent over time.  The outcomes 
of this questionnaire refer to constructs that should be relatively stable over time (e.g. perceived 
involvement in modality decision making), therefore one would expect a high level of reliability.   
 
5.4.1.5 Ethical observations 
As several participants were unaware of the existence of PD, any questions concerning the existence 
of an alternative to HD elicited a mixture of reactions.  Most patients assumed that their physician 
must have deemed them to be unsuitable for PD, hence justifying their lack of knowledge.  A few 
patients were, however, interested to find out more about PD which led to my referring them to 
their lead nurse or consultant for further information and discussions.  Although it felt 
uncomfortable to be the person that informed the patients about the existence of PD, I realised that 
the ethical issue was not related to the study itself but to the ethics of withholding this information 
from patients throughout their journey onto dialysis.  This area will be explored in the following 
study.   
  
5.5 CONCLUSION 
Despite the improvements that could be made to the questionnaire, the findings are still compelling.  
In summary, nearly a half of the participants, who were all older patients new to the HD treatment, 
perceived not having been involved in their modality decision (although this could be influenced by 
the high rate of issues with memory reported).  A third of all participants would have preferred more 
involvement than that experienced.  This appeared to be significantly influenced by the unit from 
which the participant received their renal care.  These findings suggest that a large proportion of 
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patients within these three renal units are not being supported in choosing between treatments that 
can have a significant impact on lifestyle.  This is even more pertinent in this patient group for whom 
dialysis is likely to be life long as opposed to a temporary measure until transplantation.     
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CHAPTER SIX 
6 AN INTRODUCTION TO THE QUALITATIVE EVALUATION OF 
MODALITY DECISION MAKING IN OLDER PEOPLE  
 
“Medicine is not only a mechanistic and quantitative science, it is also an interpretative art.” 
Mita Giacomini & Deborah Cook. 2000. JAMA, 284, (3) 358 
 
6.1 INTRODUCTION 
Study findings presented so far have indicated that HRQOL is comparable, if not better (depending 
on the outcome measure used), in a select group of older patients on PD compared to HD (chapter 
four, section 4.13.3.5).  We also know that most (82%) of the sample of older patients on HD in the 
study described in chapter five, section 5.3.2, expressed a preference for involvement in the 
modality decision process, yet only half perceived having had any level of involvement.  It is still, 
however, uncertain if involving patients in their treatment decisions can positively influence their 
outcomes.  The process of how and why some patients perceive to be, or not to be, involved in their 
modality decisions, also remains to be explored.     
 
Patient involvement in modality decision making could be argued to be of little clinical importance as 
the survival and HRQOL outcomes (as reported in chapter two, sections 2.1.1 and 2.2.4) are likely to 
be similar, regardless of the dialysis treatment that patients are on.  This view, however, fails to 
capture the understanding about patient outcomes relative to their involvement in modality 
decisions.   It also fails to acknowledge those outcomes (such as integration of dialysis into ones’ life) 
which are of paramount concern to patients.   
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In this chapter I argue that patient involvement in modality decision making is of considerable 
importance, not only from an ethical perspective (section 6.1.1), but from the perspective that 
choice of dialysis modality has serious implications for how people manage to successfully integrate 
dialysis into their identity to maximise their psychological and social well-being.  
 
In this chapter, I also argue why this topic needs to be explored using qualitative methodology as 
opposed to quantitative methods (section 6.2), as the two vary in their aims and scope.  This 
qualitative study not only seeks to explore in-depth the experiences of older patients as they journey 
onto HD or PD, from their involvement in the decision making process, to their experiences of living 
with their respective treatment, but also to illustrate the social and medical contexts which influence 
that decision making process.  The chapter concludes with the aims for this qualitative BOLDE study.   
 
6.1.1 The ethics of patient involvement in modality selection 
Ethical issues commonly discussed when referring to dialysis modality and care of elderly renal 
patients, are those concerning the withholding or the withdrawal from dialysis.  Little attention has, 
however, been paid by the nephrology community to the ethical issues surrounding choice of 
dialysis modality.  Deciding on a dialysis modality draws parallels, in some respects, with situations 
where informed consent is obligatory.  In chapter three, section 3.2.4, I described the case of 
Canterbury v Spence in 1972, which stated that “true consent to what happens to one’s self is the 
informed exercise of a choice, and that entails an opportunity to evaluate knowledgably the options 
available and the risks attendant upon each” (Sullivan 2003).  Historically, with informed consent, 
the patient is informed about the physical risks from procedures, but the impact on social and 
psychological well-being is often neglected.  Medical treatments, especially in the management of 
chronic conditions, may have an impact on lifestyle and social well-being, whether it be through, for 
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example, the daily administration of insulin for diabetes or the dependence on supplementary 
oxygen in chronic obstructive airways disease.  Few chronic conditions, however, require the lifestyle 
altering commitment of dialysis.  Therefore, attributing ethical importance to involvement in the 
choice of modality, with the aim of enhancing social and psychological well-being, is an area in need 
of recognition in the field of dialysis modality decision making.   
 
The four principles of medical ethics, succinctly described by Gillon, further support raising the 
ethical perceptions of involvement in dialysis modality decisions (Gillon 1994).  The first principle of 
“respect for autonomy” argues that health care professionals should inform patients of the potential 
effects of forthcoming medical care.  From this, it could be suggested that health care professionals 
should also inform the patient of the potential impact a treatment may have on social and 
psychological well-being, as can often occur when undertaking dialysis.  The second and third 
principles relate to “respect for beneficence” and “non-maleficence”, which implies that the benefit 
of medical care should outweigh its effects on the patients’ lifestyle and social issues.  Dialysis is now 
routinely used to treat older people, with the benefits of dialysis (increased survival) deemed to 
generally outweigh the impact on the social, psychological and physical aspects of the patient.  
However, this may not always be the case.  Equally, this can also be argued with reference to 
modality selection.  The impact of dialysis on the lifestyle of each patient may be different with PD 
compared to HD.  The final principle concerns “respect for justice”.  Patient involvement in their 
health care decisions involves respect for people’s rights and therefore rights based justice (Gillon 
1994).  Therefore, there appears to be solid ethical support to ensure that all patients, older and 
younger, are involved in understanding the possible social, physical and lifestyle consequences of 
each dialysis modality when selecting a treatment.     
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6.1.2 Outcomes of patient involvement in modality selection 
Unlike studies involving patients with conditions such as cancer (as described in section 3.3.3), few 
studies have investigated the impact of the level of patient involvement in their dialysis modality 
selection on their subsequent experiences of living with the treatment.  The limited evidence 
available does, however, demonstrate that patients who receive pre-dialysis education were more 
satisfied with the information they received (Coupe 1998), had increased knowledge about the 
dialysis modalities (Gomez et al. 1999) and an increased likelihood of selecting a home based dialysis 
treatment (Goovaerts et al. 2005; Jager et al. 2004; Marron et al. 2005; Mehrotra et al. 2005).  
Knowledge about dialysis treatments, however, did not always equate with understanding 
(Finkelstein et al. 2008a).  In all these studies, involvement in the modality decision is loosely 
equated to having received education.  There are however, several other mediating factors that can 
impact on involvement in treatment decisions, for example, the patient and physician relationship.   
 
Involvement in modality selection is highly valued by many patients, with some expressing strong 
views of how modality choice can impact on their future social and psychological well-being rather 
than issues surrounding survival or clinical outcomes (Morton et al. 2010a; Tong et al. 2009).  For 
example, one pre-dialysis patient described perceiving in-centre HD as “worse than death” due to 
the imagined loss of personal autonomy (Morton et al. 2011).  Furthermore, a recent systematic 
review of qualitative studies found that minimising disruption to pre-existing lifestyle was of 
paramount importance when deciding on treatment modality (Morton et al. 2010c).  Ability to lead a 
“normal” life on dialysis was also of prime concern in a group of HD and PD patients aged 53 years 
and older (Orsino et al. 2003).  Some patients, however, report not receiving enough information on 
how to integrate dialysis into their lives (Coupe 1998; Tong et al. 2009).  Survival or clinical outcome 
concerns were rarely mentioned in comparison to the impact of dialysis on lifestyle.  Sustaining 
one’s identity by maintaining one’s usual functions, activities and relationships is therefore of 
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primary concern for many dialysis patients (Kelly-Powell 1997).  The following section expands on 
some of the findings relating to loss of identity in chronic illness.   
 
6.1.3 Chronic illness and identity 
The relationship between chronic illness and identity has been explored further in other chronic 
conditions aside from renal failure, and has been the concern mostly of medical sociologists as 
opposed to those directly involved in delivering healthcare to patients.   
 
Michael Bury, a well known sociologist, introduced the concept of “biographical disruption” as a 
result of qualitative interviews on patients with rheumatoid arthritis (Bury 1982).  The concept 
describes how patients’ everyday living can be profoundly “disrupted” by chronic illness.  The 
physical manifestations of the condition can impact on routine activities, such as hobbies or 
employment, disrupting how the individual views their sense of self.  The illness may lead to 
increased dependency on those around them thereby disrupting the dynamics of relationships with 
loved ones, although this is not always the case as illustrated in an in-depth review of the impact of 
ESRD on close persons (Low et al. 2008).  The patient may also experience disruptions to their future 
life plans and expectations.   
 
The concept of “biographical disruptions” has, however, been challenged.  Mike Oliver (a disability 
theorist), amongst others (Smith 2000), argue that it is the “social restrictions imposed by an 
unthinking society” that limit how people with disabilities (of which a large proportion have a 
chronic condition) can participate in their community life, complicating how individuals manage their 
disability within their everyday life (Oliver 1998).  Therefore, it is not so much the chronic illness that 
limits how people adapt to their condition (as Bury argues) but the limitations that are present 
within society (and therefore the individuals context) that are the root of the issue.   
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Therefore, the idea of “biographical disruptions” may not fully explain the findings in relation to how 
older people adapt to chronic illness in the medical literature.  As an example, in chapter two 
(section 2.2.3), HRQOL in older people on dialysis was observed to be comparatively better than that 
in younger people.  This may be due to older people having prior experience of how to manage 
other comorbid conditions leading to adaptive responses to maintain their existing biography 
(Faircloth et al. 2004), or because illnesses in older ages are “biographically anticipated” (Williams 
2000).  This was observed in older people who had experienced a stroke and who regarded it as a 
“normal crisis” in line with other previous life experiences, such as living through the Second World 
War and poverty.  In addition, most of these older participants did not experience a disruption to 
their biography as their environment still allowed them to engage in a social life (Pound et al. 1998).  
The medical environment can also influence how people manage their condition.  This is illustrated 
by Hart who states “the actions that people do, or do not take, in the process of managing the 
stroke, need to be explored in relation to their experiences of the system itself” (Hart 2001).  The 
medical team and medical environment can therefore support the integration of the condition into 
the patients’ identity (Radley and Green 1987) and, therefore, may be able to contribute to 
minimising the disruptive effect that ESRD and dialysis may have on the individual.  Therefore, the 
consequences to the individuals’ identity of living with a chronic condition needs to look beyond the 
impact of the condition on everyday life and also take into account contextual issues such as the 
patients’ life experiences and their social and medical environment. 
 
The relationship between identity and dialysis has been poorly explored within the renal literature.  
One study reported findings of “loss of self” in those on dialysis in the early 1980’s, when dialysis 
was very different to what it is now (Charmaz 1983).  A recent focus group study demonstrated how 
patients living with CKD or dialysis had to adjust to the disruptive effect of their illness on aspects 
such as identity and lifestyle. However, the medical context, such as the way the healthcare system 
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was structured (multiple hospital visits) also contributed to their disrupted lifestyle and identity, as 
well as impacting on their energy, finances and family life (Tong et al. 2009).  This was also suggested 
in a conceptual paper which states that increased support from healthcare professionals looking 
after dialysis patients may “help patients re-establish a sense of integrity and wholeness at a time 
when their identity is threatened by change, over which they have no control” (Hutchinson 2005).  
Another study observed how dialysis patients experienced transitional stages involving the 
separation from their old selves when commencing on treatment, to reincorporation into society 
with an adjusted identity as a dialysis dependent individual (Martin-McDonald and Biernoff 2002).   
 
Thus we can start to appreciate that ESRD may lead to “biographical disruptions”, especially once 
patients are on dialysis.  However, we can also begin to see that the medical and social 
environments may be contributing to disrupting how patients are able to manage their everyday life 
on dialysis.  Two ways of supporting the patient would be by firstly through minimising the potential 
disruption on their biography by involving the patient in choosing the dialysis treatment that is likely 
to best fit into their lifestyle and secondly by supporting the patient in accepting a new biography, 
possibly through the adjustment of goals and promoting an environment that enables the fulfilment 
of these goals.  Involvement in the modality decision may allow the patient to have an active role in 
minimising these potential biographical disruptions and promote a greater integration of dialysis 
into their lives.   
 
6.2  BACKGROUND TO SELECTING QUALITATIVE METHODS 
Modality selection has been investigated using both quantitative as well as qualitative 
methodologies.  A review and critique of the contribution that each methodology has provided to 
the understanding of modality decision making is explored, which concludes with a justification for 
the chosen method for the upcoming study.     
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6.2.1 Critique of use of quantitative methodologies 
The vast majority of studies on modality decisions have been quantitative in style, designed and 
conducted by the medical profession.  One of the earliest such studies involved structured 
interviewing of dialysis patients to identify and rank the salient factors that influenced their selection 
of either HD or PD (Groome et al. 1991).  Surveys and questionnaires then were extensively used 
from 1993, when the influence of education on modality selection was explored  through a follow-up 
study on pre-dialysis patients (Ahlmen et al. 1993).  In 2001, the demographics of those selecting PD 
and HD were determined through a longitudinal prospective study using questionnaires 
administered in the pre-dialysis phase through to starting on dialysis (Little et al. 2001).  Later, large 
cross-sectional surveys were used to explore the relationship between modality selection and social 
and pre-dialysis factors such as length of time under the care of a nephrologist and employment 
status (Jager et al. 2004; Stack 2002).  Cross-sectional surveys also aimed to understand what was 
influencing patients’ modality decisions by exploring the barriers to selecting self-care dialysis in 
those dialysing with in-centre HD (McLaughlin et al. 2003), the preferred modality decision making 
styles of patients on dialysis (Orsino et al. 2003) and to determine the awareness that pre-dialysis 
and dialysis patients had about the different dialysis modalities (Finkelstein et al. 2008a; Mehrotra et 
al. 2005).  In 2005, a randomised controlled trial was conducted to isolate the effect of a self-care 
education programme on modality selection (Manns et al. 2005). 
 
Overall, these different quantitative methodologies have contributed to the understanding that 
education is a critical influence on modality selection and that different patient demographics and 
features are associated with the selection of particular dialysis modalities.  Quantitative findings 
have provided, however, little understanding as to how education of dialysis modality is conveyed or 
how the social and environmental context affects how people make modality decisions or how they 
adapt to their dialysis treatment.  An appreciation of modality decision making as an evolving 
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process has also not been shown using quantitative methods.  In addition, findings are limited by the 
structured nature of the survey which can fail to cater for the full range of patient responses 
(Giacomini and Cook 2000).  Therefore, quantitative methods are not appropriate to explore the 
range of patient experiences in relation to treatment decisions and living with dialysis.   
 
6.2.2 Critique of qualitative methodologies 
“Qualitative research offers insight into emotional and experiential phenomena in healthcare to 
determine what, how and why” (Giacomini & Cook 2000).  The qualitative studies in the field of 
modality decision making have been designed and conducted mainly by the nursing profession and 
reported predominantly in the nursing literature.  Initial studies employing qualitative methods, for 
example interviews, provided a deeper understanding of how contextual factors have influenced 
modality selection, such as family, availability of dialysis spaces and recommendations by health care 
providers (Breckenridge 1997; Whittaker & Albee 1996).   In 1997, the process of modality decision 
making was described in a study through interviews at two time points:  soon after having made a 
treatment decision and one month later (Kelly-Powell 1997).  Later, a further two studies explored 
the perceptions of future options on dialysis through interviewing pre-dialysis patients, which helped 
build a picture of their fears, dilemmas and information comprehension (Iles-Smith 2005; Tweed & 
Ceaser 2005).  Other qualitative methods, such as the use of focus groups, have been used to gain an 
overview of perceptions of modality decision making from several patient groups such as pre-
dialysis, self-care dialysis and in-centre HD, amongst others (Lee et al. 2008; Morton et al. 2011).   
 
Findings from quantitative and qualitative methodologies are rarely presented together, although 
this is gradually changing with the emergence of mixed methods studies.  One such study presented 
patients’ and caregivers’ ranking of treatment characteristics important for modality selection 
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(quantitative), in addition to their reasoning for the ranking which was the qualitative aspect of the 
study (Morton et al. 2011).   
 
The analysis methods in qualitative research studies are similarly equivalent in importance as are the 
statistical methods used in quantitative studies.  Most of the studies employed “grounded theory” 
for analysing the data.  This is where the concepts or theories emerge whilst analysing the data, as 
opposed to starting the analysis testing a particular hypothesis as occurs in quantitative research 
(Lingard et al. 2008).  Grounded theory also prevents one from applying existing theories or concepts 
(such as models of medical decision making) to the data, as the aim is to uncover new theories and 
to explore the entirety of the data rather than particular aspects.  It also assumes that the 
researcher is neutral in their perspective (i.e. the researcher’s positionality), which rarely occurs in 
practice (Flick 2009c).  One study used “interpretative phenomenological analysis” as opposed to 
grounded theory (Tweed & Ceaser 2005).  This analysis method attempts to understand how an 
individual (the patient), makes sense of a phenomenon (in this case modality decision making) 
within their social world (Tweed & Ceaser 2005).   Other qualitative studies did not mention their 
method for analysing the data and presented the findings as a description of themes.   
 
Qualitative methods have identified several additional contextual factors as influencers on modality 
selection compared to quantitative methods, such as lifestyle and family relationships (Tong et al. 
2009) .  However, as most of the studies focus on modality decision making as a single event in time, 
an overview of how people make decisions from beginning to end, remains unclear, as does the 
relationship between the patient’s context and the decision making process.   
 
179 
 
6.2.3 The chosen methodology 
As encompassed within the definition by Strohschein et al (see section 3.1), patient decision making 
is defined as an “ongoing process”, is “complex” and is contingent on its context.  This process has 
not been explicitly described with reference to modality selection.  Consequently the perceptions, 
experiences, feelings and thoughts that patients bring into the modality decision making process 
have not been evaluated, nor has the influence of the patients’ social and medical context on the 
decision making process been described.  Finally, the social and psychological (as opposed to the 
medical) outcomes of patients living with dialysis in relation to involvement in the modality decision 
making process have not been investigated.  These issues, therefore, could be argued, would benefit 
from being studied through a narrative focused qualitative methodology.  This method will be 
described in further detail in the next chapter. 
 
6.3 CONCLUSION 
Each dialysis modality may have far reaching consequences to the patient that extend beyond those 
relating to clinical well-being.  The fabric of the patient’s life (biography) is vulnerable to disruption 
through the demands of living with dialysis.  Equally, the context of the patient may mediate the 
relationship between identity and living with dialysis.  This supports the ethical imperative to involve 
patients in their modality decisions to support patients’ integrating dialysis into their lives.   
 
The following qualitative study focuses on exploring the experiences of how older people are being 
involved in the dialysis decision making process.  It also explores the social and psychological 
outcomes of living on HD and PD, with a particular focus on how the context, as opposed to the 
illness, mediates these experiences.       
 
180 
 
6.4 AIMS 
The following study on older people is composed of the following aims: 
i. To explore modality decision making as a process. 
ii. To determine the range of influences, with particular reference to contextual influences 
(social and medical), on the modality decision making process. 
iii. To describe how older dialysis patients manage dialysis within their lives. 
iv. To determine whether the contextual influences on the modality decision making process 
impact on how older dialysis patient manage dialysis within their lives. 
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CHAPTER SEVEN 
7 METHODOLOGY: NARRATIVES ON MODALITY DECISION MAKING 
IN OLDER PEOPLE 
 
“All of us come to be who we are (however ephemeral, multiple, and changing) by being located or 
locating ourselves (usually unconsciously) in social narratives rarely of our own making.” 
Margaret R. Somers. 1994. Theory and Society, 23, (5) 606 
 
7.1 INTRODUCTION 
In this chapter I outline the qualitative methods used to explore modality decision making in older 
people, ranging from the narrative methods employed in data collection, how I analysed that data 
and reported the findings.  The application of qualitative methods using narratives are, to date, 
unique in the study of modality decision making.  Through the employment of these methods, I 
aspire to deepen and broaden the current understanding of older peoples’ experiences of dialysis 
modality selection and how their context can influence their social and psychological outcomes once 
on dialysis.   
 
I begin the chapter by describing the reasons for selecting particular qualitative methodologies for 
collecting the data (narrative based in-depth interviews and observations) and why I opted for a 
cross-sectional study design as opposed to a longitudinal approach.  Since the purpose of qualitative 
research is to explore a topic in more depth than a quantitative study can achieve, I therefore 
selected the participants for the illness narratives “purposively” to capture a broad range of 
experiences relating to involvement in modality decision making, for example the inclusion of 
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experiences from both genders, dialysis modalities, a spread of older ages and ethnic backgrounds 
and inclusion of those who were referred late onto dialysis.  The observational part of the study did 
not involve individual participants but focused on my observations of group education seminars 
across the three renal units described earlier in section 4.3.  I describe how I recruited my sample of 
participants, including the difficulties I encountered and how I resolved these.  The final sample is 
described and the reasons why the experiences held within it are likely to be representative of those 
experienced by the older UK dialysis population as a whole.   
 
The methods I used for planning the study as well as those used to analyse the results are presented, 
as are my reflections on carrying out the research.  I also provide an outline of the observational 
methods used to gauge further contextual information on the education that patients receive.  I 
conclude this chapter with an assessment of the validity of the study and the ethical issues 
encountered.   
 
7.2  SELECTION OF QUALITATIVE METHODOLOGIES 
Modality decision making and patient involvement has been studied through qualitative methods 
using in-depth and semi-structured interviews as well as focus groups discussions.  However, “illness 
narrative” methods have yet to be used in this area even though this method lends itself well to 
exploring the experience of illness in relation to the patients context as well as how the experience 
changes over time.  Illness narrative methods are also well suited to explore the aims outlined in 
section 6.4.  In the sections below, I provide an overview of using narrative methods to explore the 
experience of illness, as well as the use of observational methods.   
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7.2.1 Illness narratives  
Illness narratives are “storied accounts told by ill people” (Thomas 2010) and have been specifically 
described as the following:  
 
“First the initial situation is outlined (“how everything started”), then the events relevant to 
the narrative are selected from the whole host of experiences and presented as a coherent 
progression of events (“how things developed”), and finally the situation at the end of the 
development is presented (“what became”).  
 
This was written by Hermanns (Hermanns 1995) but the quote was obtained from Flick (Flick 2009a).  
Illness narratives therefore relay time ordered events surrounding a period of change from the onset 
of an illness to how the person is currently experiencing their life with an illness (Hyden 1997).  
Illness narratives provide a reflexive account of the individual’s experience of chronic illness and how 
people manage the relationships between their chronic illness and their sense of identity and their 
family, work and social life (Hyden 1997; Mathieson and Stam 1995).  Narratives are more than 
simply the recounting of experiences, as “the very act of telling confers upon the patient the ability 
to create meaning, to revise past experiences, to emplot significance, establish coherence, and, most 
centrally, to orient himself towards the future (Kierans 2005).”   
 
In addition to using narrative to explore the persons’ individual experience of illness, narratives can 
also help us understand the experience with reference to the social context (Hyden 1997).  For 
example, one study found patients felt isolated and depressed as their difficulties of adjusting to life 
after a renal transplant and the medication regimen were at odds with the prevailing social 
expectations that they should be delighted at the gift of a new kidney (Kierans 2005).  Illness 
narratives can, therefore, enable the understanding of how individuals make sense of their condition 
over time, how they incorporate it into aspects of their identity and can highlight the social and 
contextual factors that shape that experience (Smith 2000). 
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The use of illness narratives would therefore appear to be a very appropriate method to capture the 
range of influences on how people make decisions about dialysis modality from the early influences 
prior to renal failure, to their education of dialysis modality and finally their experience of living with 
dialysis. 
 
7.2.2 Observational methodology 
Observational methodology involves field work to obtain firsthand information about events 
occurring within the natural setting of the focus of a study (Angrosino and Mays de Perez 2000).  
Understanding how the medical context shaped dialysis modality decision making was of particular 
focus within this research (see aims in section 6.4).  Furthermore, it was felt that observing the 
education that renal patients received about choosing a dialysis modality would add weight and 
significance to the findings derived from the illness narratives (Silverman 2001).   
 
Modality education within the hospitals studied occurred through group education seminars, during 
renal clinic appointments and when people received home visits (where renal staff visit the patient 
in their home to discuss dialysis options), although not all units routinely conducted home visits.  
Renal clinic appointments were most often concerned with reviewing the patient’s clinical condition 
rather than educating patients about choosing a dialysis modality.  All the units studied held group 
education seminars with the aim of educating patients about their dialysis choices.  Therefore, group 
education seminars were selected as the most appropriate event to observe.  The focus of the 
observations was to capture information about how patients are educated about their dialysis 
modalities across the three renal units and to determine how this influenced their dialysis modality 
decision.   
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Observational methods have not been employed in any studies to date reporting on modality 
decision making.  They have, however, been used to support professional training by observing 
clinical decision making in nurses specialising in the treatment of heart failure (Dowding et al. 2009) 
and how community nurses involved patients in their treatment decisions (Millard et al. 2006).   
 
7.3 STUDY DESIGN 
A cross-sectional design was deemed most appropriate for several reasons.  The single illness 
narrative would allow patients to reflect on how they came to be on their particular dialysis 
modality, whilst also exploring how they managed the relationship between their changing health 
status, their adjustment to dialysis and their identity.  The disadvantages of this design are that I 
would inevitably lose some of the detail that may have been recorded had I used serial illness 
narratives in order to capture their “real time” experiences.  I felt, however, that the advantages of 
reflection and understanding the journey and its impact on identity and life outweighed this.  In 
addition, the use of interviews at each stage of a person’s journey onto, during and after dialysis 
would be impractical as the timing of starting dialysis is difficult to predict.  Finally, as this was an 
exploratory study, capturing a spread of experiences was fundamental.  This would have been 
considerably compromised if opting for a longitudinal design as this would have drastically reduced 
the number of participants.   
 
The observations were designed to add contextual information to the findings derived from the 
illness narratives.  As there was no requirement to understand how these observations changed over 
time, a cross-sectional design was also selected.   
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7.4 PARTICIPANTS 
In this section I describe my sampling method including its advantageous and disadvantages.  
Participants involved in the observations were all those who attended the group education seminars 
and therefore were not pre-selected.   
 
7.4.1 The narrative study sample 
All participants were 65 years or over, as this was the age group under study within this thesis.  I 
decided to interview patients who had been on dialysis for six months as these participants would be 
able to discuss their experiences of living with dialysis, whilst retaining relatively recent recollections 
of their journey onto dialysis, including how they made decisions about their modality.  Patients who 
had had a transplant prior to this current period of dialysis were excluded, as their experiences of 
modality decision making may have been strongly influenced by their previous experiences of being 
on dialysis.  Those who could not articulate their stories, for example due to language barriers, were 
also excluded due to the narrative nature of the interview.  Practically, conducting narratives 
through the use of interpreters is not feasible, nor is the subsequent analysis and interpretation of 
the data.  However, those who were not fluent in English were still invited to participate, as long as I 
was able to comprehend their narrative.    
 
7.4.2 Purposive sampling for the narrative study 
Case selection is critical in qualitative studies where the number of participants is reduced when 
compared to quantitative studies.  The sampling method I employed was purposive (i.e. sampling 
with a purpose) and was designed to maximise experiential and perspective diversity from the 
sample (Giacomini & Cook 2000).  It also aims to result in findings that are generalisable to the 
population being studied (Curtis et al. 2000).  Sampling, therefore, was based on characteristics that 
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could influence the experience of dialysis decision making.  These characteristics are presented in 
section 7.4.3.   
 
In qualitative research, the sample size should be large enough to reflect the diversity of views and 
experiences of the people experiencing the issue, yet not so large that further interviews fail to 
divulge new experiences, indicating that the data obtained has reached what is known as 
“saturation” (Fossey et al. 2002).  Guest et al in their experimental study, determined that twelve 
interviews were sufficient to capture 92% of experiences of a particular issue (Guest et al. 2006).  I 
set my sample size at a considerably higher number as my sampling criteria were extensive, as can 
be seen in the following section.  Therefore, I set the sample size at 30 participants, which was 
anticipated to achieve saturation in the majority of themes but perhaps not all, such as those 
experiences relating to ethnic background.  Feasibility is a also a prime consideration when devising 
a sampling plan (Curtis et al. 2000).  Thirty participants was the largest number of participants which 
was thought feasible for myself, as a single researcher, to interview, analyse and present the 
findings, within the time frame available.   
 
7.4.3 Sampling strategy for the narrative sample 
The following list presents the five characteristics that were thought to be useful in identifying 
suitable participants that would offer a wide range of dialysis modality decision making experiences.   
i. Dialysis modality 
As the research concerned the process of modality selection, equal representation of participants on 
PD and HD were required.   
ii. Gender 
Variations in the degree of participation in treatment decisions have been observed between older 
males and females (Flynn et al. 2006).  Quantitative findings have observed that men are more likely 
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than women to opt for in-centre HD (Little et al. 2001) although the opposite has also been noted 
(Jager et al. 2004).  Therefore the aim was to obtain equal number of male and female participants.   
iii. Ethnic background 
Ethnic background may influence how individuals make health related decisions.  This has been 
observed empirically in studies exploring the perceived decision making styles of physicians and 
patients from contrasting or similar ethnic backgrounds (Cooper-Patrick et al. 1999). Indeed, there is 
some evidence to suggest that there is a difference in ethnic backgrounds in those who select PD 
compared to HD (Holley et al. 1991; Stack 2002).   
iv. Age  
As the focus for this narrative study was participants aged 65 years and older, it was essential to 
recruit participants who spanned a range of older ages.  Age can determine the exposure to different 
life events and experiences, for example living through World War II and recent retirement, which 
may influence how participants manage challenging situations in life, such as dialysis.  The oldest old 
may also have higher functional limitations that may impact on their modality selection.  
v. Renal unit 
The potential impact of the medical context on involvement in modality decisions has been 
discussed in chapter 5.  The characteristics of the dialysis populations within the renal units varied as 
indicated in Table 4-1.  Therefore, sampling from the three units could contribute to the diversity of 
the experiences due to the potential spread of participants from different social environments, as 
well as the exposure to different medical approaches within the renal units.   
vi. Late referral 
Those who have been under the care of a nephrologist for less than three months prior to starting 
dialysis (defined as a late referral) have been observed to have different measurements of QOL to 
those who are referred early and have a planned start (Caskey et al. 2003; Loos et al. 2003).  
Therefore it was important to ensure that this path onto dialysis was captured in the sample.   
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7.4.4 The observational study sample 
Group educational seminars are open to pre-dialysis patients who have been invited to attend by 
the pre-dialysis nurses and/or doctors.  This invitation criteria were likely to be variable as there are 
several nurses and doctors across the three units.  My observations incorporated adult patients of all 
ages and a variety of staff who delivered the education (nurses, other healthcare professionals and 
“expert” patients recounting their experiences of living on dialysis).     
 
7.5 RECRUITMENT 
Participant recruitment for the narrative interviews was enabled with the assistance of medical 
“gate keepers”, such as renal nurses and the nephrologists from the three hospitals.  This 
recruitment process for the narrative study is described, with an outline of the issues encountered.  
Finally the selection of the sessions for observations is also described. 
 
7.5.1 The narrative recruitment process 
The recruitment of the 30 participants occurred between September 2009 and August 2010.  As I 
was not directly involved in delivering the patient’s renal care, I relied on the lead renal nurse or 
consultant to identify participants who were aged 65 years or over and who had been on dialysis for 
approximately six months.  It was also stipulated that the patients should be able to converse in 
comprehensible English.  There was a far larger pool of potential participants on HD than on PD.  
Therefore, I initially recruited HD patients who were known by the nursing staff to be good 
communicators.  This may have influenced my sample as, initially, I sidelined patients who were not 
optimal communicators and who therefore may have had a very different experience of dialysis 
decision making.  In contrast, all potential PD participants were initially approached.  As recruitment 
progressed, the sampling became more targeted as potential participants had to fit specific criteria 
to ensure representation from all the sampling characteristics listed earlier in sub-section 7.4.3.   
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Recruiting patients to talk frankly about their experience of renal failure and modality decision 
making involved a staff member approaching the patient to obtain verbal consent for me to contact 
them to discuss taking part in an “interview” based study.  If consent was provided, I contacted the 
patient to discuss an outline of the purpose and involvement in the study, as well as confirming their 
suitability, including noting my ability to understand them.  If the patient remained interested, an 
information sheet was posted which they had for a week, after which I contacted the patient again 
to determine continued interest and to address any issues.  A mutually convenient time and place 
was arranged for the interview during the day, which was either in the patient’s home or in hospital, 
depending on their preference.      
 
7.5.2 Narrative recruitment issues 
Below I discuss several issues that I encountered when recruiting my sample that involved adapting 
the study in order to fulfil the sampling criteria.   
 
7.5.2.1 PD participants 
Suitable PD participants were in short supply, with one unit not having a single potential participant.  
Therefore, to achieve the target of 15 participants on PD, a fourth renal unit joined as an additional 
site towards the end of the study (Barts and the London NHS Trust).  This unit was chosen as it had a 
large pool of PD patients and was within commuting distance to the other units.  The process of 
adding this site to the study was straightforward.  As no consent was to be undertaken on site, the 
site was registered as a “Participant Identification Centre” and no further ethical or management 
approvals were required.   
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7.5.2.2 Late referral criterion 
One of the criteria for recruitment included the selection of those who were late referrals.  The 
experiences relayed during the interviews rapidly established that the quantitative definition of a 
late referral did not capture all those who perceived their dialysis start to be unexpected.  Therefore, 
this criterion changed to ensure inclusion of those patients who perceived having had an 
“unexpected” dialysis start, rather than limiting recruitment to a pre-determined definition of late 
referral.   
 
7.5.3 The selection of group education seminars 
I aimed to observe one seminar in each of the three renal units.  The selected group education 
seminars in the observational study were based on convenience of timing and took place between 
February and April 2010, when fourteen interviews had been completed and overlapped with a 
further eight interviews.  Although I was aware of some of the emerging themes from the 
interviews, the themes did not extensively refer to the seminars.  The observational arm of the study 
had already been completed by the time the fourth renal unit was added for the purpose of 
recruiting additional participants on PD. 
 
As a participant observer it is important to exert as little influence as possible on the proceedings 
under observation (Silverman 2001).  However, my presence and purpose had to be made explicit to 
the patients attending the seminars (as required by the research ethics committee), although there 
was no requirement to obtain written consent from them (to be discussed in further detail in section 
7.11.2).  As the patients and some of their relatives arrived, I provided each with a brief written 
outline of the study, the purpose of my presence and their involvement as patients and relatives 
being observed to understand the process of modality education better.  The information sheet also 
provided my contact details in case anyone had concerns or queries regarding the nature of the 
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study.  Prior to the start of the seminar, I introduced myself to the group and re-iterated the 
information that was on their paper. None of the participants expressed any concern with my 
presence.   
 
The renal staff organising the education seminars were also made aware of the purpose of my 
presence.  They were provided with information at least a week in advance (similar to a patient 
information sheet) on the purpose of the observational study and were asked to sign a consent form 
on the day of the observations.  All the staff accepted my presence and there were no issues to 
prevent me attending and observing the seminars.   
 
7.6 REFLECTIONS ON THE FINAL NARRATIVE SAMPLE 
This section gives an overview of the sample I obtained as well as its advantages and disadvantages.  
The final sample consisted of 30 participants.  Data saturation was achieved with some themes.  
There were, however, experiences missing in relation to the influence of ethnic background on how 
decisions were made.   
 
Details of the recruited participants according to the sampling criteria are presented in Table 7-1.  All 
participants had experience of living on dialysis for approximately six months (ranging from five to 
eight months). There was a spread of older ages ranging from 65 to 88 years and 9 of the 30 
participants were from ethnic backgrounds other than White European.  Only 5 of the 30 
participants experienced an unexpected start onto dialysis.  In relation to other features that were 
not directly sampled for, the length of time patients had been diagnosed with a renal condition 
varied, ranging from several decades ago to those who had been diagnosed only shortly before 
starting dialysis.  The sample also contained participants with a range of physical abilities, with some 
leading active lives and three participants who were predominantly housebound.   
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There were some disadvantages to the final sample.  The sample consisted of patients who all lived 
in their own homes or those of their families.  None lived in supportive accommodations such as 
sheltered accommodation, residential care or nursing homes.  The absence of this characteristic may 
have limited the range of experiences captured as these patients may have had unique influences on 
their modality decision making.  This was not a conscious selection but may partially reflect that 
those living in supportive accommodations were unsuitable as they may not have fit the sampling 
criteria, or it could reflect “positive recruitment” by the renal staff, who may have excluded patients 
who were in need of a significant amount of support.  The final sample was also too small to be able 
to draw firm associations between decision making and living on dialysis in those from different 
ethnic backgrounds.  There was also only a very small representation (two participants) who were 
aged 80 years or over and who were on PD.   
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Table 7-1: Distribution of recruitment criteria in the final sample 
 PD n HD n Category n 
(% of total sample) 
Participants 15 15 30 (100) 
Male 7 8 15 (50) 
65-79 years 13 11 24 (80) 
80+ years 2 4 6 (20) 
Ethnic Background    
     White European 11 10 21 (70) 
     South Asian  3 2 5 (17) 
     African Caribbean 0 2 2 (7) 
     African 1 1 2 (7) 
Renal unit    
     One 3 7 10 (33) 
     Two 8 3 11 (37) 
     Three 0 5 5 (17) 
     Four 4 0 4 (13) 
Late referral 2 3 5 (17) 
 
7.7 DATA COLLECTIONS METHODS 
The methods used for collecting the data for both the narrative and the observational aspects of the 
study are described below.   
 
7.7.1 The narrative interview 
The level of participant engagement in the illness narrative can be influenced by where the interview 
is held, how long it lasts, as well as the dynamic established between the participant and the 
interviewer.  These factors are each explored in the sections below. 
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7.7.1.1  Interview style 
An interview style that encourages participants to talk freely about their experiences of renal failure 
and decision making was vital to the success of this study.  In-depth interviews allow for this and are 
described as a form of conversation that have a purpose (Legard et al. 2003).  In-depth interviewing 
is often based around pre-determined themes identified through prior reading and through 
influences gained through working with patients with ESRD.   
 
7.7.1.2 The evolving topic guide 
Prior to undertaking the interviews, I formulated a topic guide which was themed according to the 
distinct stages of the patient’s journey into renal failure starting from its onset (including prior 
knowledge of renal disease and treatments), the development of renal failure, starting on dialysis 
and concluding with living on dialysis.  Topics explored with participants included their experiences 
of the medical profession, the support of family and friends, other social and past influences on 
modality selection, issues relating to the relationship between their financial status and managing 
dialysis and their feelings about being on dialysis and their future.  The topic guide evolved as the 
interviews progressed with topics added in such as going away with dialysis, spirituality, coping and 
changes in functional ability after the start of dialysis.  Despite the addition of topics to later 
interviews, these themes appeared to reach saturation.  The topic guide can be viewed in appendix 
11.5.     
 
7.7.1.3 Interview setting 
The interview setting is important for several reasons.  To engage in a free flowing narrative, it is 
important that the participants feel as relaxed as possible.  Therefore, all participants were offered 
the opportunity to be interviewed either in their home or in a private room within the hospital.  All 
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except two participants preferred to be interviewed at home.  Indeed, Legard et al argue that the 
home is the “territory” of the participant in which the interviewer enters as a guest and where they 
are more likely to feel in control and at ease compared to a hospital setting (Legard et al. 2003).  The 
importance of choosing the most appropriate setting is also highlighted in the COREQ (consolidated 
criteria for reporting qualitative research), a framework designed to provide guidance on how to 
report qualitative research (Tong et al. 2007).  I believe the opportunity to interview participants in 
their own home contributed to the high recruitment level in this study, as there appeared to be an 
increased willingness to participate once this was known.   
 
7.7.1.4 Presentation of the interviewer 
Throughout this study, I was aware of my dual role as a healthcare professional (renal dietitian) who 
had worked clinically within one of the participating renal units for five years, as well as my current 
role as a researcher.  I opted to keep the two professional identities separate for two important 
reasons.  Firstly, I did not wish the participants to directly associate me with their healthcare team as 
they may have perceived that their medical treatment or confidentiality could be compromised.  
Secondly, I also did not want my background as a renal dietitian to detract from the theme of the 
interview by introducing a possible focus on nutritional concerns.   
 
I therefore presented myself as a “researcher” employed by a University (Imperial College London), 
who worked closely with their renal unit.  The participants understood that I had experience with 
working with renal patients and was familiar with the clinical terminology used (for example, terms 
or phrases such as “fistula”, “having a line”, “needling”, “creatinine” and “in the end it got to 5%”) 
and their clinical journey onto dialysis.  The separation of roles was relatively straight forward as 
none of the participants had known me whilst I was working as a dietitian. It was, however, 
impossible to separate the two roles completely.  For some participants, dietary restrictions were a 
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cause of concern and distress.  In these instances, I revealed my dietetic background to offer 
assurances to them concerning their diet (although no additional advice was given due to my lack of 
knowledge of their medical history), or to offer to refer them to a renal dietitian covering their 
locality.   
 
I considered that the initial rapport generated between the participant and myself was important, as 
were first impressions, to enhance the level of disclosure within the interview (Legard et al. 2003).  I 
therefore aimed to present myself as approachable by dressing in smart, casual wear to strike a 
balance between someone who could inspire confidence, as well as someone who would listen to 
and value their experiences.  This was also achieved by behaving professionally and arriving 
promptly, being respectful and courteous when entering the participant’s home and confident when 
setting up the interview.  I introduced the interview by outlining the study, its expected duration as 
well as my expectations that they would be doing most of the talking, with only a little guidance 
from me.   
 
7.7.1.5 Presence of significant others during the interview  
At the initial stage of arranging the location and time for the interview, I informed the patient that it 
was important to have a quiet room where we would be free from distractions, including the 
presence of others.  Despite this, on a few occasions, partners requested to be present, although in 
some cases this was at the request of the participant.  When this occurred, I attempted to dissuade 
the partner by informing them the interview would last approximately for one hour and that they 
would not be actively involved in the dialogue.  This was because I was concerned that the partner 
may influence the narrative or the openness of the participant.  However, four partners still chose to 
remain throughout the interview.  In three of these interviews, the partner seemed keen to be 
present and the participant also seemed to value their presence.  With the fourth interview, the 
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partner had strong emotions about the topics under discussion.  In this situation the interview 
involved the partner as well as the participant, despite my best efforts to focus on the patient alone.  
Despite my initial reservations that the presence of partners might limit the openness of the 
participant, I concluded that these four participants’ were comfortable with sharing their thoughts 
with their partners, as the participants appeared to be open and forthcoming about their 
experiences.  In fact, the presence of the partner generally added some useful insights into the 
patients’ experiences that sometimes had been forgotten by the participant themselves.   
 
7.7.1.6 Conducting the interview 
Prior to conducting the interview, I informed the participant that I was interested in hearing their 
experiences, thoughts and feelings from the time they first found out they had a problem with their 
kidneys, during choosing a dialysis modality and up to the present time living on dialysis.  I would 
begin the interview with an introductory question along the lines of “so tell me how you first found 
out you had a problem with your kidneys”.  After their opening narrative, I got the participants to 
reflect on aspects of their narrative to clarify details and to further understand their reasoning.   
 
During each interview, I focused on remaining neutral in relation to the conversation and did not 
offer an opinion when asked to by the participant(s).  Indeed, in several interviews I was asked about 
the prospects of receiving a renal transplant and whether age was a factor.  In all cases, I directed 
the patient back to their healthcare team.  In other instances, it was important to remain 
unemotional (yet empathetic) when listening to distressing experiences.  In these cases, the 
participants were provided with information on accessing their local renal counselling service.   
 
The interviews ranged from 37 minutes to 80 minutes, averaging approximately one hour.  The 
length of the interview was dependent on several issues: the participant’s and my own mental and 
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physical condition on the day and the “depth” and detail of narrative achieved.  The presence of 
partners generally lengthened the time taken to interview participants.   
 
All the participants appeared to respond positively to being interviewed and relaying their “illness 
narratives”, although some found it easier to engage in the narrative process than others.  I sensed 
that a few participants were uncomfortable with the narrative style (due to the short answers they 
provided), possibly due to the unexpected lack of questioning.  Some of these participants 
attempted to steer the interview into a more structured and perhaps a more familiar format.  
Overcoming this was challenging and in some cases this was not possible, despite several attempts 
at asking open questions.  These reservations and reactions of some participants to narrative style 
research are not atypical (Flick 2009a).   
 
7.7.1.7 Recording and transcribing of interviews 
Each interview was digitally recorded and was immediately transferred onto an encrypted laptop to 
ensure the safety and protection of the participant’s data to fulfil the requirements set by the 
hospitals’ research departments.  The protection of the identification of the participants’ audio clips 
was enhanced by creating anonymised file names.  Approximately 30 hours of recorded interviews 
were transcribed.  I transcribed half the interviews to re-familiarise myself with the interview data.  
The other half of the interviews was outsourced to professional transcribers.  The accuracy of these 
transcripts was checked by randomly checking five minute excerpts from each interview.  The 
transcripts were not returned to the participants for them to review or edit as I wanted to retain the 
honesty that was captured during the interview itself.   
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7.7.1.8 Post interview field notes 
Post interview field notes are invaluable for providing additional information on the interview as I 
documented my reflections on my interview performance, the participants’ response to being 
interviewed and the topics that arose.  It also allowed me to reflect on the dynamics between the 
researcher and the researched.     
 
My notes served to improve my practical undertaking of the interviews.  I observed how events 
leading up to the interview or during the interview could impair my concentration.  Examples of 
these include feeling flustered at arriving late due to getting lost en route and the disruption caused 
by the arrival of a pre-booked taxi prior to the end of an interview.  By taking notes, I was also able 
to reflect on my interviewing style and observed how this was partially driven by my own 
perspectives on life.  I noted how I experienced a high degree of empathy for some patients, yet with 
another I felt uncomfortable in their presence.  Questioning why this was the case allowed me to 
reflect if these feelings were influenced by my interviewing style.  Furthermore, not all the 
interviewees gave me the insight into their experiences of renal failure I was seeking.  The field notes 
were therefore useful to reflect on the possible reasons for this, such as the participant perhaps not 
being clear as to the nature of the interview.  Finally, in relation to the interview itself, the field 
notes helped refine the topic guide by noting new emerging themes that could be relevant for 
discussion in future interviews.  
 
7.7.2 The observations 
I aimed to be present at the seminar location prior to the official start time to commence my 
observations of the educational process.  Observations were noted from the moment I entered into 
the seminar room until the end of the seminar.  I used a pen and paper to record my observations 
and wrote up the notes afterwards.  
201 
 
7.7.2.1 Recording observations 
It was challenging to identify what the precise focus of the observations should be, despite nearly 
half of the interviews having already been conducted.  The aim was to provide contextual 
information to the narratives about how patients are educated about dialysis modalities.  I therefore 
attempted to enact the role of a patient who had minimal knowledge on renal disease and dialysis 
and observe how the seminar would meet my informational needs.  The observations largely 
recorded objective information but also included my subjective impressions.  The observations 
focused on the following areas: 
 
1. The number of attendees, how the room was set up and the teaching tools used (slides, 
handouts etc) were noted. 
2. The patients’ characteristics such as gender, estimated age and ethnic background and whether 
they were accompanied by others.   
3. The topics discussed, how these were presented and conveyed, as well as the level of audience 
participation and interaction with staff members. 
4. My thoughts in response to the information provided. 
 
The observations were recorded with pen and paper, for which there are advantages and 
disadvantages.  Inevitably I was unable to capture a complete description of the events as my 
attention was focused on listening as well as recording.  A far more extensive data collection method 
which would have enabled more reflection and exploration of nuance would have involved the use 
of video or audio recordings.  However, it is likely that these recording tools would have influenced 
events as both staff and patients may have been more conscious of being filmed.  It would have also 
been necessary to obtain informed consent from each participant and their relatives or carers, which 
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would have added logistical and ethical complications and may have even prevented patients from 
attending the education seminar.   
 
7.8 DATA ANALYSIS 
The specific methods for analysing the rich and complex qualitative data obtained from the 
interviews and observations are detailed in the following sections.   
 
7.8.1 Analysis of the interviews 
Once transcribed, the interviews were imported into a qualitative analysis computer software 
package called NVivo 8. This package allowed me to organise the data into themes and to cross-
reference experiences between different patients. The software package also facilitated useful 
content searches for key words such as “transplant” or “choice”, speeding up the analysis process.  
The software cannot, however, detect meaning or relationships between events.  Therefore, its use 
is principally confined to facilitating organising and exploring the data for themes.     
 
Each transcript was analysed for themes.  These were initially explored by assigning each line or 
sentence to a particular code, for example “awareness of diagnosis of renal disease prior to dialysis”.  
Once this initial coding was complete, the codes were reviewed and all similar codes were collapsed 
into a smaller number of categories.  For example, conversations had with the nurse and those had 
with the GP were placed under a category entitled “interactions with healthcare professionals”.  The 
analytical process was systematic, rigorous and thorough, with each experience being matched 
against each available category, which also lead to the identification of deviant cases.  The categories 
were then modified to incorporate these deviant cases as to reflect the entirety of the experiences 
held within the sample.  This process of data analysis is termed the “constant comparison method” 
and is described as “a progressive process of classifying, comparing, grouping and refining groupings 
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of text segments to create and then clarify the definition of categories, or themes, within the data” 
(Fossey et al. 2002).  Finally the break down and reformulation of categories gave rise to themes that 
captured the variety of experiences within the data.   
 
After finalising the themes, I searched these themes for evidence of the three models of medical 
decision making termed paternalistic, informative and shared (described earlier in chapter three, 
section 3.2).  I also explored the themes for evidence of how participants managed dialysis modality 
choice and how their experiences of dialysis impacted on identity.   
 
The initial coding and the development of categories, as well as matching the experiences to the 
medical decision making models and the discourse on identity, was undertaken by me with the 
support of a senior qualitative researcher with whom I extensively explored and discussed the data 
and its analyses to ensure its validity and interpretation.  This researcher has also had personal 
experiences himself of choosing a dialysis modality and living on dialysis and therefore is a key 
informant and has contributed to determining the validity of the data from a patients perspective.   
 
7.8.2 Analyses of the observational data 
The analyses of the observations of the group educational seminars were framed within the context 
of where the data was collected i.e. the individual renal units.  As the observational study was 
designed to be supportive of the narrative study, the findings from the two studies are reported 
together to provide a greater understanding of modality decision making from a patient’s 
perspective.     
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7.9 REPORTING OF FINDINGS 
There are different ways of presenting qualitative data.  To date, the qualitative literature on 
modality decision making has generally been presented as a list of themes under which the evidence 
is described with a few illustrative quotes.  None of the studies have reported findings in 
chronological order.  Chronological presentation of the evidence allows the decisional making 
process to be described as an evolving and unfolding process, with an appreciation of how external 
influences such as education, family needs or experiences from the past can influence its trajectory.  
This process may be missed when findings are reported as abstract themes unrelated to time and 
place.  This structuring of the findings is also clear for the reader to understand and follow, 
regardless of their professional expertise in the area.   
 
 In order to report the modality decision making process chronologically, I needed to first identify 
what time periods formed distinct episodes.  The four time points identified from the data were:  
“life prior to renal disease”; “diagnosis of renal failure”; “choosing a dialysis modality” and “life on 
dialysis”.  It was not always clear which time period a particular experience belonged to, as 
participants often reported their experiences in a non-linear fashion.  This was particularly evident 
between the time periods of “diagnosis of renal failure” and “choosing a dialysis modality” where 
experiences often overlapped, thereby requiring me to make a judgement as to where each 
experience was best placed.  Presenting the results in this way was particularly revealing as findings 
were uncovered that were not apparent in the raw data or themes.  The chronological presentation 
of the findings of narrative data therefore added an additional layer of analysis and understanding to 
the topic under investigation.   
 
Throughout the analysis chapter, quotes from participants are presented to illustrate the findings 
from the patient’s perspective.  They also allow the reader to assess whether the quotations 
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accurately reflect the findings.  In order to preserve the anonymity of the participants, I used 
pseudonyms and removed any potential social or geographical identifiers throughout this thesis. On 
a couple of occasions, the omission of the patients’ age was necessary to preserve anonymity.   
Quotes, on some occasions, have been edited by removing words that detracted from its flow, for 
example phrases such as “you know what I mean” and repetitions such as “and, and”.  There were 
also instances where the participant was discussing an experience in non-consecutive sentences 
which have been condensed into a single meaningful paragraph.  No words were ever added to the 
quotes.  Whenever the quotes were edited, rigorous attention was made to ensure that the original 
meaning was always conveyed.   
 
7.10 VALIDITY OF THE STUDY 
Qualitative research, similar to quantitative research, benefits from critical inspection to ensure that 
the methodology and the analysis techniques applied, lead to valid findings.  The following section 
describes how the validity of qualitative research can be assessed before providing a summary of 
aspects to consider when determining validity for this BOLDE study. 
 
Reliability of findings is difficult and mostly not appropriate to strive for in qualitative research as the 
patient’s context and experiences will inevitably change over time, leading to variable findings 
should the same patient undertake an interview twice (Lewis and Ritchie 2003).  Validity, however, 
can be demonstrated.  Validity refers to the credibility of the research findings and “whether the 
researchers see what they think they see” (Flick 2009b).  Lewis and Ritchie refer to internal validity 
as the response to the question “are we accurately reflecting the phenomena under study as 
perceived by the study population?” (Lewis & Ritchie 2003).  This can be determined by assessing 
the appropriateness of methods of data collection and analysis, which should be transparent.  This 
way the reader can judge whether the findings have been obtained through reasonable processes 
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(Mays and Pope 2000).  Validity can also be enhanced through the use of key informants, such as a 
patient, throughout the analyses of the data.  Evidence that deviant cases have been included in the 
analysis and not simply dismissed, can also contribute to the validity of the findings (Mays & Pope 
2000).  Furthermore, external validation involves assessing if the findings are supported elsewhere 
within the study or when using a different methodology.  This can be achieved through triangulation.  
Triangulation allows the researcher to identify common findings between different methods  
(Silverman 2001).  Finally, the relationships between the researcher and the interviewee, the 
positionality of the researcher, as well as the organisational context, need all to be made explicit.  
These will also contribute to evaluating whether the findings have been biased in their 
interpretation.   
 
The validity of the current study can be established in several ways.  My positionality within this 
research is outlined in the preface where I describe how my prior experiences made me conscious 
that the medical environment in which the patient undergoes modality decision making may be 
contributing to a bias in choosing a particular form of dialysis.  Furthermore, my analysis process has 
been explicitly outlined allowing the reader to judge the appropriateness of the methods used to 
derive my findings.  I have also demonstrated that I have accounted for deviant cases to ensure that 
the data reflects all the experiences, rather than those of a select few.  The method of reporting the 
findings has also been made explicit and the provision of quotes will allow the reader to verify if the 
evidence supplied corroborates with the interpretations I offer.  The observational findings are 
presented to support and “validate” those found within the main narrative study.  I have also 
benefitted from having an experienced qualitative researcher acting as a key informant to 
corroborate the findings from a patients’ perspective.   
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The validity of the illness narratives could be called into question as they are reliant on memory.  I 
was able, however, to triangulate accounts through exploring the literature and my knowledge of 
the dialysis environments where the participants had their treatment, as well as professional 
knowledge about the renal condition itself.  However, it is important to reiterate that the focus of 
the narratives was not to obtain objective accounts of events but to understand the participants 
thoughts and experiences with respect to choosing a dialysis modality and understanding that in 
relation to living on dialysis (Flick 2009a).    
 
7.11 ETHICAL ISSUES  
I was mindful that older people may feel obligated to take part in research studies, either as a result 
of being deferential to healthcare professionals or as a perceived obligation in return for their HD 
treatment.  Therefore I ensured that it was made clear that their participation was optional and that 
it was perfectly acceptable to decline to participate if they chose to do so.  Even considering this 
approach, there appeared to be little hesitation or reluctance to take part, with only 10% of the final 
sample declining to participate.  The reasons given for non-participation were due to limited time to 
commit to the interview, upcoming admission into hospital for surgery or due to feeling too unwell.  
 
Some ethical issues were identified through application for ethical approval, yet others were 
encountered whilst undertaking the study.  These are described for both the narrative and 
observational studies.   
 
7.11.1 Ethical issues encountered in the narrative study 
Ethical approval was obtained for the whole study by Charing Cross Research ethics committee 
(reference number 09/H0711/35).  The letter of approval can be found in appendix 11.3.3.  They 
requested that the data obtained through the interviews remained anonymised throughout the 
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study and that counselling support services would be made available for participants post interview 
if necessary.  It was also an ethical requirement that participants provided written informed consent 
prior to be being interviewed.   
 
Additional ethical concerns arose during the undertaking of the narrative study.  I was often struck 
how the interview appeared to be used as a surrogate counselling session, with a few participants 
commenting on the benefits of opening up to someone, other than family members, about their 
experiences of dialysis.  This brought up questions for me about the informed consent procedure.  
Consent was taken at the beginning of each interview, as stipulated by the ethics committee.  
However, most of the participants may not have appreciated how much personal information they 
would divulge until after the event.  I therefore felt I had possession of some very personal accounts 
without the appropriate consent.  To manage this, I incorporated a further verbal consent at the end 
of the interview in which I reconfirmed their original consent.   
 
Another ethical issue encountered concerned the ending of the interviews.  On occasion, 
participants became emotional during the interview.  Indeed, on one occasion, it was difficult to end 
the interview on a positive note and I felt that the participant was left in a greater state of distress 
than that in which I encountered him when I arrived.  I informed him of the renal counselling service 
which he had already previously used.  The question of whether this interview was ethical arose in 
my mind.  I reflected and concluded that it was the participant’s experiences that were upsetting 
him, rather than my role as an interviewer or the study itself.  I also concluded that the experiences 
were a part of the patients’ life and were likely to be equally distressing whether they were actively 
verbalised or not.  From my readings, this is not an aspect of conducting qualitative interviews that is 
often reflected on in the literature.   
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Finally, I observed that the ethics committee were concerned with patient anonymity in reference to 
data collection and storage but had not appreciated the importance of anonymity when presenting 
the findings.  Great care was therefore taken to ensure that the participants were unable to be 
identified through the use of pseudonyms but also in relation to the information provided in the 
interview excerpts. Therefore, in the presentation of the findings, a few participants’ ages will not be 
disclosed.   
 
7.11.2 Ethical issues encountered in the observational study 
Imperial College London was the sponsor for the study and their research office expressed concern 
that I was proposing to gain implied consent, as opposed to written consent from all patients and 
their carers attending the group seminars.  I amended the application to reflect their wishes but 
subsequently raised my concerns with the ethics committee directly.  My concerns were multiple.  
Written consent requires the provision of an information sheet in advance.  I considered this process 
to be disproportionate to the level of patient participation as no personal details were to be 
collected.  The logistics of providing the information sheet in advance may have prevented some 
patients from attending the seminar, a far greater ethical risk.  The ethics committee agreed to the 
alternate consent process which is described in section 7.5.3.  None of the attendees objected to 
being observed.  If any individuals had objected it was agreed with the ethics committee that I would 
leave the group education seminar and repeat the process with an alternative group.  There were no 
further ethical concerns that arose during the observational study.   
 
7.12 STUDY LIMITATIONS 
All the participants were recruited through the medical gate keepers (the renal staff) which lead to a 
sample that excluded all patients living in supported accommodations.  This may have limited the 
range of experiences of modality decision making within the sample.  The renal staff may have also 
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biased the HD sample, although it is difficult to ascertain if this happened in reality.  The 
representation of those who started dialysis unexpectedly was lower than anticipated which meant 
that the findings from this sub-group did not reach saturation.   
 
7.13 CONCLUSIONS 
Within this chapter, I have highlighted that narrative and observational methodologies are novel 
approaches to investigating modality decision making both as an evolving process and in terms of 
how information is conveyed within medical environments to educate renal patients about choosing 
dialysis modality.       
 
There was an attempt to recruit a sample that would be representative of the experiences found in 
older dialysis patients. However, the sample may have been biased towards those who were more 
articulate and who required less support in relation their living environments.  The sample size was 
thought to be adequate as some themes were found to have reached saturation.  The analysis 
process was systematic and thorough, substantiating the validity of the forthcoming findings.   
   
In the subsequent chapter, the narrative findings are presented in chronological order allowing the 
reader to unravel the process of modality decision making and its consequences as they are 
experienced by participants over time and in relation to different social and medical contexts.   
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CHAPTER EIGHT 
8 ANALYSIS: NARRATIVES ON MODALITY DECISION MAKING IN 
OLDER PEOPLE  
 
“Forewarned, forearmed; to be prepared is half the victory.” 
Miguel de Cervantes, Don Quixote, 1615 
 
8.1 INTRODUCTION 
This chapter explores the experiences of patient involvement in the dialysis modality decision, how 
patients live on both PD and HD and how their identity has been affected.  Exploring participants’ 
experiences of dialysis decision making will enhance our understanding of the questionnaire findings 
presented in chapter five.  This will provide a more thorough understanding of why participants 
perceive varying degrees of involvement in treatment decisions and how patients’ modality 
decisions are influenced by their social and medical environments.  Finally, this chapter will explore 
the participants’ ability to integrate their chosen dialysis modality successfully into their life and 
sense of identity.   
 
Modality decision making has also yet to be explored as a process.  This will be addressed by 
presenting the data in chronological order in four parts to allow for the participants’ decision making 
process and its influences to be unravelled from the time of diagnosis of CKD or ESRD (whichever 
came first), through to the selection of a dialysis modality.   
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Part one “life before end stage renal disease” explores the health and activities of participants prior 
to the diagnosis of ESRD.  It explores their awareness and understanding of kidney disease and their 
reactions to the possibility of needing dialysis.  Part two “learning about the dialysis modalities” 
describes how participants are educated about the different dialysis modalities within the hospital as 
well as the information they sought within and outside the hospital environment.  Part three 
“choosing a dialysis modality” goes on to illustrate how the participants chose their dialysis modality.  
The final part, part four, explores how participants’ experience living on their dialysis treatment and 
its impact on their life and sense of identity.  
 
8.2 PART ONE: “LIFE BEFORE END STAGE RENAL DISEASE” 
Part one illustrates how participants experienced their health in relation to how they lived their lives, 
their expectations of future goals as well as exploring their knowledge and understanding of renal 
disease, prior to being diagnosed with ESRD.  The reactions to the diagnosis of ESRD requiring 
dialysis are also described.   
 
8.2.1 Health and lifestyle prior to ESRD 
Most participants had experiences of serious illness or other chronic conditions.  These conditions 
included diabetes, rheumatoid arthritis, stroke, traumatic bone injuries affecting gait, asthma, 
cardiovascular disease, ulcerative colitis, polymyalgia, parkinson’s disease and hypertension, in 
addition to conditions that were in remission (bowel and breast cancer).  Some participants had also 
been diagnosed with a renal condition for several years.  These conditions, on occasion, contributed 
to some participants taking early retirement, yet most of the participants led independent and active 
lives and did not require assistance with activities of daily living:   
 
213 
 
“Parkinson didn’t affect me that badly because it was gradually happening.  I’m shaking a bit, 
I can’t use my right hand so much but it didn’t affect me that bad to sort of say “oh God, I 
can’t travel, I can’t work”. I was still cooking, I was still driving, I was still working. So it didn’t 
bother me that much.” 
          Selina 
 
Several participants were active and regularly exercised by swimming, walking, cycling and going to 
the gym or gardening.  As part of this active lifestyle, several participants discussed travelling, either 
within the UK or abroad, or spoke of their wish to start travelling within their future, now that they 
had the time and the financial means to do so:   
 
“All our young age we worked really hard - me and my husband - so our plan was once we 
retire we thought we will travel.” 
         Anjali, 67 years 
 
Despite living with chronic conditions, these participants were able to integrate their health 
problems into their sense of identity and therefore continued to have expectations that they would 
live and remain active in the future to enjoy and fulfil future life goals.  This was also sometimes 
reinforced by their social context such as the longevity of family members:  
 
“I don’t feel old, I feel I’ve got a lot of life left in me. My parents were, well, my father’s 94 
and my mother died at 93, and I have a long-lived family.” 
Fiona 
  
A few of the participants were, however, limited physically by their chronic conditions and needed 
others to help them with activities such as household chores and activities of daily living such as 
washing themselves and cooking.  These participants were less able to continue some of their 
hobbies or go away on holidays: 
 
“My hobbies were ballroom dancing, latin dancing, right up till I was 70 when I had the heart 
attack. We haven’t been on holiday for years and that’s my fault. It’s certainly since the 
heart attack.” 
                                                                           Frank, 81 years 
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In these participants, there were signs that their sense of identity was affected by their health which 
prevented them living independently or being able to undertake or continue particular activities that 
had been central to their lives:   
 
“I think that’s where I get the upset from because the arthritis is stopping me from being 
how I know I should be.” 
         Penny, 73 years 
 
All participants lived in their own or familys’ home and most lived with their partner.  Those that 
lived alone were all women.  Most of the participants relied on their partner or others to assist them 
in managing household chores such as shopping and cleaning.  This support also came from their 
children, neighbours or in a few cases, paid carers who were required up to three times a day.  
However, a few participants, despite having a chronic condition, had to also care for other family 
members such as an ill partner, or in one instance, a son with health problems: 
 
“I’ve got one major problem running at the moment, I have a son who has lived 
independently all his life but he’s just started developing fits. I do his housework.” 
         Esther, 81 years 
 
 
 
8.2.2 The path to diagnosis of renal disease 
Some of the participants were diagnosed with a renal condition up to forty years ago, yet others only 
became aware of their condition shortly before requiring dialysis (ranging from days to a few 
months).      
 
There were several paths leading to the diagnosis.  Many of the participants were diagnosed with a 
renal condition as a result of being monitored or investigated for other health conditions, for 
example rheumatoid arthritis, sarcoidosis, hypertension, post surgery and diabetes.  These 
participants were then referred into a nephrology clinic.  Other participants were diagnosed after 
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consulting their GP for advice on symptoms.  The GP sent the patient for investigations which 
resulted in the diagnosis of a renal condition.  There were, however, a couple of participants who 
went to their GP with symptoms but who were not investigated and therefore experienced delays in 
accessing specialist nephrology care.  When this occurred, participants sought alternative 
explanations to understand their symptoms:   
 
“It was about 2005 and I had swelling of the ankles and went to the doctors *GP+ and I 
mentioned it to him and he says, like, you are a diabetic so you are going to have some 
problems, so I came away and thought well he’s not bothered, he’s not worried.  I’ve heard 
of people when they get too much water and I thought I am getting older, perhaps it’s 
something to do with that.” 
         Eric, 68 years old 
 
Administrative errors also resulted in a delayed referral to the nephrology clinic in three of the 
participants: 
 
“The GP said “we’ll refer you to the Renal Consultant” and I didn’t get an appointment and 
actually it fell through some black hole and it got lost and I had to get the GP to chase it all 
up and he had to make a fresh application so that they weren’t in trouble for going over 
eight months without seeing me. And when they did see me, they did say I’d got level five 
kidney failure.” 
Fiona 
 
This demonstrates that the delays in referral to specialist nephrology services may compromise the 
access to appropriate nephrological care that could delay the onset of dialysis.  It can also 
significantly shorten the length of time the patient has to adapt to the diagnosis of renal failure.     
 
8.2.3 Perceptions about renal disease and dialysis 
Most participants spoke about having a poor understanding of the kidney’s function, renal disease 
and its consequences:  
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“I’m saying to the doctor, where are the kidneys, I know they are somewhere here, what do 
they do.” 
          Selina  
 
There were also misconceptions about renal disease and who it would affect.  Some participants 
associated renal failure with afflicting only young people, while others felt that it was potentially 
reversible if appropriate lifestyle changes were implemented: 
 
“I really believed that if I kept to a good diet and, had plenty of rest and plenty of exercise 
that my kidneys, because they weren’t diseased, they were only small, I thought maybe 
they’ll sort of get better. I really believed that.” 
Beverly, 68 years 
 
Few obtained some information about renal failure and dialysis (in particular HD) from the media, 
but overall the media was a poor source of information on kidney disease: 
 
“On television, which to do this day I really feel very sorry for this poor woman, she’s been 
interviewed, she says she has to get a train 150 miles to have dialysis and I thought what a 
journey for the poor woman, it took all day to come and all day to come back. But that’s the 
only thing that I can remember. But what it actually involved I didn’t know.  I knew you had 
to lay there with needles and blood coming.” 
          Aziz, 74 years   
 
Some participants, however, were acutely aware of the impact of renal disease as they had 
witnessed its effects on family members and acquaintances.  This awareness often arose from a time 
before dialysis interventions and therefore often highlighted the difficulties and poor prognosis of 
living with renal failure: 
 
“I knew one person who was on haemodialysis years ago.  It was the husband of the deputy 
head at the school where my husband was teaching, must have been twenty years ago.  I 
knew that Tim [person on HD] carried on working, [but] he looked awful, he was always very 
white and thin.  And he just didn’t look fit.” 
Beverly, 68 years 
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It was observed that often preconceptions about dialysis were formed around experiences that 
referred to HD as opposed to PD.  This awareness of HD was further reinforced when patients 
attended hospital based clinic appointments.  During these visits, several participants observed 
other renal patients on HD and observed their access sites (fistulas), the dialysis unit environment 
and how physically frail many of the patients were:   
 
“I certainly notice down at the renal clinic, there are a number of people who have extreme 
difficulty in walking and moving, I don’t know what’s caused it, but I know I wrote to the 
chief consultant because in the early stages of me attending the clinics I was concerned that 
nothing was happening and I wrote to him and said that one of the things I fear most is 
ending up like many of the other people I see in the clinic who appear to be quite crippled.” 
Michael, 70 years 
 
At this stage, understanding about renal disease and dialysis was poor, contained misconceptions or 
was outdated.  Attending clinic and media reports was reinforcing the notion that living on dialysis 
was problematic and that HD was the only dialysis modality available.   
 
8.2.4 Reactions to the diagnosis of ESRD 
Most participants accepted the medical diagnosis of ESRD despite several feeling a sense of shock.  
Some participants drew on their cultural upbringing, past experiences, faith or philosophical 
approach to life to help them to integrate ESRD into their life: 
 
“I just felt it *the diagnosis of end stage renal failure+ was another step in my life, another 
step along the journey if you like.” 
         Esther, 81 years 
 
Others, however, were fearful about what life on dialysis would entail due to preconceptions based 
on knowing or seeing others who had been on HD: 
 
 “I’m talking about sort of in the late 70’s and the *haemodialysis+ equipment that was 
needed to keep them alive took up a whole wall as I remember, and looking at somebody 
218 
 
that was on a dialysis machine then was how I expected myself to look, and I thought if I’ve 
got to live like that - looking dead, absolutely, your skin dead, and his eyes were yellow, [and 
when] his lips moved it was *with+ a vacant expression in his eyes; I’ll never forget it.  Jesus, 
if I got to live like that, I ain’t going to”. 
Bob, 69 years 
 
Therefore, dialysis (in the form of HD) was perceived to be the cause of losing one’s identity due to 
the perceived effects on the person’s physicality.  The initial rejection of dialysis was also seen after 
a few participants observed others on HD at the hospital whilst attending outpatient clinic 
appointments: 
 
“I use to go for iron injections because of my kidneys, but then in the end the doctor [renal 
Consultant+ said I should have *dialysis+, I said no, I don’t want to go for dialysis. I’ll go 
through there [dialysis unit when going for her iron injections] and see them all laying there. 
No, I’m not going *doing+ that.” 
Patti, 84 years 
 
However, in those who initially reacted by rejecting dialysis, there were various influences that made 
them change their minds.  In a couple of examples, the families were instrumental in persuading the 
participant to have dialysis:   
 
“In the first place I said no, I wouldn’t *have dialysis+.  And then my daughter said well if you 
don’t mother you’ll die.  We don’t want you to, so. What could I do?  I’ve got lovely 
children.” 
Patti, 84 years 
 
In other cases, education from the renal unit managed to balance the negative preconceptions by 
providing a more accurate picture of dialysis:   
 
“And it was really the biggest relief of my life and I walked into the seminar with all the 
people in a similar situation to me that were inevitably going to go onto a dialysis machine. 
The relief for me was I couldn’t pick out the ones that were ill to the ones that were 
accompanying them.  So once I had got in my mind that the treatment on dialysis was not 
what it was 35 years ago, I just came to the understanding that inevitably I’m going to go on 
the dialysis machine.”       Bob, 69 years 
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The progression of CKD was often associated with a range of symptoms described by participants 
such as blood in the urine, physical weakness, weight loss, loss of appetite, vomiting, forgetfulness, 
tiredness and shortness of breath.  Reluctance to start dialysis was sometimes moderated by the 
perception that symptoms would improve once on dialysis, as promoted by the medical team:   
 
“I wasn’t feeling very well, I was getting poorer [in health], weaker in strength.  Now the 
reason I wanted to go on dialysis was because I knew I had to but I was also under the 
impression that as soon as I did, I would be so much better. Everybody tells me that once 
you go on dialysis you feel so much better and you get into a better condition than I was 
experiencing.” 
Michael, 70 years 
 
Other participants reacted differently by attributing their symptoms to other causes (such as aging) 
and rationalised not needing dialysis.  A few participants were, however, relatively asymptomatic 
thereby casting considerable doubt in their minds as to whether they actually needed dialysis: 
 
“I’m sure I won’t really need to go onto dialysis because I was feeling well and didn’t have 
any other symptoms.” 
         Beverley, 68 years 
  
Most participants however understood that dialysis was a “do or die” intervention.  Some took a 
positive view and were thankful that renal failure and dialysis had been diagnosed at a later stage in 
their lives: 
 
“Well I suppose I am lucky to go to 70 before I start all this *dialysis+, I’d hate to be 30 like 
some of them look, 25 or 30 years old and some even younger.” 
         Cybil, 72 years 
 
Therefore the reactions to the diagnosis of needing dialysis varied from rejection of the treatment 
and preferring death, to integrating dialysis into their life.  Predominantly, dialysis was not viewed as 
choice but as an essential condition to survival.    
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8.2.5 Summary of part one 
Participants have several co-existing conditions aside from their renal illness.  Despite this, most are 
able to maintain their sense of identity by continuing to lead active lives by pursuing their interests, 
despite relying on others for support in managing day to day activities.   
 
This section also demonstrates that some participants faced considerable delays in accessing the 
nephrology team.  This could significantly influence their course onto dialysis and their subsequent 
level of involvement in their modality decision making. 
 
Prior and up to the diagnosis of renal failure, the participants showed a considerable lack of 
knowledge about renal disease and the different dialysis modalities.  This was seen in relation to 
their inability to understand their renal symptoms, their lack of awareness of PD, and their 
perceptions about HD.  Their knowledge of dialysis was confined to HD and focused on being tied to 
a machine, looking ill and frail, leading to concerns regarding how dialysis would fit into their 
identity.  Negative and biased perceptions of dialysis modality were further reinforced within the 
hospital environment.  There were, however, signs that these negative impressions could be 
counterbalanced through education.  Finally, it was shown that some participants’ acceptance of 
dialysis was moderated by their interpretation of their symptoms, their perceptions of dialysis, views 
from families as well as views from the medical team.   
 
8.3 PART TWO: “LEARNING ABOUT THE DIALYSIS MODALITIES” 
Part two explores the sources of information provided to or sought out by participants, within and 
outside of the hospital environment, concerning renal failure and dialysis type.  It focuses on how 
participants experience the education provided within the hospital environment using data from the 
221 
 
illness narratives, as well as the observational data obtained from attending three group education 
seminars across three renal units.   
 
This part is composed of two sections.  The first part focuses on the participants’ experiences of 
learning about dialysis modality during homes visits from renal nurses as well as the educational 
materials and information gauged from peers.  Home visits occur regularly at two of the three renal 
units.  The second part explores the participants’ experiences, as well as my observations of the 
group education seminars.   
 
8.3.1 Educational resources: home visits, materials and peers 
Home visits were sometimes the first exposure that the participants had to the existence of different 
types of dialysis other than HD: 
 
“Two ladies [renal staff] came round and they gave me a pep talk [about] peritoneal and 
haemo, but no, not really *they didn’t go into detail about each type], because I said 
peritoneal seemed absolutely wonderful to me, because there was no blood involved, you 
know, it seemed the perfect answer. I’d never heard of it.” 
Daniel, 79 years 
 
Although some participants were exposed to PD for the first time through the home visit, some 
participants, however, discovered that they were unsuitable for PD.  In fact one participant was 
given the impression that she was not a suitable candidate for any form of dialysis due to her pre-
existing medical conditions:  
 
“They *renal nurses+ told me I couldn’t have peritoneal dialysis because of the ulcerative 
colitis. And because I’ve got other health issues besides the kidney problems, they [the renal 
staff] felt that probably conservative management would be the best plan.  And I was not 
happy about that, and they said I ought to consider not only the quantity of my life, but the 
quality of my life if I went on and she [the renal staff member] laid it on with a trowel, of all 
the problems, and quite depressing. And they left me to think about it and I did talk to my 
GP and I said “They don’t seem to want to put me on dialysis.” 
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Fiona 
 
In this case, the modality education appears to have been biased by the renal staffs’ perception of 
the anticipated quality of life of the patient if she were to commence treatment on HD.  As a result, 
the participant was left feeling depressed and discussed the situation further with her GP.    
 
In addition to home visits, books and leaflets were commonly used by the participants to learn about 
the different types of dialysis which were also shared with family members.  These sources were 
generally obtained from the renal unit.  DVDs were also provided to a few participants, despite the 
renal staff not always being sure of their content: 
 
“The renal nurse lent me a DVD and she said “I haven’t looked at this” she said “but you 
might find it helpful.” And that was good [the DVD], it just went through it.” 
          Fiona 
 
One participant spoke of being given a DVD, despite his visual impairment and was subsequently 
asked to make his dialysis modality selection: 
 
“So we [the participant and his partner] had to make a decision then and there in that room, 
now, I can only see that much then of the television about 18 inches away from it and the 
room was well lit which made the glare even worse for me so I’m only taking in bits and 
pieces of what I’m seeing on screen.” 
Eric, 68 years 
 
In addition to learning about dialysis through hospital based resources, a few participants sought out 
their own sources of information.  Some found it valuable speaking to others who were already on 
dialysis as it provided an account of dialysis that the participants could readily identify with:   
 
“On the other hand everyone *other renal patients+ were saying that you know, with haemo, 
that’s three half days a week completely written off and just don’t go there was the story, 
and that chimed with me anyway, so my views were therefore formed more by that than by 
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anything the renal nurse said or anyone else said, and so I think that sharing the experience 
is something quite important for other people.” 
Vikram, 68 years 
 
These views from other patients could, on occasion, be influential in forming the participant’s 
perspective about a particular dialysis modality: 
 
“I think somebody *a patient on HD+ said to me once that when they did it you go up there 
[to the hospital] and they say it [dialysis] takes three hours but she said by the time you’d 
waited for your transport, it’s a whole day you are up there, it’s only one day that you 
actually feel well and you’ve got to go back up there again. She said it was really tiring.” 
Cathy, 68 years 
 
Some participants also spoke of gaining a sense of encouragement hearing about how other patients 
managed to integrate dialysis into their lives:  
 
“My son, who lives in the south of Spain, he has a friend who’s on dialysis and he gets a lot 
of information from his friend, and I know that Luiz is actually a man of my age. And I’ve met 
Luiz quite a lot, he gets on quite well, so I’ve seen that he’s coped with it and so you can get 
a bit of encouragement that way and it’s just moral support.” 
Fiona 
 
In addition to speaking to other patients, a couple of participants sought out information from the 
Internet to gain further understanding about the different dialysis modalities.   
 
8.3.2 Group education seminars 
This section explores using the interview and observational data, how the information on choosing a 
dialysis modality was conveyed during the group education seminars.    
 
All the seminars were held within the main hospital building.  Several features of the group education 
seminars differed between the three renal units, as did the numbers of new patients starting at each 
unit.  Contrary to expectations, the number of new dialysis patients did not correlate with the 
frequency, duration or number of attendees at each of the seminars.  This suggests that some renal 
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units do not structure the seminars as the forum through which the majority of their patients will 
receive their modality education.  The characteristics of the three renal units and their education 
seminars are illustrated in Table 8-1. 
 
Table 8-1: Characteristics of the three renal units and their group education seminars 
 Imperial St Helier Lister 
New to dialysis in 2009, n 359 206 97 
Seminar frequency ’09-‘10  2-3 times/ year Monthly, except Dec. Every 3 months 
Duration of seminar Half a day Half a day Full day 
Hospital transport  Yes No No 
Patients attending, n 4 6 7 
 
The content of the group education seminars differed somewhat between the units.  Two focused 
on the topic of modality selection whilst the third included additional topics such as medications and 
accessing benefits and financial support.  The complexity and delivery of the information also varied.  
In two units, the information was technical, with slides filled with medical terminology such as 
“stages of renal disease” and “to line a machine”.  The slides were often devoid of diagrams and the 
environment did not appear to be conducive to allowing the patients to ask questions about the 
information they were listening to.  I found the seminars to be content heavy, containing 
information ranging from the basics of the functions of the kidney to choosing a dialysis modality, all 
in the space of between three to six hours.  This overload of information was also commented by 
one of the interview participants:  
 
“I felt that it wasn’t quite long enough because it’s a lot to take in on your first meeting 
because they go through both types or all types and it’s hard to understand which is actually 
going to suit you. Now, younger people may grasp it quicker than maybe older people.” 
         Penny, 73 years 
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The staff from one unit, however, appeared relatively skilled at illustrating and describing complex 
medical issues through the use of analogies which were easy to comprehend.  For example, they 
described the peritoneal membrane as “wrapping paper surrounding your organs”, a PD exchange as 
“siphoning petrol”, the comparison of the formation of a fistula to a motorway and B roads and 
likening changing modality to “changing schools, it can’t happen from one day to the next and needs 
planning”.   
 
The seminars all included a visit to the HD unit.  Occasionally a visit to the PD unit was included if the 
PD equipment (such as a dialysate bag and an APD machine) was not available during the seminar.  
One unit, surprisingly, offered the patients the choice to visit the PD unit or the HD unit, but not 
both.  While most participants found these visits interesting and informative, some found the HD 
unit visit an emotional and distressing experience and rather than educating and acclimatising them 
to a future on dialysis, it made them more fearful.  These observations were also substantiated 
during the interviews:  
 
“On that programme we went and looked at the haemo place where everyone was having 
haemo, and I just thought, no, I couldn’t do this every, you know, the atmosphere there was 
horrible, sort of dead and heavy and hot and I thought, there’s no way I could do this three 
times a week.” 
         Beverly, 68 years 
 
I observed that the focus throughout all the seminars was on imparting medical information about 
dialysis such as the technicalities and going to see others undergoing treatment (HD visit).  
Information regarding the experience of living with dialysis was limited.  Supporting this, I observed 
that in all of the group education seminars that I attended, there was only a maximum of one 
“patient expert” present who brought the experience of living with dialysis “to life”.  This provided 
an unbalanced view of the different dialysis modalities as accounts were only presented about either 
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living on home HD or on PD.  The talks by these patients were always engaging and the audience 
appeared to interact to a greater extent with these speakers.  
 
Despite all the renal units running group education seminars, not all the participants were invited to 
attend for reasons which were not clear from the interviews.  A few participants chose not to attend 
as they felt that they already had sufficient information through discussions with their renal staff or 
from the educational materials provided.  Some of those who were invited were unable to attend 
due to prior commitments such as holidays, or because dialysis was started earlier than expected: 
 
“So in the end things happened very quickly. And that was probably why I didn’t go to a 
group meeting, so it probably is because of that and not because of a failure in the system.” 
Fiona 
 
I found attendance at each seminar was far lower than capacity which suggests that education 
seminars were not held frequently enough or not in the right location or at the right time to cater for 
patients who were unable to attend a particular date.  The poor attendance also suggests that there 
are some difficulties in promoting the seminars to patients or that there are factors preventing 
patients from attending which are not being accounted for by healthcare professionals.     
 
8.3.3 Summary of part two  
Part two provides an overview of the educational resources that patients are exposed to and seek 
out when learning about the different dialysis modalities.  From this section, it is apparent that 
education is fundamental to increase the knowledge about dialysis modalities, especially PD which is 
relatively unknown compared to HD (as explored in the previous section 8.2.3).  The education, 
however, can be piecemeal with evidence of staff biasing the presentation of treatment options and 
using resources that may not always suitable for the patient.  The information conveyed through the 
hospital resources also had a tendency to be focused on the technicalities of undertaking the 
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different forms of dialysis as opposed to information relating to integrating the different forms of 
dialysis into one’s life.  When “expert” patients were invited to speak at the seminars about their 
experiences of dialysis, their stories were unbalanced as only a maximum of one treatment modality 
was presented at any one of the seminars observed.  Therefore, at this critical stage of assimilating 
information about the dialysis modalities, it is still difficult for patients to perceive how their lives 
will be affected by starting on either PD or HD, aside from the technical experiences they are taught 
and witness in the hospital environment.   
 
Peer experiences were found to be influential in the dialysis modality decision making process.  
These stories were occasionally a source of hope and encouragement as the participants could see 
how others managed to preserve aspects of their identity in the face of a life changing treatment.  
Other participants, however, biased their modality choice when hearing about the experiences of 
others already on dialysis.  
 
Shared decision making, as discussed in chapter three: section 3.2.3, involves a discussion with the 
patient to gain an understanding of their views about their dialysis options.  This was not commonly 
seen in the home visits or the group education seminars.  The renal staff involved in home visits did 
engage in discussions but were also perceived to present heavily weighted choices (characteristic of 
paternalism).  The seminars were presented in a lecture style format with limited opportunities for 
discussions between staff and patients, characteristic of the informative style of decision making.  
Therefore, elements supportive of shared decision making are currently not observed to be 
pervasive in the education patients receive about their modality options.   
 
228 
 
8.4 PART THREE: “CHOOSING A DIALYSIS MODALITY” 
Part three focuses on the medical and social influences on choosing a dialysis modality.  The first 
section describes the medical influences and includes the role of the medical staff in influencing the 
patients’ modality selection.  “Medical” refers to all healthcare professionals.  The second section 
highlights the social factors that influence modality choice, such as the family support available, their 
emotional relationships and the desire to maintain a particular lifestyle.   
 
8.4.1 Medical influences on modality selection  
The medical team were found to influence the modality decisions of those participants who have 
had a planned dialysis start as well as those who started dialysis unexpectedly, where there is limited 
time to educate patients about their treatment options. 
 
The medical team were instrumental in influencing the treatment selection in a large number of 
participants.  Five participants had been informed by the medical team that they were medically 
unsuitable for PD.  Other participants were advised which treatment might be medically more 
suitable for them: 
 
“I’ve had a stroke, heart attack, AV heart like you name it, but apparently [according to the 
medical staff] if you have haemo you’re more likely to have a stroke or heart attack. So I 
went for peritoneal.” 
         Philip, 76 years 
 
For other participants, however, it appeared that the medical team took the lead in the selection of 
dialysis modality based on medical opinion as opposed to clinical need: 
 
“And they said this *PD+ is the one is the best for me so I took that one, so I won’t argue with 
you [the doctor]. So he [the doctor+ talked to my son as well, he said “I know what I’m doing 
so this is the right choice for her”. He said *the doctor+ “if you need that one *HD] I will put 
you on that one but I know you can cope with this one [PD+, we’re gonna come and look at 
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what kind of house you live in, what kind of family”. [I have] full trust in them, yes [to select 
the right modality treatment for me+.” 
         Anjali, 67 years 
 
For this participant, there was a lack of discussion of the different dialysis options and the medical 
team assumed full responsibility for assessing the impact of a dialysis modality on the patient’s life.  
The patient was unquestioning of this approach. However, one participant questioned the medical 
opinion to undergo conservative management:  
 
“And I wasn’t prepared to just let things take their course and so I came up to the clinic and I 
was ready to fight my corner to go on dialysis. I’d got all my arguments ready and *the renal 
staff member+ called me in clinic, and *said+ I feel I don’t want to go for conservative 
management, I would rather go for dialysis. And she *the renal staff member+ said “Well, I 
think you’ve made the right decision” and you could have knocked me down with a… 
because they were so negative when they come to see us [her and her husband] and it 
wasn’t just me, my husband was there too, and so it wasn’t just the impression I’d got.”   
Fiona 
 
Another participant who also had a planned start onto dialysis remained unaware of his modality 
options due to the way in which the choice of dialysis treatments were presented to him by the 
medical team: 
 
“All they [renal staff] asked me if I wanted to do it at home. I said, I was thinking about that 
before whether I will have it home but I don’t think it’s a good idea.  From what I see down 
there in my experience, it’s best you have it in the hospital.  Now, when you having it home, 
are they going to have a nurse stay with you?  What I see at the moment, the best place is in 
the hospital.  You always have a nurse there, I mean two, three nurses there.” 
Lawrence, 76 years 
 
As this participant was aware of the existence of HD (possibly through witnessing it in the hospital 
environment), he assumed that this was the modality under discussion.  He therefore perceived he 
was being offered a choice of dialysis location as opposed to dialysis type.   
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A few participants feared having a treatment that involved blood and needles, based on negative life 
experiences.  This led the participants to select PD as opposed to HD: 
 
“No, not really [renal staff did not explain about the different dialysis modalities], because I said 
having peritoneal seemed absolutely wonderful to me, because there was no blood involved, 
you know, and it seemed the perfect answer. I’d never heard of it.” 
Daniel, 79 years 
This participant based his modality decision on an emotional response and consequently did not 
engage or was not provided with the information about the different treatments.  The reality of life 
on PD may outweigh the fear of blood and needles as was discovered by this same participant: 
 
 “No, *not disappointed at not being able to do PD+ because I found it such a nuisance.” 
Daniel, 79 years 
 
A few of the participants started dialysis unexpectedly, either soon after having seen a nephrologist 
for the first time or as an inpatient having been admitted for another condition (new stroke and 
pneumonia) or due to a sudden decline in renal function.  In all cases, dialysis was either completely 
unexpected or was started far in advance to when it was anticipated.  The experiences described by 
most of these participants reflected the urgency of starting dialysis:    
 
“And next thing was cut here and tube was hanging in and I said what is all this?  “Didn’t you 
know it’s a tessio line”, “what is tessio?” I don’t know what a tessio line. Nobody explained. 
Maybe I’m very ignorant, so I should have known all this, I don’t know.” 
          Selina 
 
The urgency to treat the participants not only curtailed the quality and quantity of information they 
received about the different modalities, but also sometimes came at the expense of knowledge 
about the technical details of their dialysis treatment.  Another participant was provided with a 
limited amount of information and was under time pressure to select a dialysis modality without an 
opportunity to discuss his concerns.  His decision was therefore based on this limited information:     
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“I didn’t like the idea of the fistula in the arm cos I thought it would stick out somewhere 
there and you would be catching it all the time and in the end I thought I don’t think I mind 
the stomach, I’ll have it done in the stomach you know? And that was it, we had to tell her 
*renal staff member+ straight away and it was booked and you had it done”.” 
Eric, 68 years 
 
One participant started dialysis unexpectedly yet had adequate time and information to consider her 
modality choices, during an inpatient three week stay around the time of starting dialysis:   
 
“A West Indian doctor, who explained everything [about dialysis], and left me for a day or 
two [in the hospital] to consider which one [dialysis modality] do I want.  While they were 
explaining to me, what they did was to leave me, go away and leave me. They explained to 
me that I can change my mind [about which dialysis modality to choose].” 
         Gladys, 68 years 
 
This section on medical influences illustrates the many ways in which the medical team can impact 
on the patients’ modality decision ranging from how information is provided, the time and 
opportunities available to reflect on this information, to the medical team deciding the optimum 
treatment modality on behalf of the patient.   
 
8.4.2 Social influences on modality selection  
Social influences on modality selection only occurred when patients were involved in their dialysis 
modality decision.  Family support was often cited as an important influence on modality selection, 
with some participants selecting a modality in line with the medical and/or emotional needs of their 
partner: 
 
“We’ve been together since 1945 which I think is 65 years and over that period a lot of the 
independence goes and we rely on each other very much. She’d rather I was on home 
dialysis so she hasn’t got these worrying waits on her own.” 
                                                                          Frank, 81 years 
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The ability to choose a home based dialysis modality, such as PD, was often dependent on whether 
the participants’ family could support them practically: 
 
“If I lived on my own, I couldn’t do it PD, seeing I’m on these *crutches+ permanently, I 
wouldn’t be able to lift the bags from out of that bedroom into that machine, not at all.”   
Deirdre, 70 years 
 
The technical and practical issues of undertaking PD, such as the space required for storage of 
equipment, meant that some participants found it difficult to obtain the necessary familial support 
to enable a choice of a home based dialysis modality: 
 
“You had to have so many *PD+ boxes that she *his wife+ thought it might interfere with her 
work [his wife worked from home], because we have a room dedicated to that and I think 
she was a bit concerned it might infringe on her work area.” 
                                                                        Michael, 70 years 
 
Furthermore, one participant chose not to undergo a home based dialysis modality because he felt 
fearful of not being able to undertake the treatment without medical support on hand:  
 
“I didn’t think I could have handled that *PD+ myself.” 
Douglas, 88 years 
 
For many participants, maintaining relationships and their lifestyle through hobbies and activities 
influenced which dialysis modality was selected:  
 
“We were both keen gardeners and greenhouse and all the rest of it, you know, and I 
thought well if I could have the dialysis during the night it would have freed me up to do all 
the things that I normally do during the day.” 
         Esther, 81 years 
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For some participants, preservation of lifestyle was associated with maximising time at home and 
minimising the time attending the hospital for treatment, which then influenced their modality: 
 
“I’m quite happy doing stuff at home, I have a wife who looks after me fantastically well and 
I’d much prefer to be able to do things at home rather than have to go to a hospital every 
alternate day and spend half a day there.” 
Vikram, 68 years    
 
Conversely, for other participants, preservation of lifestyle involved segregating the social 
environment (home) from the medical treatment (dialysis) environment:  
 
“I chose haemodialysis because it seemed to be quite straight forward and didn’t make any 
inconvenience to your lifestyle...it was like going to work in a sense. Three days a week I 
would be off.” 
                 Michael, 70 years 
 
Therefore, social factors are also influential in the dialysis modality decision process.  These social 
factors include considering the needs of family members, as well as the support they can provide to 
enable a home based dialysis treatment.  The participants were often observed to have selected 
treatments that would preserve their existing lifestyle, relationships and identity.   
 
8.4.3 Summary of part three 
Decisions about modality are influenced by medical as well as social factors.  The medical team had a 
strong input into dialysis selection and in several cases, appropriately so.  However, paternalistic 
decision making was observed with the medical team taking modality decisions on behalf of patients 
and limiting the patients’ ability to select the best treatment for their lifestyle.  This was rarely 
challenged by patients which may be illustrative of the older generation preferring to leave 
healthcare decisions to their medical team (Flynn et al. 2006; Orsino et al. 2003).  
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There was evidence that the medical team were attempting to involve patients in their modality 
decisions, yet failed to provide sufficient information, time or opportunities for discussion.  This lead 
to ill informed decisions being taken by the participants or the participants did not perceive they 
were being provided with a choice of modality.  Therefore the shared decision making approach was 
not always visible.  There were, however, instances where patients experienced shared decision 
making, although time before starting dialysis was needed to deliver this approach.  
 
The participants who perceived having some involvement in selecting a dialysis modality often based 
their decisions on social factors.  Modality selection was not viewed as an individual decision but one 
that encompassed the emotional relationships with family members and often depended on family 
support to enable a home based treatment.  Maintaining one’s lifestyle, whether this involved 
segregating dialysis from one’s home life or not, was also a major factor in modality selection.   
 
Finally, there appeared to be a disparity between the mainly technical information that was 
conveyed to patients during the education of treatment modalities (as illustrated in part two) and 
the predominantly social factors that patients based their modality decisions on.  In addition, outside 
of the forums of the group education seminars and the home visits, it is not clear how families were 
involved in learning about dialysis modality, except perhaps through the patient themselves.   
 
8.5 PART FOUR: “LIFE ON DIALYSIS” 
Part four focuses on the participants’ experiences of living with dialysis for approximately six 
months.  These can be divided into the participants’ initial experiences of starting on dialysis and the 
longer term impact of integrating dialysis into their lives.   
 
235 
 
8.5.1 Initial experiences of dialysis  
Dialysis was started unexpectedly, in some cases, as a result of medical urgency.  In these situations, 
participants found the initial experience of dialysing emotionally and physically overwhelming: 
 
“I was put on dialysis and when I saw the machine and the blood coming out, I was feeling 
sick, I was literally throwing up.  And every time dialysis started I used to put a patch on my 
face and not look at that because the blood was affecting me so much, then one of the girls 
next door she was on dialysis she says to me, no they are getting the blood out, purifying it, 
cleaning it and dirty blood is going out and all this. Then I started getting even blood clotting 
because my dialysis wasn’t working and I didn’t know about that so I had to go through 
learning lots of things, it was such a shock.” 
Selina 
 
Some of the participants, despite having had a planned dialysis start, expressed a lack of 
understanding about the technicalities of the treatment and a sense of “learning through 
experience”:  
 
“Nobody *renal staff+ didn’t tell me anything. All they say, you know, it’s *HD+ no problem, is 
just a motion or something. Nobody say this going to happen or that going to happen or 
anything. So there was nothing I was expecting.  As I said to you before, is only now I having 
it …I started to see certain system.” 
Lawrence, 76 years 
 
Some participants had their expectations of dialysis set by the medical staff, yet experienced a 
disjuncture between this information and their initial experiences of dialysis, such as concerning 
access formation:  
 
“*the consultant+ says, “just a walk in the park” he said for you having dialysis he said, “it’s 
nothing to worry about” you know so I thought when I was having the line put it bloody well 
is, you know, more than a walk in the park.” 
Andrea, 65 years 
 
The initial experiences of dialysis also affected partners with one feeling overwhelmed by the initial 
prospect of undertaking dialysis at home:  
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“I wanted to run out.  I wanted to run away. That’s what I wanted to do.” 
Eric’s partner 
 
Receiving a combination of informational resources such as educational materials, a visit to the HD 
unit and personal experiences of seeing others on dialysis appeared to prepare one participant for 
the dialysis procedure: 
 
“I had a trip to the hospital where they showed me the dialysis centre.  Previously I had been 
having iron injections so you sort of see the patients on the chairs or their beds anyway.  By 
the time I got there the people, the patients were already being dialysed so we didn’t stay 
very long, I didn’t talk to anybody but the nurse gave me some booklets and sort of went 
over things, so I quite knew what to expect.” 
Cybil, 72 years 
 
The initial experience of starting on dialysis appeared to be moderated by how extensively the 
participants have been educated or prepared for undertaking or undergoing the dialysis procedure 
itself.   
 
8.5.2 Longer term impact of living with dialysis 
This section reviews how patients managed their lives and identities on dialysis.  It also reports on 
the participants’ reflections of their dialysis modality decision processes. 
 
8.5.2.1 Integrating dialysis into everyday life and impact on identity 
A few participants described how dialysis had profoundly impacted on their lifestyle and their 
identity:  
 
“I go for dialysis three times a week and my life is totally changed, I can’t go anywhere, I 
have to be here to go three times a week if I don’t I am going to harm myself. Now I’m 
restricted I can’t travel...I used to be a fighter, I used to be a positive person, and I used to 
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do my work, housework, work outside and I had a responsible job. I used to take my car and 
just go anywhere. But since dialysis my confidence went down and I don’t believe in myself, I 
feel as though I am just no use now, I don’t go anywhere, I don’t do anything.” 
Selina 
 
The daily commitment of dialysis was found to restrict the lifestyle and identity of some participants, 
one of whom found these limitations affected her ability to perform her desired role within her 
family and pursuing her hobbies:   
 
“I find it really restricted. That after a certain time I have to be here *at home+, like my 
daughter was in the hospital last five, six days.  I found it really hard that I can’t sit with her 
all day.  So it means that I’m in there for a couple of hours and coming back here again and 
then turning back.  Another thing I was feeling that she needs me and I’m not there and 
she’s the youngest as well. So there are the things that really upset me quite a lot.  It’s very 
restricted for me to travel now which I loved and that really hurts me quite a lot, but even in 
the Europe, I still have to be a certain place a certain time to have my dialysis done, so this is 
the things that really hurts me, that this is the time I’ve got freedom now and my freedom is 
gone.” 
Anjali, 67 years  
 
Adapting to a life on dialysis for several participants was difficult, with one participant expressing 
thoughts of withdrawal from the dialysis treatment:  
 
“My worry is that I’m not going to be able to cope with it *dialysis+ and that I might need to 
discuss and talk about you know, how to end it.” 
         Michael, 70 years 
 
In addition to the various limitations that the dialysis treatment exerted on the participants 
lifestyles’ and the impact on their identities, one participant described the additional strain of being 
treated differently by his family and his community.  This change in the way he was perceived by 
those around him led to a diminishing of his social roles and responsibilities which greatly affected 
his sense of identity:  
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“Before even when I was not working, I was the head of the family.  Now, I am the one who 
my wife is taking care of so the head of the family changed. I was a responsible man. Even 
the children, they feel that I am nothing to them which I mean they will not respect me as 
they used to respect me. People used to come to me to ask me something, for my 
experience, for my knowledge, especially those people who came from where I came.  Now 
all these things gone.  Nobody is coming to me to ask me something.  I can tell you I am 
feeling, that I am hopeless.  Hopeless.  I am feeling that I am no more responsible for 
anything.” 
Asad, 65 years   
 
The difficulties in adjusting to living with dialysis could also have been mediated by the expectations 
patients had of their life once on dialysis, often set by the medical team:   
 
“*the renal staff+ do not tell you the truth.  Many of them have got stories to tell you about 
how much better people feel, you’re not going to have problems with eating and drinking 
and you can feel so much better. And you can’t because you can only go back to the 
condition that dialysis takes you, it doesn’t take you back to a better condition... I think an 
emphasis that you are going to be so much better is just false.” 
Michael, 70 years  
 
One participant, however, reflected on why he thought the medical staff provided this optimistic 
view of dialysis, but equally why this was misplaced because the information given failed to convey 
the real experience of dialysis: 
 
“I have to be honest, the people who telling these things [that he would feel better after 
being on dialysis for three months], they has an idea but they never gone on dialysis 
themselves.  So what they [are] telling you is only to give you a bit of courage.  You have to 
be in it to know it.” 
Lawrence, 76 years 
 
Inaccuracies and incompleteness of information provided by the medical team also contributed to a 
participant selecting a dialysis treatment that was unsuitable for his visual impairment and negated 
the participant’s desire to minimise any impact of the dialysis treatment on his partner:   
   
“If they’d had said to me, simple human things, that you gonna have about 18-19 inches of 
tubing which will have to be folded in a bow, and that your trousers won’t fit you anymore 
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and you’re gonna have a swollen stomach for a long time, that’s fine, but not to tell that my 
clothes are not gonna fit me so we’ve had to go out and buy two different sizes of trousers, 
you felt absolutely awful...I did stress to her, I wanna be able to do it myself, bearing in mind 
I am partially sighted right? I don’t want to tie my partner up in doing this.  Yes, yes, you’ll be 
able to manage, even a blind man can do it you know?  So on their reassurance of that I 
went ahead with this choice. Well it wasn’t the case.  I can’t read the scales to weigh the 
bags, I can’t see the bags to see if there is any fibres in the bags.  You gotta do your own 
blood pressure, I can see the blood pressure machine but I can’t read the scales on it.” 
Eric, 68 years 
 
The dialysis treatment, in this participant, dramatically affected his lifestyle, his relationship and his 
identity.  This participant recognises that he would have chosen HD had he been provided with 
further information about how PD would have affected his lifestyle, in addition to the technical 
aspects:      
 
“I’ve always been independent.  That is something that made me feel awful, that she’s *his 
partner] tied to me, you know and I am dependent, I am really dependent now on 
somebody.  I didn’t expect it.  I wish I’d had gone in for the fistula straight away cos it’s three 
days at the hospital and that gives you a few days off if you want to travel.” 
Eric, 69 years 
 
Other participants, however, managed to incorporate dialysis into their lifestyle by maintaining 
hobbies and activities in order to prolong their enjoyment in life.  The motivation for one participant 
to integrate dialysis into her life stemmed from a desire to remain active and to continue activities 
with her husband, whilst recognising the adaptations that she needed to make:   
 
“I’ve tried to maintain it *lifestyle+ as much as possible, but some things have had to go. I’m 
quite involved in the church I go to, which is a big church with a lot of activities on and I can’t 
go to anything on a Tuesday evening or a Thursday evening because of dialysis. But I like 
involvement, so as much as possible, I have tried to maintain going out and being involved 
with different things, partly because I don’t want to become a couch potato and partly for 
the sake of my husband too. We want to live life as much as we can.” 
Fiona 
 
Another participant recognised that his capabilities once on dialysis would be different to those prior 
to dialysis, yet he identified ways in which he could cope with this:  
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“When you go on dialysis, you know you are not going to feel like everybody else or like 
years ago, you accept that, but there’s not much that I can’t really do. I can tackle anything 
really, it's just going to take longer, you have to think differently and that’s it.”  
Aziz, 74 years 
 
Others simply expressed resignation to living on dialysis as there was a lack of alternatives available.  
This could possibly have been influenced by the participants’ culture: 
 
“We have our saying back in Caribbean, come what may.  As far as I concerned, come what 
may!  Nothing to worry about or anything, I just seek life as it is.” 
Lawrence, 76 years 
 
Some participants had the support of their friends and family who also adjusted to the participants’ 
living on dialysis:   
 
“All my friends know that I am on it, they don’t take no notice so it’s fine, my little grand daughter 
who is six, she says to me can I weigh it, she likes to weigh it, it’s quite sweet so I don’t take much 
notice of it really, you know I just get on with it.” 
Cathy, 68 years 
 
Seeing how other people have coped in dealing with adversities in life was seen to be a source of 
encouragement by some participants in managing their own lives on dialysis:   
 
“I think because my eldest granddaughter has got leukaemia.  She’s six now, so she’s only going up 
to the hospital now every six weeks, she’s only just got the three year bits and I sort of think well she 
copes so, that was worse than what I’ve got.” 
Cathy, 68 years 
 
Some participants spoke of how dialysis had positively enhanced certain aspects of their lifestyle 
through the enlargement of their social life (those on HD):   
 
“I love it *going to haemodialysis+.  We all meet down there and it’s like a mothers meeting 
isn’t it (laughs), well it’s almost like a new lease of life.  Crazy innit? I see it as ‘me time’ now 
going off and having a chat with all the guys (laughs).”   Esther, 81 years 
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8.5.3 Summary of part four 
The initial experiences of dialysis appeared to be directly influenced by the quality and quantity of 
education the participants and families received about the dialysis procedure itself.  Therefore, 
providing information on the technical aspects of dialysis greatly assisted patients in their 
preparation for the dialysis procedure, whether starting on HD or PD.     
 
The longer term impact of living on dialysis was variable.  The restrictions imposed by the dialysis 
regimen (PD as well as HD) affected some patients’ lifestyle by impacting on their ability to continue 
hobbies, activities as well as undertaking their social roles, which often contributed to their identity.  
In addition, patients experienced being treated differently by their families, friends and 
acquaintances in a way that reduced their social standing with their family and community, again 
impacting significantly on their identity.  Expectations of treatment, as relayed by some renal staff, 
could be misleading, thereby ill preparing the participants for the realities of life on dialysis as well as 
life on particular dialysis modalities.  Lack of preparation for and misleading expectations of dialysis 
were largely responsible for some participants feeling that they could not continue their current 
existence on dialysis.   
 
Other participants, however, integrated dialysis into their lives through revised expectations of how 
they would manage their lives on dialysis or resorted to their cultural upbringing to integrate dialysis 
into their lives.  
  
This part therefore demonstrates that patients who are prepared, through the provision of timely 
and comprehensive information that is not misleading, for the dialysis procedure as well as the 
longer term consequences of the treatment on lifestyle, relationships and roles, are more likely to 
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integrate dialysis into their lives and identity.  Appropriate support and involvement in modality 
decision making can assist patients in selecting the dialysis modality that is of best fit for them.   
 
8.6 DISCUSSION  
The original aims of this study were to explore modality decision making as an evolving process and 
to determine the social and medical factors that shaped how participants chose their dialysis 
modality and how participants managed dialysis within their lives.  The following will discuss the 
findings with reference to these aims.   
 
Dialysis modality decision making was observed to be a process where preconceptions about dialysis 
treatments were formed, in some cases decades prior to the diagnosis of ESRD.  Although several 
participants had little knowledge about renal disease, some participants had envisaged how their 
lives would be on dialysis by referencing their existing knowledge and past experiences, such as 
seeing or knowing others on dialysis within and outside of the hospital setting, as well as through 
fragments of information obtained from the media.  These often negative perceptions of life on 
dialysis served to threaten the participants’ sense of identity and overwhelmingly highlighted the 
existence of HD rather than PD.   
 
Currently, modality education is not adequately available to all patients.  This is supported by 
evidence presented of participants starting on HD without an awareness of the existence of PD and 
equally participants on PD having a distorted view of life on HD.  These perceptions can, however, be 
counteracted through comprehensive education, thus influencing the course of the modality 
decision.   
 
243 
 
The influence of family on modality decisions is complex with this BOLDE study highlighting how the 
dynamics of the relationship between patient and partner, can support or dissuade the participant 
from undertaking a particular form of dialysis.  Therefore, the family and partners who support the 
patient (financially, emotionally or physically) should be formally involved in the modality education.  
Currently, it is difficult to ascertain when and how this occurs, aside from the opportunities to attend 
a group education seminar or through a home visit, events that were not available to all patients, let 
alone to their families and partners.   
 
Modality decisions were considerably influenced by medical factors.  Renal staff were perceived to 
present heavily weighted choices, make decisions on behalf of the participants, provide incomplete 
information on dialysis options and provide little opportunity for discussion to clarify 
misconceptions.  These interactions with the renal team highlighted the perpetuation, in some 
instances, of the paternalistic model of medical decision making.  The group education seminars 
amongst the units were also variable in quality and quantity, with a focus on the technical aspects of 
treatment delivery rather than the practicalities of living and adapting to a life on dialysis.  The group 
education seminars were delivered mostly in an informative style with little reflection whether this 
information was being understood by patients and their families and/or partners.  This qualitative 
study demonstrated that the renal staff did attempt to share and involve patients in their modality 
decisions, but the process was not successful with some participants questioning the veracity of the 
information received from healthcare professionals due to the disparity between participants’ 
expectations and the lived experience on dialysis.  This suggests that implementing shared decision 
making is not straightforward, with a “gap between aspiration and reality” (Marshall and Bibby 
2011) and is likely to be more complex than solely meeting the four principles highlighted by Charles 
et al: 
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 “Shared decision-making involves at least two participants – the physician and patient. 
Both parties (physicians and patients) take steps to participate in the process of treatment 
decision making. 
Information sharing is a prerequisite to shared decision-making. 
A treatment decision is made and both parties agree to the decision.”  (Charles et al. 1997) 
 
The evidence provided within this thesis illustrates that patient decisions are made incrementally 
over time and are influenced by their social and medical context, emotional relationships, 
experiences and culture.  Therefore, shared decision making involves more than establishing the 
procedure between the patient and the physician.  It is a process that involves considering the 
individual patient and their context to enable them to select a treatment that can be incorporated 
with the least disruption into their life and identity using the medical education and information 
they are provided with.   
 
Therefore, patients would benefit from modality education that addresses their existing 
preconceptions of dialysis, explores the needs within patients’ social networks, provides timely and 
quality information that is delivered without bias and provides opportunities for the patient to 
discuss their thoughts and feelings about the various treatment options.  The provision of unbiased 
information is especially pertinent to older people, some of whom expressed deference to the 
opinion of medical staff, even when this opinion was in reference to the participants’ presumed 
quality of life as opposed to expert clinical opinions.   
 
The question of what equates to “quality information” was raised through the narratives and the 
observations.  Participants were mostly concerned with how each dialysis modality would impact on 
their lifestyle, relationships and consequently identity.  Yet, the group education seminars 
predominantly focused on providing information about the technicalities of dialysis, with little 
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balanced (if any) information provided on how dialysis can be integrated into ones’ lifestyle and 
identity.   
 
The integration of dialysis into the lives of these older participants was explored once dialysis had 
started.  Some participants found their identity to be severely affected.  This was found to be due to 
the restrictions imposed by the dialysis treatment, a fall in their social standing due to the changes in 
the way patients were treated by family, friends and acquaintances and due to the information 
patients received from some renal staff which encouraged an overoptimistic view of life on dialysis.  
This latter reason simply underprepared participants for their upcoming reality of living on dialysis.  
Several participants managed, however, to incorporate the restrictiveness of the dialysis routine into 
their lives using coping and adaptation skills.  These skills appeared to originate from the 
participants’ cultural upbringing as well as through seeing others managing their lives on dialysis or 
having themselves coped with other adversities in life.  It was also observed that those participants 
who had not yet integrated dialysis into their life were either patients who were prevented from 
being involved in their dialysis modality selection or were patients who were lead to believe their life 
would be better on dialysis compared to that which was experienced (as implied by comments made 
by the healthcare team).  Therefore, integrating dialysis into ones’ life and ones’ identity, appears to 
involve a degree of adaptation, whether this be psychologically or through adjustments to lifestyle.  
This process of “redefining of self” when patients start on dialysis is not a new concept and is 
comprehensively described by Gregory et al (Gregory et al. 1998).  What is new is establishing that 
quality modality education and effective shared decision making can influence this “redefining of 
self” process.   
 
These issues highlight that the healthcare system has built a service that has neglected the patient 
perspective in how they are involved in medical decisions and their resulting social and psychological 
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well-being.  The health service focuses on clinical well-being by ensuring that patients who need 
dialysis, receive dialysis.  However, this study also observed how clinical well-being was 
compromised with a few participants experiencing referral delays into specialist nephrological 
services.  Social and psychological well-being can therefore be improved by ensuring that dialysis 
modality education is accessible to all patients (regardless of the timing of their dialysis start) and is 
delivered in a timely manner.  It should also address the patients’ contextual issues surrounding 
existing knowledge of treatment options, the patients’ social context and should provide the 
technical modality details in addition to information and examples of how to incorporate dialysis 
into ones’ life.  Having such a dialysis modality education system that meets the needs of patients, 
could also set a positive example to healthcare professionals on how to incorporate shared decision 
making into their clinical practice.   
   
This study, however, does leave some questions unanswered.  Although appropriate educational 
support about dialysis options is likely to help patients adapt to living on dialysis, there is still some 
uncertainty about how to manage those patients who prefer to delegate their decision making to 
others.  Laine and Davidoff propose that this preference can be supported by informing the patient 
that their modality decision will have lifestyle implications that the medical team are ill placed to 
advise on (Laine & Davidoff 1996).  Therefore, an active discourse with a patient may be all that is 
required to ensure that they are aware of the consequences of relinquishing their role in 
participating in the treatment decision.  
 
There were limitations to the current study.  The experiences of those who started dialysis 
unexpectedly were possibly under-represented in this sample.  There was also limited scope to 
explore how ethnic background and culture influences the decision making process as well as the 
integration of dialysis into ones’ life.  Nonetheless, a wide spread of experiences was obtained.   
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Modality decision making is therefore far more intricate than simply the weighing up of the 
perceived advantages and disadvantages of each modality treatment.  It is a process that begins 
early on in the patients’ renal journey and is influenced by several contextual factors such as 
speaking to or seeing peers on dialysis, modality education, interactions with the medical team, 
family needs and medical suitability.  Supporting patients’ involvement, through education, in their 
dialysis modality decisions can help older patients maintain or minimise the impact of dialysis 
treatment on critical aspects of their identity, such as social roles within and external to the home 
and ability to continue activities that bring the patient pleasure and meaning.  Therefore, the 
implementation of quality education and shared dialysis modality decision making can minimise the 
“biographical disruptions” that dialysis may confer onto a patient and is therefore an important and 
ethical imperative.   
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CHAPTER NINE 
9 CONCLUSIONS AND FUTURE WORK 
 
This thesis sets out to quantify and compare the quality of life outcomes in older people on HD and 
PD, to understand the extent to which older people are being involved in their dialysis modality 
decisions, to explore what influences the dialysis modality decision making process and how these 
influences can impact on patients’ experiences of living with dialysis.  This chapter aims to provide 
an overview of the findings as well as suggestions of areas for future research.   
 
The first study within this thesis found that older people on PD have a quality of life that is 
comparable, if not better than that of older people on HD (depending on the measure used).  The 
sample was predominantly composed of participants of a White or European ethnic background and 
the participants were able to complete time consuming questionnaires.  The sample may not have 
included representation from the frailer and older dialysis population.  Nonetheless, the finding 
taken together with existing survival data, confirmed that all older people approaching dialysis (or 
indeed those patients who have recently started on the treatment), in the absence of medical or 
social reasons, should be offered a choice of dialysis modality.  UK data from recent years has, 
however, indicated a decline of the numbers of people on PD aged ≥ 65 years, suggesting that 
dialysis modality distribution may be influenced by other factors aside from patient choice.  These 
suspicions were confirmed in the second study of this thesis through a questionnaire to older 
patients new to HD which highlighted that half of the sample was not involved in their dialysis 
modality decision.  The findings hinted that the hospital environment may, somehow, be influencing 
the extent to which patients were involved in their modality decisions.  It was also found that older 
people may have a propensity to experience mental or physical limitations to learning about dialysis 
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modalities.  This study led to the question of whether the current modality education system met 
the needs of the older person.   
 
The design of this questionnaire study limited the collection of information from which the findings 
could be interpreted and understood.  This led to the third and final study focusing on qualitative 
methods to explore, in-depth, the retrospective dialysis decision making experiences of 30 older 
people living on either PD or HD.  It also explored their current experiences of living on dialysis.   
 
The qualitative study found that many of the participants were either not involved in their modality 
decisions or did not perceive themselves to be involved, suggesting that paternalistic decisions by 
healthcare professionals are still occurring.  The study also highlighted the deficiencies in the way 
older people are educated about their modality choices and the influence that healthcare 
professionals have on patients’ modality decisions.  The participants were observed to make 
modality decisions based on information drawn from their social, cultural and medical contexts over 
time, which together built up perceptions of what they envisaged their life would be on each form of 
dialysis treatment.   
 
The qualitative study also explored the impact of the process of modality decision making on how 
older patients integrated dialysis into their lives.  Incorporating dialysis into ones’ life involves having 
the resources to know how to adapt hobbies and activities, manage relationships and adjust identity 
to the restrictions that dialysis brings with it.  These resources were seen to originate from the 
patients’ cultural background, from support provided by close family but also through patients being 
prepared for how dialysis would impact on their lives.  Educating patients on both the technicalities 
of each dialysis modality and on how each modality would affect their lives, can enable them to 
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select the dialysis modality that would best integrate with their identity, maximising their social and 
psychological well-being once on dialysis.       
 
Therefore, the implementation of effective shared decision making together with comprehensive 
modality education on the different dialysis modality options can indeed broaden the dialysis 
options for long-term dialysis in the elderly. 
 
Future work should focus on how to support shared decision making in clinical practice, as there are 
several areas that would benefit from improvement.  This can be achieved by assessing the 
effectiveness of implementing broad based as well as targeted interventions (such as educational 
tools or decision aids) to support patients in making their dialysis modality decision.  In fact, the 
BOLDE project is currently in the process of evaluating the impact of a DVD on older patients’ 
desired level of involvement in the modality decision making process.  The DVD features six older 
patients and their experiences of living on different configurations of PD and HD.  The DVD aims to 
present examples of how older patients have adapted their lives to living with their particular 
dialysis modality and, thereby, providing the information that has been found to be lacking from 
group education seminars.  It also aims to present a balanced view of all the different treatment 
options available.  In addition, a modality decision aid is currently under development which will 
contribute to increasing patients’ awareness and understanding of the different types of modality 
treatments available and how these treatments can impact on patients’ lives.   
 
The success of these interventional tools is, however, dependent on how their use is supported by 
healthcare professionals.  The BOLDE qualitative study raised several concerns regarding the 
opinions that healthcare professionals present to patients regarding their modality decisions.  There 
are indications of bias towards different modality options, accounts of patients not having received 
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appropriate information and some examples where the role of the healthcare professional extended 
beyond that of providing medical expertise, to the provision of judgements about the quality of life 
of the patient.  Further qualitative research could uncover the thoughts and opinions of 
nephrologists and other renal staff in relation to patients’ modality decision making processes.  This 
may highlight not only the service related barriers to delivering shared decision making (such as 
time) but the perceptions of its uses and benefits, as well as the confidence and knowledge 
healthcare professionals have in participating in shared decision making.   
 
Given the findings in this thesis, it is reasonable to assert that effective shared decision making in 
modality decisions can lead to improved quality of life outcomes, possibly with the result of fewer 
symptoms of depression, although this remains to be confirmed through empirical studies. It is also 
uncertain whether shared modality decision making results in the improvement of “hard” outcomes 
such as adherence to medication and other treatment plans which could lead to, for example, an 
improvement in morbidity and mortality.  These areas would merit further exploration in how 
involvement in dialysis modality decisions can result in improved patient outcomes (clinical as well 
as social and psychological well-being).   
 
It is likely that the influences on younger peoples’ modality selection and how they integrate dialysis 
in their lives are different to those used by older people.  This area, therefore, also deserves further 
study to help improve quality of life outcomes in younger people on dialysis.     
 
Finally, involving older people in their dialysis modality decisions through effective shared decision 
making could alter the current distribution of older people being dialysed with HD and PD in the UK.  
The increasing use of assisted PD is now opening up a further treatment option aimed at frailer 
patients who would have been deemed unsuitable for PD in the absence of an existing support 
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network at home who could perform the treatment for the patient.  It is anticipated that effective 
shared decision making may promote a higher uptake of PD as well as other home based dialysis 
treatments.  This is also likely to translate into cost savings for the NHS as treatments that can be 
managed within the home, such as home HD, CAPD, APD and assisted APD where available, are 
thought to be a lower cost alternative to in-centre HD.  Therefore, a comprehensive study on the 
cost-effectiveness of implementing shared decision making would have the potential to provide 
evidence for significant cost savings for the NHS.    
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11 APPENDICES 
11.1 HRQOL ASSESSMENT TOOLS 
11.1.1 SF-12 v2 
Your Health and Well-Being 
This survey asks for your views about your health.  For each of the following questions, please mark 
an ‘X’ in the one box that best describes your answer.   
 
1. In general, would you say your health is: 
Excellent    Very Good  Good  Fair  Poor 
    □        □       □       □       □ 
2. The following questions are about activities you might do during a typical day. Does your health now 
limit you in these activities? If so, how much? 
  Yes, limited 
a lot 
Yes, limited 
a little 
No, not 
limited at all 
a Moderate activities, such as moving a table, pushing a 
vacuum cleaner, bowling, or playing golf 
    □   □  □ 
b Climbing several flights of stairs     □   □  □ 
 
3. During the past 4 weeks, how much of the time have you had any of the following problems with 
your work or other regular daily activities as a result of your physical health? 
  All of the 
time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None of 
the time 
a Accomplished less than you would 
like 
 □  □  □  □  □ 
b Were limited in the kind of work or 
other activities 
 □  □  □  □  □ 
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4. During the past 4 weeks, how much of the time have you had any of the following problems with 
your work or other regular daily activities as a result of any emotional problems (such as feeling 
depressed or anxious)? 
  All of the 
time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None of 
the time 
a Accomplished less than you would 
like 
 □  □  □  □  □ 
b Did work or activities less carefully 
than usual 
 □  □  □  □  □ 
 
5. During the past 4 weeks, how much did pain interfere with your normal work (including both work 
outside the home and housework)? 
Not at all  A little bit     Moderately     Quite a bit     Extremely 
    □          □       □           □       □ 
6.   These questions are about how you feel and how things have been with you during the past 4 
weeks.  For each question, please give the one answer that comes closest to the way you have been 
feeling.  How much of the time during the past 4 weeks… 
  All of the 
time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None of 
the time 
a Have you felt calm and peaceful?  □  □  □  □  □ 
b Did you have a lot of energy?  □  □  □  □  □ 
c Have you felt downhearted and 
depressed? 
 □  □  □  □  □ 
 
7. During the past 4 weeks, how much of the time has your physical health or emotional problems 
interfered with your social activities (like visiting friends, relatives, etc)? 
All of the time Most of the time Some of the time A little of the time None of the time 
   □    □    □   □    □ 
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11.1.2 Illness Intrusiveness Ratings Scale 
 The following items ask about how much your illness and/or its treatment interfere 
with different aspects of your life.   
 PLEASE CIRCLE THE ONE NUMBER THAT BEST DESCRIBES YOUR CURRENT LIFE 
SITUATION.   
 If an item is not applicable, please circle the number “1” to indicate that this aspect of 
your life is not affected very much. Please do not leave any item unanswered.   
How much does your illness and/or its treatment interfere with your: 
1 HEALTH 
 Not very much 1 2 3 4 5 6 7 Very much  
2 DIET (i.e. the things you eat and drink) 
 Not very much 1 2 3 4 5 6 7 Very much  
3 WORK 
 Not very much 1 2 3 4 5 6 7 Very much  
4 ACTIVE RECREATION (e.g. sports) 
 Not very much 1 2 3 4 5 6 7 Very much  
5 PASSIVE RECREATION (e.g. reading, listening to music) 
 Not very much 1 2 3 4 5 6 7 Very much  
6 FINANCIAL SITUATION 
 Not very much 1 2 3 4 5 6 7 Very much  
7 RELATIONSHIP WITH YOUR SPOUSE OR PARTNER 
 Not very much 1 2 3 4 5 6 7 Very much  
8 SEX LIFE 
 Not very much 1 2 3 4 5 6 7 Very much  
9 FAMILY RELATIONS 
 Not very much 1 2 3 4 5 6 7 Very much  
10 OTHER SOCIAL RELATIONS 
 Not very much 1 2 3 4 5 6 7 Very much  
11 SELF-EXPRESSION/SELF-IMPROVEMENT 
 Not very much 1 2 3 4 5 6 7 Very much  
12 RELIGIOUS EXPRESSION 
 Not very much 1 2 3 4 5 6 7 Very much  
13 COMMUNITY AND CIVIC INVOLVEMENT 
 Not very much 1 2 3 4 5 6 7 Very much  
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11.1.3 Symptom assessment tool 
For each symptom below, could you please place an X against the most appropriate box for severity 
and frequency 
Symptom Severity   Frequency  
Pain in joints None  Never  
Mild  Once a week or less  
Moderate  More than once a week   
Severe  Every day  
Blurred vision None  Never  
Mild  Once a week or less  
Moderate  More than once a week  
Severe  Every day  
Weakness of limbs None  Never  
Mild  Once a week or less  
Moderate  More than once a week  
Severe  Every day  
Headaches None  Never  
Mild  Once a week or less  
Moderate  More than once a week  
Severe  Every day  
Light-headedness or  
Dizziness 
None  Never  
Mild  Once a week or less  
Moderate  More than once a week  
Severe  Every day  
Cold hands and feet None  Never  
Mild  Once a week or less  
Moderate  More than once a week  
Severe  Every day  
Cramps in legs None  Never  
Mild  Once a week or less  
Moderate  More than once a week  
Severe  Every day  
Shortness of breath None  Never  
Mild  Once a week or less  
Moderate  More than once a week  
Severe  Every day  
Continues on next page 
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Page 2 of Symptom assessment tool 
Symptom Severity   Frequency  
Unsteadiness None  Never  
Mild  Once a week or less  
Moderate  More than once a week   
Severe  Every day  
Dry mouth None  Never  
Mild  Once a week or less  
Moderate  More than once a week  
Severe  Every day  
Sleep problems None  Never  
Mild  Once a week or less  
Moderate  More than once a week  
Severe  Every day  
Swelling of legs None  Never  
Mild  Once a week or less  
Moderate  More than once a week  
Severe  Every day  
Nausea None  Never  
Mild  Once a week or less  
Moderate  More than once a week  
Severe  Every day  
Itching None  Never  
Mild  Once a week or less  
Moderate  More than once a week  
Severe  Every day  
Lack of energy None  Never  
Mild  Once a week or less  
Moderate  More than once a week  
Severe  Every day  
Taste changes None  Never  
Mild  Once a week or less  
Moderate  More than once a week  
Severe  Every day  
THANK YOU VERY MUCH FOR COMPLETING THE QUESTIONNAIRE 
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11.1.4 Hospital Anxiety and Depression Scale 
This questionnaire is designed to help your doctor to know how you feel.  Read each item and place 
a firm tick in the box opposite the reply, which comes closest to how you have been feeling in the 
past week.  Don’t take too long over your replies; your immediate reaction to each item will 
probably be more accurate than a long thought-out response.  Tick only one box in each section 
1. I feel tense or ‘wound up’:  8  I feel as if I am slowed down:  
 Most of the time   Nearly all the time  
 A lot of the time   Very often  
 Time to time, occasionally   Sometimes  
 Not at all   Not at all  
2.  I still enjoy the things I used to enjoy:  9  I get a sort of frightened feeling like 
“butterflies” in the stomach: 
 
 Definitely as much   Not at all  
 Not quite so much   Occasionally  
 Only a little    Quite often  
 Hardly at all   Very often  
3.  I get a sort of frightened feeling as if 
something awful is about to happen: 
 10.  I have lost interest in my appearance:  
 Very definitely and quite badly   Definitely  
 Yes, but not too badly   I don’t take so much care as I should  
 A little, but it doesn’t worry me   I may not take quite as much care   
 Not at all   I take just as much care as ever  
4.  I can laugh and see the funny side of things:  11. I feel restless as if I have to be on the 
move: 
 
 As much as I always could   Very much indeed  
 Not quite so much now   Quite a lot  
 Definitely not so much now   Not very much   
 Not at all   Not at all  
5.  Worrying thoughts go through my mind:  12. I look forward with enjoyment to 
things: 
 
 A great deal of the time   As much as I ever did  
 A lot of the time   Rather less than I used to  
 From time to time bur not too often   Definitely less than I used to  
 Only occasionally   Hardly at all  
6.  I feel cheerful  13. I get sudden feelings of panic:  
 Not at all   Very often indeed  
 Not often   Quite often  
 Sometimes   Not very often  
 Most of the time   Not at all  
7.  I can sit at ease and feel relaxed:  14. I can enjoy a good book or radio or TV 
programme: 
 
 Definitely   Often  
 Usually   Sometimes  
 Not often   Not often  
 Not at all   Very seldom  
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11.1.5 Mini-Mental State Examination 
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11.1.6 Trail Making Test-B 
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11.1.7 Social networks questionnaire 
 Please answer all the questions below, by placing a ‘X’ in the box beside the answer the best 
describes your response.   
 There are no ‘right’ or ‘wrong’ answers, so please just choose the answer that best fits your 
own personal experience 
1 Who normally lives at home with 
you? 
I live with my spouse 2 
I live with my family 2 
I live with a carer 1 
I live alone 0 
2 Does anyone else in the family 
live close to your home? 
My children 1 
Another relative 1 
None of the family 0 
3 Do you have a circle of friends? Yes, a large circle 2 
Yes, a small circle 1 
No, not many friends 0 
4 Considering the people living with 
you, do you think any of them 
understand your illness and the 
dialysis? 
Yes, they understand well 2 
Yes, they understand a little 1 
No, they don’t understand 0 
I live on my own 0 
5 If you have to come into hospital 
(other than to dialyse), who 
would you normally expect to 
visit you? 
Several family members and/or friends 2 
One or two family members and/or friends 1 
Nobody 
0 
6 When you have a problem with 
your illness, who can you turn to 
for help or support? 
Several family members and/or friends 2 
One or two family members and/or friends 1 
A Doctor or nurse 1 
Nobody 0 
7 Who would turn to you for help 
or support if they became ill? 
Several family members and/or friends 2 
One or two family members and/or friends 1 
Nobody 0 
8 If you receive some good news, 
with whom would you normally 
share this? 
Several family members and/or friends 2 
One or two family members and/or friends 1 
Nobody 0 
9 Who would come to you with 
their good news? 
Several family members and/or friends 2 
One or two family members and/or friends 1 
Nobody 0 
10 If you felt generally fed up and 
miserable, who would you turn to 
for support? 
Several family members and/or friends 2 
One or two family members and/or friends 1 
Nobody 0 
11 Who would turn to you for 
support if they felt fed up and 
miserable? 
Several family members and/or friends 2 
One or two family members and/or friends 1 
Nobody 0 
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11.1.8 Subjective Global Assessment (7 point) 
Assessments Factors Response Grading SGA 1-7 
1a. Weight Dry weight 6/12 ago  
7 = stable 
6 = recent decrease  
5 = >5-6% 
4 = 7-8% 
3 = 9-10%  
2 = 10% + recent 
stabilization or minimal 
improvement  
1= long term 
 
Current dry wt  
Weight change in 6/12  
% weight change  
1b. Weight change 
 
Over last 2 weeks (no 
change, increase or 
decrease) 
  
2. Dietary intake Adequate  
(meeting reqs) 
 
 
 
 7 = usual/adequate  
6 = recent, short term 
decrease  
5 = sustained decrease, 
but usually adequate  
4 = sustained decrease, 
off and on adequate  
3 = sustained decrease, 
variable, but occasionally 
adequate  
2 = sustained decrease, 
variable but mostly poor  
1 = sustained decrease, 
very poor intake  
 
Inadequate (not meeting 
reqs for>2/52) 
 
 
 
 
Poor (poor intake for 
>2/52) 
 
 
 
3. Gastrointestinal 
symptoms.  Choose 
between: never; 
daily; 2-3xweek; 
1-2xweek;less than 
every 2 weeks; once 
every 1-2 weeks 
None 
 
 7 = no symptoms 
6 = few or uncommon  
5 = 1 or more symptom, 
not every day  
4 = >1 symptom, almost 
daily  
3 = most symptoms are 
present, almost daily  
2 = all symptoms are 
present, almost daily  
1 = all symptoms are 
present, daily  
 
Anorexia 
 
 
Nausea 
 
 
 
Vomiting 
 
 
 
Diarrhoea  
4.Functional 
capacity 
No dysfunction 
 
 6-7 = "usual" for patient 
or not related to 
nutrition  
3-4-5 = lower than usual 
or recent change related 
to nutrition i.e.muscle 
wasting, lack of energy  
2 = mostly bed/chair-
ridden related to 
nutrition  
1 = bedridden, unable to 
perform activities of daily 
living  
 
Change in function 
 
 
Difficulty with ambulation 
 
 
Difficulty with activity 
 
 
Light activity 
 
 
Bed/chair ridden with little 
or no activity  
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5a.  Disease state/  
comorbities related 
to nutritional needs 
Primary diagnosis  6-7 = nothing more than 
renal disease  
4-5 = co-morbid diseases 
such as frequent 
infections, 
 fever, peritonitis, brittle 
diabetes  
1-2-3 = severe such as 
ulcerative colitis with 
diarrhea  
 
Comorbidities  
Normal requirements  
Increased requirements  
Decreased requirements  
Acute metabolic 
stress 
  
  
  
None  
Low  
Moderate  
High 
 
6. Physical exam Below eye 
  
 6-7 = slightly bulged fat 
pads 
3-4-5 = slight depression 
1-2 = hollow look, 
depression, dark circles, 
loose skin 
 
Subcutaneous fat 
  
Muscle wasting 
  
  
Temple  
(Observe straight on, have 
patient turn head side to 
side) 
 6-7 = well defined muscle 
3-4-5 = slight depression 
1-2 = hollowing, 
depression 
Interosseous muscle  
(Back of hand, 
move thumb and 
forefinger back/forth) 
 6-7 = muscle protrudes, 
could be flat in well 
nourished 
3-4-5 = slightly depressed 
or flat 
1-2 = flat or depressed 
area between thumb & 
forefinger 
Overall SGA rating Scoring  6-7 most 
categories/significant, 
continued improvement 
3-5 no clear sign of 
normal status or severe 
malnutrition 
1-2 most categories or 
significant physical signs 
malnutrition 
 
Very mild risk/well 
nourished 6 to 7 
Mild-moderate 3 to 5 
Severely 
malnourished 
1 to 2 
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11.1.9 Stoke Comorbidity Score  
(as cited in Davies et al, 2002)  
Comorbid domain Details of domain 
Malignancy Active, non-cutaneous disease e.g. myeloma, breast cancer 
Ischaemic heart disease As evidenced by previous myocardial infarction, angina 
pectoris, positive coronary angiography or other diagnostic 
procedure (e.g. exercise test, thallium or dobutamine stress 
test) or the presence of ischaemic changes on the resting ECG 
(as distinct from left ventricular hypertrophy). 
Peripheral vascular disease To include distal aortic, renovascular, lower limb and 
cerebrovascular disease. Includes either symptomatic disease 
in these vascular territories (e.g. CVA, claudication, 
amputation) or significant stenoses (>50%) on vascular imaging 
or Doppler ultrasound.   
Left ventricular dysfunction Defined as clinical evidence of pulmonary oedema, not 
attributable to errors in fluid balance, and/or moderate to 
severe left ventricular dysfunction on echocardiography. 
Diabetes mellitus Type I or Type II. 
Systemic collagen vascular disease For example, systemic vasculitis, rheumatoid arthritis and 
systemic sclerosis, either active or requiring treatment. 
Other significant pathology A condition severe enough to have an impact on survival in the 
general population. Examples include: severe chronic 
obstructive airways disease, cirrhosis, psychotic illness. 
Treatable conditions (e.g. peptic ulceration) or non-life 
threatening diseases such as severe osteoarthritis would be 
excluded.   
Scoring 
 The Stoke Comorbidity score corresponds to the number of domains affected and therefore can 
range from 0 to 7.   
 The grade of comorbidity is derived from the above score:   
o Low risk/grade 0= zero score 
o Medium risk/ grade 1= score of 1 to 2 
o High risk/ grade 2= score of ≥ 3 
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11.3 ETHICAL APPROVAL LETTERS 
11.3.1 Chapter four:  “Comparison of HRQOL in older people on PD and HD” 
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11.3.2 Chapter five: “Older patients’ involvement in HD selection”  
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11.3.3 Chapter six to eight: “Qualitative evaluation of decision making in older people”  
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11.4 CHAPTER FIVE STRUCTURED MODALITY DECISION MAKING QUESTIONNAIRE 
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11.5 THE ILLNESS NARRATIVE TOPIC GUIDE 
 
